niper placement brochure 2011
TRANSCRIPT
������������� ��� � � ���������������������������������������������� !"�����!��#����������� !�$�%���� �&��!"��'�(�����������)�*��+�
������������������������ ������������������������ ���������� �������������������� �������� ������������������ ����������������� ������������������������������ !"�# � � $ % &#��$%'#���������(� �����
��������������������� ��� ���������� ������������������������������������ �������������������������������������������������������������������������������� ����������� ������������������ ����� ����������������� ������������!� ������"��� ! #���������������� �������������$����� !�%&�����'���� �������������� ��'�� ����������� �������������� �'���������������'������($)$���������� !*�+�������&�����'��$��������������',���������������� ! �� �������������������������� ������ � ��������������� � ������������ ������'������������������������ ��������� ����������������������������'������������������������ � ������������������������������������� $��� !%�&�����'���� ������������ ������($)$�������� !*�+�������������� ��� ������������������������������"*������������������������#�-��� �����$�� !*�+�������� ������������������������������ �������������������� !%.&.�������/$.$�"�����$#���������� ������� !%&�����'���-����� ����� ���'��������0%��11����������� ������ !*2 � ����������� $��������������� ��������'����������� ������� �������������������������� ����� �������������������������������������������������������������$����� ����������������������� ����� ���������������-�������������������� ',��� �-�����������������'������ ����� $������ ����'���������� !�&�����'�������������������� �������� ������������� ����������������������� �������� ����� �������� ������� ������������'����$��� ����������� ���������� �� �������������������������� �����������������$3456789:7;<4:=854>?7;:?@ ���,����*���������� !�&�����'��;4A7B::8C7D94<EC?8CEC F
������������ ��� �������� �� ���� �� � ������� ������� �� ���������������� ������������ ������ �� � ��� ! �� �� �"���� ������� �� ��������������� �� ��"���� #�$� %������& "������ $����� �� �������� �� ������ ������ ������� ������ �� � � �����" ���������� %������'��& ����"� �( ���������������� �� �� ���� � ��� �� �� �� � "������ ���� �� ������ �� �� ���� ���"� �� ��� (�� ���� ��� #�$� %������& ������� �� ������� ����"��) *���"������( �� ������"���"� �� � �� ��� �������� �� �� ������( ��� ���� ��"��� �� ��( ���� � "�� ����� ���� "���� ���� �� '��) ��++�$����� �� �����) ������ ��� ��� ������� ����( "�����) ��"��"���) ���������� �� �������� �������� ����� ���� ��,"� ���- �� ���. ��� ����� �"������� �� �� "��� ���� �� ���� ����"� � "����/������ 0� "����"���� �� �(������ �� �����) ������ ��� �� ���� - ��� �� ��� �� � "������� �� �������� �����"���"�� ��������) �"���� �� ��������( ����� � �(� ����� �� ����������� �� ������"���"�� $"��"� �� 0"������( ��� ���� ������/ ����� �� "����� �"���" ������ �� ����� �� ����� ������ �� �"������" "�������( �� � "����� ������� �� ��"��� �� ���� "����� ���� �� ��� �� ����"� ���� "���"� �� ��� ��"���( �� ��� ���� � �����( ���� ���� ��� ������ �� ��� ����� �� ����� �( ��� ��"���( ����� �� �"������� �� *�1� ���� ���. ���� �� �� �� � "������� �� ���� ����� � ��(���� "������( ����� �� �!. ������/������ �� ����� ������( �� ����� ����� ������) "���"� "�� �� �������� �� ���� ������� � ��������� �� �� ������ �������� ���� ��� ��������� ������ ��� ��"- �� ��� ����� ��� ���� ����� ��������234567896:9;743 .��"���*�1� ���� ���. ����) ������<3=6>?47@6ABC@DBC E
��������� ���� ����� ������������������������������ ���! ����"� ��!��#���$��� ����"�����%�����&�� ������"� �����"��$�!�������!��"���"�����!"����������!�!�$��������!�!�%�������������� ���$#���$��� ���$ !���!$�$���"�����%��$���������!�"�$��'���"����������$$!��&��������!"�����"��$�!��!�������� ���! ���$ !�� �$#��� �����%'���"�����%������!��(�"!���$�)�����$�!�� �����!�$����*�����+�$��,$!�#�-�$��,$!����"�,��! �&� ���.���� ����������!������!���!�������� ���! ���$ !�� �$���"��� �����%'��������'���������!�"�$��'�.�����$��������/!�%�!�0"�����$��"!�$����"��%�$����!���� �#���� �!��!�%���� �����!�'���"�!�$�!���!������������ !�$���"������� ���! �������%�����&��1� 2��� 113(4+5�0��,���"�.�"���$�.����"�!�%�!�$�.�$����������������������$$!����!$���������!�$�$��"���$&�4�� ���������$��"���$�)�����$$�����6&*&�74����&8���$�.��������������!��!�'���������!�$�!����&�����4�� ������9���!����� ����!$�$������� ������ �0��"!�����$���"�$��"���$�)������/�������������� ������� �!�!�!�$�)�! ���������'�!����� �$�)!������!��$���%��!:��!��$�����4��;� ��<�=�.���� �������������$��"���$������%�����0 ����$>���0 ����$�!�����!�)$�.�����$�����"$������!��������$!�!������!��"����)��"$������$$!����!$����"�����!"�����������$����%�.� /��������$��� �$#�$����������'�� ?�!��������$$���!����@����!$����"����!��"������@ ��&�3(4+50,���"�.�"�)�$��$��.�!$��"�!������'����ABBC����D&�E&�4���������������������������4����� ���! ���+"� ��!���<�5�$��� ��F�����������74+5F8�9�������$������������!�$�!����&�����3��!�����(�$�!��������4����� ���! ���+"� ��!�����"�5�$��� ��73(4+58���"�.���� �����"��$���9����������@ ����� ��!��!�����!�%��!%������"� ��!��#���$��� ����"�"�����������!�������� ���! ���$ !�� �$���"�)�$������!�$��(�$�!��������!�$�/!�"�!�� �����'&�����!�$�!�����)�$�"� ����"��$����(�$�!��������3��!�����(������� ��.'�G�������������(�"!�������%�����, �������4���!�����#����!�!�"����AH�=���#�IJJK&�������(�$�!�����!$������.����������,$$� !��!������(�"!���L�!���$!�!�$���"�,$$� !��!������9�����)������L�!���$!�!�$&� MNOPQMRMQ
����������������� ��������������������������������������������������������������������������������������������������������������������������������� �������!��������������"����# ����������������� ������������������#������������������#��������������������������������$�����������$��������� ���������������������������������%�����������������������$����������������������������������&�������������������������������������������'���������������������������$�������()*+,-).-/.-0(,12-0134-516,31 7��� ���8����������������������������9���������9���$����������"������������$�������#� ����$�������������������������������������������'��!����������������������������$��������������������������$����������������������������������������������������������� �������!������"�����������������������������������������������������&�����"�����������:�;�������������������������������������&���������������������������<����������������������� ����������������:�;�����!�����������������������=�������� ����>�����������������������������!�����������������?@��A��"���BCCD�"������������E��:��F��E������E����������<�������<�������#�����������������������������������<�������������������&�����������"�������*)G15,H/1I��������������$�����������������������$�$������������������������������%�����������������������������$�����������������������J���;�����$������KL &�$�����������������������������������������������������9�������������������������������������������������������������L ������$���������������������������������������������������������%�������������������L ���������$����������������������������������������������%���������������������"�������������������������������������;����L ���� ��������������������I,(,+I-*M-,N1-516,31L <��������������������������������A�����%������L �������%���"��&������:�$������������������������������������������������L ��� �����������������%���"��:�;����O��$�������&�����"��P�E��<��O��$�������������P�8����:�;����O��$�����������P����$������O��$����������$�����P����������������<��������������������������������8�����O��$�������&�����"����L :���9��9�����������������������:�$����������:�;����L E����������������8�����9�&�����"����������%���"����� �����������<���������#�������������������Q <��R��:�$����������������������
��������������� � ��������������������������� ���!��"��� �#����$��$�������� ��� ��%��$���������������&�%����'�($#���������$����&����!�$��)*+��&�,��� ���$������,���$�����������!�$��)-+��&� ��� ���$�������.,���'�/�������%�����0($#����"�1����������"�������#������2�����$����&����3���4-+��&���$5�,���$�����'�6��������������&� ��������������!�����$�����&����,�� $ ����$���78����� ��������������������&&��������!����,����������&��$���!���,���� �����&���5���$����5���$�����'�9:;<=>?@�ABCD��ED@F=G=F��=:HI=J�;<=<:C>�<C���K���L�MN�ON�K=<@H�K��9�?@><B@P�:;�QQRD�IE:?E�?=>�G@�?CS@B@F�I:<E:>�TU�D:>V<@;�NWX�������W���K���Y9:;<=>?@�ABCD��ED@F=G=F��><@B>=<:C>=H��:BZCB<�<C���K���LMN�ON�K=<@H�K��9�?@><B@P�:;�Q[RD�IE:?E�?=>�G@��?CS@B@F�I:<E:>�E=HA�=>�ECVB�N
������������������������� ������������������������������������������������������ ! ��"#�$�#��������!�%������������&����'����(�������&����)! ��"#�$�#�����*���(���������������%��+������'��'���'�(������������,�- .�('������������������(��$�'�/0 ������- .�('��������������$���(�����'�1 ������- *����(�����2����!*�����(��$�- 3�����+�4��$�����(�����������*���(���������������%���� ���������+�5�&(�(�!*����(��$��������$���(�(��$#6��78�9���:8;<4�������%������(���������('������������*�$����(�*���(��%����= ���$����(�!�����(��(����(������������(�#�������������(��+��>����?�(@�(�8A3�B�C=0/�8>?�8�����D����E= C F!����*�$����(�*���(������58:GDH6����%��D;H6����%��I8?�.����(����+������$�J�?;??�EA������F!�*��$�(�%�E3������������$���(�F!�?�&��0#K�E�(�����8��#!�G?.F���(�L?.4�����3�������(�3������+!�3��(�������(���������M���������/ =HD;H/ N���M������&�������M�+��#�- ����������8���(�$��������- ��$���2����- �������������*���(�- ������(�J�3�������(�A����+�- ��������6��+- ��($����������7�($�������- ��($������������������+�- ��($���M�������- �����($���������- ��($�����+�- �B�����+��- �������$���(�- ��($���+����- �������������4�����������- ���������J�3���������*��$���(�..A**;;;A;�;;4?8�������(�����@�(�=) ��"#������������+����= �&��M������$�(�������0 �O��(�����@���$�������$������+�����������������������($�������������������������������+��@�9#�- ��($���������- ��($������������������+�- ��($����������7�($��������- ��($����������.�������- ���(���;(������- ���������J�3������������$���(�- ��($���M�������- ����������+�- ��($�����+�- �B�����+�- ����������������#;;;;:?;A;�A��P���Q ��PR���R����RST�������
�� ��������������� ������ ������������ ������ ������������������������ �!"#$%�� &�����'���(����������)�*�+���,�-./�-.������� 0��+���+����� ������ 12��������3��4�5���3�6���7%7%"#��-8-�9�9�� 4�3:�����3�5���;�������5�3���� ������ <=�'�����3������+���;�������5�3��� ������ >�'�����3������+�(���+�������;�������5�3�7��� �� ����������'��?��@�A���3���B��C� ��� D���:�3����'������3��+6���E�����-F.�� .�� 0�;���������3:����5�3�G ����H-�9�� 0�;����*�'�3��:�����3���������'"����-.��I�� *�''������3���������'�J0@�K�"����-.��I�� *�''������3�����L@��5�M����'�������N�#9�#-�9��-���� �����������3:��+��3���JO4P�0+���QQQK�N�#9�#-�9��-���� 0�;����&���;����+�0�'���"����-.��I�� 0�;����*�'��3:��'5���0�'���"����-.��I�� 0�;����D���3�''�0�'���"����-.��I�� *�:�����R��3������������'�E��H�.!.�� �������3���S�'��������T-.. U��� �� 1��������:3�����4��S��45�A��"����-.��I�� ��3�������'����V����3:����5�3�W���� �XPP����'����'����3:����5�3�W���� 0��3'���������'�:��V�����V:L�Y�-#�-E����9/Z�� 0��3'���������VV�'��3������'+'����N�#9.#7�9��-���� O����'��3������3�3:�(��5�[8���-���I�� D������+��5��;���V���'��;����+�'�����'"G"�Q\40�O�1\0M]�4OPPX�0�&X��PDM��M�1O0Q�4)�PDM��M�1O0Q�M]�01�D\X]X _
�� ���������� ������������� ������������������������ � !"#�$$���� %������&���������'��������� �()�*+,�-$./01����� 23���4���3��������5���3� ��$6"��71/�8+99��� :���3�����3��������:����� .�/�;�<)8+��� &=�>�5���3� �?<@?,�?/A"�B�/�CB�"/�D��� D�AE6���DF�� G����H���&�3����� �(�!�$!�8999,�IAJ�("1E�J�DK�� %���������L��������5��M� �N<�8*N,�IAJ�("1E�J�DK� D�AE6���D�� O�25:�%����P�Q����� �(�!"������ :���3����>��������R����3�����:���S:������� �TU(?,���� =>%V�'������������������ �T00AE�!"���W�X"���AE6�CNU���� %���H�3�=>%� �?00$�A��Y�!�.�6A/����� >Z�2���R����� �N(�+[9,�(�E�A",�I1��"A��\� 4�������=�����3�3��� �]]@N�$��A��D�AEDA��� �����_���_�G=�������� �]]@N�$��A��D�AEDA��� =����������3������� �(]-�C?N��� O������������� �TN�+99,�@BA"/!��#�E6���� 5��M����Q����G���� � ( �9,�(�YY.� 6A"$�E���� \�4�L��O�������������5���3� �N$A#A"� D�AE6���D���� 2�_����'��������� �a1E���� 4��&��� �bc9�dN�++9a,�C!$�"���� Q����=������� �e�$$��f�(�!DA$,�e�$$0!"A�� %���������>�������� ��E�#A"��$�8U,�aA66�DB�� GZ4�2���R����� �N]Nbg+F�N]I@T)�� O�����3����� �Te�g[F�N!E6"!$��.�6A/��A#�DA��� 5��������� � !E�0"A0,�e T�� h�����5�����Q����G���� �] �8[9i,�CT]�25H%h'OH:��5h==Z%H�&Z%�G2ZHO>� Z�ZLjV�'2>%ZG2Z�ZLjV�=�:%':>Z�ZLj�P�HZk2>Z�ZLj
��� �������� ������������������������� !�����"��#������$�%������� ��&�����'���(���� ��)*+���$��,�-./0�����1$2�345��� ��)*+)*+���1##0����6���%������1$2�7888��� 9���&:; ���'�������<538�"�$��,�-.�/0����1!���%������=>��� +?�@AB;?C;A;D�A�B��&CB�� ����%����-����"������� !�7E58�"�3<88��� +?�@AB;FGH;BD�A�B����>�34E��/>2'I�>��������� J&KL�+?�@AB;?C;A;D�A�B���6!�,�����-��M����588���� N+��O�&9P���$��,�-./0�����QR1�S�"�T�'�S���K+&LU*V&P��+U��WL&�JWL���PL*P�W9W+XY���X&W��V*K+&LX�O�PP�X&K�P��NV�PL&*V&
��������������� ��� � ��������� �������� ������������� �� ���!" ��# �����������$% ��&����!�� #��'� �"�()�����&����*��#�)�������������+����#,����-�# �� �.�/ ����,�"�� ����0 ,,����1��� �� ��#��,��� ���# �)���� �� ������ ����,,���� �, � ��#����0#� ����" ������ ���#��,��#�"�1��� ���2#� �#��)�1��� ���,�"�)�1��� �� ��#��)�/#��� ���,��� �����-���� �#���� #����&�/� � ����� ������� �������,�������#��� ������� �2��0, �" ���� �#������ �� ��#��,���# �� �������"����# ��#�#�����,#���#���������� ����� ��,���� ��,� ��#�� �-�# ��#������� ���"�#�"����� ����0�#��� ��� �������������#���������,# ��� � ��������0 ,,����� ����,�"��� � ,�� ��&3�4�354�3�6�4�6�7�4�7�894��:�:6:�:�;<=�5:�:>:�: ?@A���B4=CDEFG�GD;<HIED�JI�GEFK<CF;L�M<JNOKJN�GJ�GKE�PK;DQ;FERGCF;L�C<=RHGDS:*�� ����#���,T�����������U��#���,T�VV�W#�#�T� ������� ��� �, � �,#���������,#���#����XY����TZZ000&� ��� ��� &�� Z� ��� �� �Z���,#���#���&�� ,�A5[6��6�>��K:3����@��77��\�#"������� ������� ��,,��� ���� ����������� �� , �� �������������,�����# ������� ����#����� �#������� �����,�#�� ��# 0&�/� �#�� ��#��#�,#��������#�#�"�� � #� ������� �#���#��� � ]�#����� ������,�� ���#��#�����������0 ,,�������� #�&�-������YY�1�&%&����� ������� �� ���0��� ���� �� "� )�0�#����� �0 ,,��,�� ��#��� ��� ������ �� ��#��,�#������# ���������� #��#���#���#����#��*��#������������&�+��� ��,��Y����� ����#���#�� � ���� ���� ������ �� "#�� � ������1�&%&����"�� ������ �+ ��� &56����>�[�@_/� �� ���� ���#��0 ,,� ]�#�� ��0#��������� �����#,#�# �&�/� � �������"�#�"����� ����#���� �� ��&��� �" � ��#, ��#�"���#�"��U!#�� ����,�"�)� ��������#�� �#�� �����"�� ,#� ��)�1��� ���" �� #��)���������#�, ��������"����" �#�")�� � ��,�"�������� #�� �� ��#���#���,��������� �2�����#�� #���� �)� �, ��,��� ��2 ����� ���� ���#]� ������� �� � � #���#�������]��,#���# ���� ���#���,����)��� ���# ���,�"�)����a�#��,����, #����#��� ,#� ���)����#����� ��#��)�� ������� ��#��&�-#��������,�� "� ����� �����,��"�0#���bc�d&�-&�$1��� (�\#�� ����,�"������ ������ �0��2#�"������ � ����� ���&�/� ����� ������ ����� ���������&��" ��# ��,#2 � �/� �� ���� ��������,���� �������# �,��#��� ���,��� ����#,#��&�!��#�"����#��2#������� ��� � ,�� ��#���� �� ���� ������� ,���� ����� �����# ������" ���#"����� �� ������ �������#��#�, ��������� ���" �� #�������#��#�#���,#e �� �#�#� &�/� �� ���� ���0����,���#���,� ��#���� �#�#�#�,��,���#�"������ ��#�"������� �0#�������&�����������&76���56�[�@_! ��� �������������#�#������� ����#���� ��#�")��#"�������"�������� �#�"����� 0��� #��,� ��#�# �������� #�����# #����#�,����#�#������� �� � ,�� �������� ��������#���������,�����#� )���� ��� ����#�#�# ����� ���2 ������� �� ���� ��& 354���6�:�;fLC�5CJGEFK��;DM� � ����#������� �� ���# �������� �����3EP;DGQE<G;L��FGCfCGS
������������� � ������������ ������������������������ ����!�"�#!$�#$��%"#���&�'#� �$����(���������!#)#�*������+�� �$��#,��$�"&���$��"�$"#�-�� �#��&�!����)�$�"&#�$.�/ ��&���������� �$�&�,�)���&�,��#�"$�!�����))�&���&�$"$��#��&���)��$������")��#��$�����+$�$��0#&�(1(�����#�����2�3��0���4��#��2���&��#!)�����!.�+���&&#�#��2�+0"�������!�������&�-�)2�5�����)�!�)��-��!�#�-�-�)2�5�����)�!��� � �)�#!�$�)"�#��2���&�)��-��!�#�-�3#����)�6�!#���� � �)�#!�$�)"�#��� �$�0����$"!!�$$�"))*�&�,�)���&���&���! ��)�-*� �$�0��������$�����&����� ��#�&"$��#�$.�3"�����)*2�� ��&����������#$�#�,�),�&�#��� ��&�,�)������������,�)�&�"-�&�)#,��*�$*$���$������#6�&�&�$��!��0#���#���������#�"0��!")���&�"-$.�/ #$����7�!��#$��"�&�&�0*� �/ ��&���������� �$�!���)���&����7�!�$�#��� ����������&�,�)�����������$���#!��"��$�����$*! #���#!�&�"-$���&�8�)�(��")$#�*#�-�&�"-��&�)#,��*�$*$�����������#(�����,#��)���&����#�"�-�)�&�"-$2�����$&����)�� �����"�#!�$*$���$�����$����#&�)�!�����!���#,����&�9:;�#� #0#���.�<��#�"$����7�!�$�#�,�),#�-���,�)�� �����"�#!�$*$���$�)#=�2�8�)#&()#�#&���������#!)�$2�;��&#$���$#0)���#)�$2��")$��#)����82�3�)������-���&���82�9#!������#!)�>�9#!��(��")$#��$���!2��)��-�'#� ��'��#�&"$��*�$���$���&����7�!�$� �,��0������$"!!�$$�"))*�!���)���&.������������� � ������������/ ��&����������#$�'�))��%"#���&�����$�"&#�$����,��#�"$��$��!�$����� *��! ��#$��*2�� *��� ����!�)�-*2�?��0�)�@���")��#�����������#��2��)����/#$$"��3")�"�����!.�;,��� ���� ��0�)�&�"-$���&�����")��#��$����+�&#���8*$�������9�&#!#��$� � �,��0����&�,�)���&��$��������������7�!���"�&�&�0*�+39A���&�� ��9#�#$��*����?��)� ���&�@��#)*�'�)����2�B�,�.����+�&#������� ����!����#�)�$���&��&$.�/ ����7����!�#,#�#�$����� ��&���������$������ ����!�-��$�#!�)���&�� *��! ��#!�)��,�)"��#������ ��0�)�&�"-$2�� ����!�)�-#!�)�$!����#�-������ �����"�#!��!�#,#�#�$2�#$�)��#���������=���!����"�&$2�/C3��#�-�����#��#�-���&��#!�������-��#������$"���#���%"�)#�*���&#!#��)��)���$���&��)����!�))���&���-���!")�"�������$�!��&��*�����0�)#������&"!�#��.�@#,��&�!����)�&�-����$�"&���$��)��-�'#� �DD�9.�8.�E� ���F�G��"��)����&"!��$�"&���$�����'��=#�-����,��#�"$����7�!�$.�/ ��&���������� �$��#)�&����������������� � �H�������/ #$�&���������� �$�� ���6����#$������"�&����=#�-����!)#�#!�)�I�!)#�#!�)�$�"&#�$�)#=���� ����!�=#���#!���&�&�"-�����0�)#$��$�"&#�$�#����#��)$���&� "���$2��$�'�))��$�!��&"!�#�-�J#��,�#)�0#)#�*�I�J#��%"#,�)��!��8�"&#�$.����������� �$��#��!��&#�#���&�:�#��)�?�"$�� �'#� �KLM��#���6! ��-����!#)#�*��$������ �,#�-�&#����������#��)�$��!#�$�)#=��8���-"����')�*�I�N#$����A��$2�8'#$$�:)0#��2�J�)0O!�I�31P�9#!�2��"�=#��?���)�*�B"#�����#-$2�G�'�Q��)��&�N #���A�00#�$2�B�)&���8*�#���?��$���$.�8�����������-�����:�#��)���&�)$�����#���������� �����"�#!�����$�)#=�R�:��##��)�������*2�:��#")!��2�:��# *���)#�#&��#!2�:��#����#)#�*2�:��#��$� ���#!2�:��#�6#&���2�:��# *������$#,�2�?����������!�#,�2�:��##��)�����#��2�:��#&#�0��#!2�:��)-�$#!�I���!#!���#,�2�:��#&#��� ��)2�3�����!�2�:��#�$���-��#!2�3���0��)�+$! ��#��I�N�"�&�?��)#�-� �,��0����&�,�)���&.�S"-")���<�#��3���")��#������ �&�#�����$�#$�"$�&������������&�0)��&�$���)��'#� &��'�)������!��$!#�"$���#��)$�����:�#��)��5O���$�"&#�$.����������� �$�&�,�)���&����)*�#!�)���� �&�)�-*���&�!��&"!��&�J#��,�#)�0#)#�*���&�J#��%"#,�)��!��$�"&#�$�� �:�TU(0�&2��#�(!��&#�#���&�3)#�#!�)�N#�-�'#� �+3V���!#)#�*�#$��,�#)�0)����� �"$�� ��)� *� "����,�)"�����$2�' #! �#$��"))*��%"#���&�'#� �#����$��"!�"�����&������'���I�!��&"!��&��,���KLL�8;��-"#&�&�!)#�#!�)���#�)$�$������#��,��#�"$�� �����"�#!�����$./ #$�&���������� �$�#�#�#���&�'��=�����&�,�)��#�-�#�(,#,��$*$���$������!"�����&�! ���#!���6#!#�*�$�"&*�#�����$���&��#!�2��$�'�))��$2�$��!#�)#4�&�#�(,#����$*$���$����� �������6#!#�*��,�)"��#��.�/ #$�&����������#$��)$��#�,�),�&�#��0�$#!���$���! �#��� �������)#=�������&"!�#,��� *$#�)�-*2��������#!$�I���)�!")���� ����!�)�-*. WXYZ[\]_X abcb\XdZb � d_\X d\] ef]\b [dg g �]h]_ WX[a]_Xi j]d] � klgmn ZXXhY]doep���q m �a_] d]b eg YbfXh_rba st ��������� Ybu[_YbZb eipl�vl�q YbfXh_rba st k���
���������������� ������� ��� ���������������������� ���!� ����"��#���"���$�!$��������!!�%��&���"��� ��� ��$����"�"' ���"�()*+"������������'�� �����"����������"��!�,������-���!�������#.�����- �� ��.�����-/� �����!.�����-�"# ���� .���'������� �����.�������"������".������"������ ����������&���"�"0�1� '"��� ����'���!�/���#�"#����"�"�����$����'"� �������"0������2� �"������ ��$����� �""���$�!����������/'!,���'&"����� '"����"#����"�"0�3��'�����"������!��&�2�"#����"�"������$�!����'�����"45������������"���!��� ����65�"�&������7#����"�"����(�$�!�����8�!��2��������������!�&'�"�����������3��!� ���������9'�����'���5�"��"�"�����)�� ��+����� ���$����!����������������$�!���������!�����-���!�������#��&���"4���� �������� ��� ���������������"'��������/#�$����'"�"����"�� ��������!#�� �!���"��'����"�!�,�����"���$�!������:�����"�����;'������ �����������'&"���������������/�!���"������/��!�&� �!������:�!�,���!�"�������������/��#��!'��"4�����������������"�������������� �������������<9=<*����>� ����$�!$��&���'&����!#"�"������ ������������������"���$�!��������!#�� �!�������"�������'���?@� �����!#�'"�����'&"����� �����/'��������'����'"����&���!���"��� ���'/!� �����"4�('����'"��4�A���������A�454�"�'����"���$��/�������������!��&�%�����������"������7�*"4�B�C� � �� �����������������������$���"�"��$� �"������������"�&���������������&���������:������������ �!!� ������������!#"�"��������4�����"����"�� �!�"��$� �"��������$�������������������������� �'�� ".������� �!�&#.���:� �!�&#.���������!�&#.� !��� �!�����!"���$�!$��&� �����!"�������� �����4�����������������"�"'������������"�'����"������4�74�DA����4E����&�����������������������'&����������%��������� ����������������� ���:����������D(3A*F-G**E� ���' ����/#�(3A*F4����������;'�"���������������������"��:�����������"�'����&���'������&��������H9�*�;'�!��� �����4�����"�'����"����� �'�"�!��������������!�"�����(3A*F-G**�����������������(3A*F�I�9�����/��4��������������"�'����"������"������������ ���������������&���'���"������3����4�5'���&��%��#��������4�74�DA����4E����&���.����#������'�������������������&����������"��$���������"� �������3����������/����4(3A*F�I�9�����/��������"�"�'����"����������!!�%��&�J���" ��!���"K�������"��"���"���������"�"�$���!� ������ �'�"�"���������"� ����"���"���������"�"�$���!���" ��!���"+�"�� ��� � �'�"�"����������!"����%�� ������&�$�������4�����������������'����"���"����������"��$�������"�&���� ������"��� �����>� �4����������.����� '��� '!'�����!� �"��:���"�$���������&���� ������ '��� '!'���'���&��������"��"���"���.�"�� ��!�8������ '��� '!'���'���&�����"� ����"���"���������:���"�$����"��� ���������&��'���&�������������'����"���"���"41����L@M@���%���".�(3A*F-9�����/�����"����������"�'����"������������������" ��!���"����A����� �!�&#.����� ���!�)����"��#������A����� �'�� �!�9��!#"�"4N�OPQRSQ TRURS�SVWPS�PQRSQT ���X�� �X�Y��X�Y��Y��XZ�P[\]Q�^O_PTPTP O_RT]TWSaUP_WVPQRVRQb\VTcObPdPe\fWSRQWeTWS[W\Rg]WUP_RSeRPSV[W\PUPW_P[W_WQh[h\dWaWSP__WeRSTRVOd\iRTTW\SP_T\iQjPdRT_WfR����k��� � c�cBW\QRebS\_\ahlc�PQ]dP_�d\V]eQT�c�bPdPeR]QWeT�c�c�bPdP�d\adP R
������������ �� ������������� ������������������������������ !�������" #�$� ��%��&'�����(�)���*�� !�������" +�,���-.���/��'������������0�01" 2 304��0�01" -55�����.���.�'��������*� 6�0����*0�01" 2��"�0��������"7�$�+�,8� '������������������ +�,9&�+���'������������������ ��55� �:,�,89�� �'������������01*0�";��"�0��������" :,��+���<���'�����=�1�*�� ��������">������ ��0)���� -55 �$����&��,'�����6�0����*0�01":$������'������������������ �����&,8'������������������ :���,�?9��'�+��@A*��"����� !�������" B�95������B���8'�+��@A*��"����� !�������" ��5����5 '�+��� �6�0����������C�/��$���C�'������!��� 6�0�01" 2 >���0�01" ����5��'�����6�0����*0�01" + 55�:D���� '�����(0������� 6�0�01" 2!��� 6�0�01" :,��&����.���.�'�����6�0����*0�01"�?�E�?�E?B:C�FGCC?H�BG�G:B�I�:��?�J:EG�
������������� ��������������������� !�"�#$�������������!%�&'%"()'�*&��+ �������������) %',%��&���+
������������� ����� � �� ��
���������������� � � ��������������������������� �������������!��"���#�"�������$�������%&��&�'&��'���&%�"��������������������������( )���������"��'� ���'�*+,����"��&�&'-.( /��&"-�&��������������� '�����!��-.( 0�����"&'��&��"�.( +��&�����"��������� '����'����'.�( 1����&�&'& ����&������2������&������������� 3��-&��"���"�&4��.( 5&��" �������3���4�������"���� ���#&����2������������&������� ����-�����&!���������������.�( � �&����� �&�&'-.�( +&�6!������ "���"��"�������!��-�.( *���&��&��"��&�.��� �&��&��"��&�$� 7�2��&"�&������'������ ��������&�'�������������89�5$�7$�:0����$;�<�&��"��&�&'-��� �����������&�3��'�&����������&%�"��$�������&%�"�������# �����4-�)&!�$��'��"������3��=<�>�?7@*$���������������������������&����� ������������� ��" �� ���#�"����-$�,����'�&���"�3�������4������!��&�����������������������&����������"��"������������&�'�����'�������������4�����&������"������&#�������"&'��&��"����������!�� ���A�������"���$�����������������������&���!&�!�������������������������'�����������'� ��&#�7�!���<�&��"��0��3������)&!�$�&#�) %����$������������&#��-���4 ��&#�5$7$�:0����$;�����'�!�������$ �B C���DCCEFGHIJKLMNOPLQRSSTUVWSWXYTZTUVW[\R]V_YTUaVTWbTcdXTe[_VWfghR[_aSTefaSYVgRhaa_VWfTiR[\fVjdRkV[WlVWSWXYUVW_a_V_V[TgR]VfamRfRaSTnalTophRVRf[RqLPLKrLJMsMtqLPLKrLJMsMtttgYfWhVuRRf_a_VWf GJLvwrKxxxyyxyzy{xxxxyyxyxy{{z|}zyx{~qLPLKrLJMsMt��HrO�MGJLvwrK�HrO�MGJLvwrKi\RVcRbRf[RTWbTTi\RV�HrO�MGJLvwrKM�tMrHMt�MqLPLKrLJ��HrO�MGJLvwrK qLPLKrLJMsMttkWSR[dSaTUVWSWXYmRfW]V[�TuW_RW]V[Taf�TgY_R]TUVWSWXY�R[W]lVfaf_Tc�eTiR[\fWSWXY�]]dfWSWXYTaf�T�]]dfW_R[\fWSWXYefaSYVTWbT�R[W]lVfaf_TuW_RVfTZTcVaXfW_V[u\a][WSWXV[aSTg[RRfVfXTaf�Te aYUVWVfbW]a_V[gR]VfamRfRaSTnalTophRVRf[RT�fTi\RTeRaTWbTghR[VaSV�a_VWf�HrO�MGJLvwrKGHIJKLMNH�i�T�T{}|i�T�T{}}UiT�T{x~kQT�T{y~kQT�T{yy�uT�T{y~uiT�T{y~moT�T{y~moT�T{yynmT�T{y~UiT�T�y~UiT�T�y�UiT�T�x~UiT�T�z~UiT�T�{~uQT�T�yymoT�T�y{moT�T�yyngT�T�y~i�T�T�}|i�T�T�}} B C���DCCEF
������ �������� ������������������������������� ������������� ���������������������������� ������ ��������������������� ��!!"!�!!������#$%��������������� �&�'($)�(*($)(+,-,./01234,56789:;<1=9>[email protected]>9:.=9ABC6.-D3E;@.=9AFFGH.IDJ32:.K9>[email protected]:13DM0D=;AHNNOPF6.+21232Q1:32+9R,.S.TUN.UVONB.NCFFUQW2:8@R2M2:82X?428>,<94 �������������������������������������YZ(Y[)Y\$Z]]#_] )%Y%a$Z]_(#]b$)[#_%$])Y)Yc(cc(d)(Y[]ddd)Y]����[]ddd)Y]�b)Y\*)aa]_]Y$$_($]\)]������������������������� Q:e 03;Q;=:;M..f9Q:;3..;=:8:>;M.g�Y$)*)(__Z%(]d([$)h)$i%ajklmnopqkrsmtslpu.2:.:1;.VN.v=M82=.012342<;D:8<2>.K9=?3;QQ6.w14;M2R2Me 02f;3.;=:8:>;M.g�$b*i%Y$Z]#_][_)#$)%Y#($$]_Y)Y#($)]Y$')$Z�iabY[$)%Y(d=M�$]_)Y]�d]]*)Y\�����)Y�bY]x.Q;>;<:;M.y93.f9Q:;3.f3;Q;=:2:89=.8=.VC.v=M82=.012342<;D:8<2>.K9=?3;QQ.:9.R;..1;>M.2:..+2=8f2>����� �������z����e {D2>8y8;M.|v0}~A�}}.COOU.W8:1�dd�Y*)(�(Y�����e {D2>8y8;M.Iw�}.COOU.W8:1.�!����]_[]Y$)d]�)Y(d�Z(b*Z(_)+,-,./01234,56.789:;<1=9>9?@w:.|2=8<1;36.0,�,.~2:2=826�2>S..+2=ME86.�8Q:S.-D32:.APUHNVO6.IDJ232:+9R,.S.TUN.UUUF�.NOHHC.f12342�48=2>X@2199,<9,8=�������������������������������������nq�m�lk(Y*�nq�m�k]h(db($)%Y%a%c]]d][$]*Y%h]d�����([$)h($%_(_(*)%#_%$][$%_�������������������������03;Q;=:;M.Q;48=23Q.2:.|v0}~Aw14;M2R2M� I;=;.Q8>;=<8=?.W8:1.-=~|0S.w.|9E;>.�;<1=9>9?@� -�w�v|-S.09:;=:82>.�1;32f;D:8<.~9>;.8=.~;Qf832:93@.�8Q;2Q;����� �������z����� {D2>8y8;M.|v0}~A�}}.COOU� {D2>8y8;M.Iw�}.COOU.W8:1.!�� ��]_[]Y$)d]������ �������� ������������������������������� ������������� ������������������������ ������������ ��������������������� &"!� ������#$%���������������
������ �������� ������������������������������� ������������� ������������������������������� ������ ��������������������� ��!�" �!#������$%&��������������������� �������� ������������������������������� ������������� ������������������������������� ������ ��������������������' !���"(� !������$%&��������������� �'�������������������������������������)&*+,)+**-)+,./01202003456/01748&-%9*:*;*<&$=*+%&8=>?&@A<;A??)+*A,A)+@%BC7DE66/5FG4EH1I/7E5�J$*����������������������������-*@*+%*:@*=)+A-@A%������9=*:AKA:L MNOPQRSQTUVWXNYPZV[\PQSON]ZVS_aZUbVbcVb\PVbQPSbdPZbVceV_TSRPbTUVUcdOfTUSbTcZgL hP_TUSfV_PiTUPgVjVZPP_VceVVb\PV\caQ����� �������k����L laSfTeTP_VmnopqVrsstVuTb\V�<<�+:)A�A+v��#!L laSfTeTP_Vw[pVrsstVuTb\V'����*-?*+%)<* �)$A+xA:)AhyzyV{o\SQdy|}~TcbPU\ZcfcYNVV�tV�z\P�\SQVU\\SNS��\c�gTOSQ�VgcU}~\S_aSbZSYSQ}VhSZTZSYSQ}\dP_SRS_]s�hcRyVjV�t�Vtt�t�Vs����_TOSZ�����YdSTfyUcdV�>+)<�9A>9A+hyzyV{o\SQdy|}~TcbPU\ZcfcYNVV~]rs�VgTfiPQfTZPVQPgT_PZUNWOO}V�TQbSZVUcdOfPX}mPuV�ywVQcS_}V�\SZ_�\P_S}�Tgb]\dP_SRS_]��r�r�hcRyVjV�t�Vt�r��V�st�sgaZTfyyU\Sa\SZs��YdSTfyUcd�������������������������������������:*+%)8)?A%)&+&8,*+*%)?=A-v*-8&-�-*A@%?A+?*-�������������������������oQPgPZbP_VgPdTZSQgVSbVVmnopqV\dP_SRS_� o\SQdSUciTYTfSZUPVSZ_V_iPQgPV_QaYVQPSUbTcZVdcZTbcQTZY� �O_SbPgVcZVgbPdVUPffgVSZ_Vb\PTQVSOOfTUSbTcZVTZVQPYPZPQSbTiPVdP_TUTZPg����� �������k����� laSfTeTP_VmnopqVrsstVuTb\V�<<�+:)A�A+v����� laSfTeTP_Vw[pVrsstVuTb\V'��� �*-?*+%)<*
����������������� ����������������������� �!"��#$%�&��'�����(�'�)�*��+ �,���#�-� ����'��� �.����� ��� ��)� �!�����/���/���� 0�1��2�%33345� �����.���� �1��6�789�839:;�%3339<=����98;>?!��� ���� �@�ABCD@�@EBABFGD�HIJFABEKLDFK�MELNB@GIO�OPQR�OS�����T�O��USOQ��VURRQS��WXW�Q��@YL�TWW�WQ��MEBIBFG�GDLFIZMJ[HD@�GDLFI\ ]0���0��'��.���'��0 ��0�������� �����_����� �.6���+�������.���!���.�����0�������!��!����,<�&2#���'�1�'\ a � �1� ��!�����������0���� .����,<�&2#���'�1�'�@YDBbBCBFGIZ�c�EAI\ ]0� ���'�,<�&2d �5338�+�����WW�D��Q��E��e2�fg\ ]0� ���'�h#i�5338�+����jklgm�MT�OQWMQn��e���M���n ����������������������� �!"��o�,��9;>��i0 .��,�!���p��'����!+���h��-���!��2%43335 �'�"�����'�.�� �1��6�789�8q4:%�::%55�_��"��/�r��� 9?"�������� �@�ABCD@�@EBABFGD�HIJFABEKLDFK�MELNB@GD��OQsQT�OQS��Ss�P�OQT���e�sS�AQ�tORMEBIBFG�GDLFIZMJ[HD@�GDLFI���.����'�.������.����,<�&�#���'�1�'\ ����� ���������.�1�����/��\ �������'�������!���'�����2�u�'�����������_����_�u� ��@YDBbBCBFGIZ�c�EAI\ ]0� ���'�,<�&�5338�+�����WW�D��Q��E��ev�jw\ ]0� ���'�h#i�5338�+����j�lww�MT�OQW@LJEIB [L�EAZ�JFDbBEIDGxClIlyMY�EClz[DLGB@YFLHLKx xB�E�L{�M�IIDFK EBIJHGFDMBEv�YCBA�[�AJFDbBEIDGx�L{�MJFB B|MB@GBA�NJFBv��kk���j w�lk��}gl��@KM��y~U�OS�DD�IBClz[lMY�EC�@LJEIB [L�EAZ�JFDbBEIDGxClIlyMY�EClz[DLGB@YFLHLKx xB�E�L{�M�IIDFK EBIJHGFDMBEv�YCBA�[�AEKMb���[�SU�W B|MB@GBA�NJFBv��kk���j gjl���}�l�w�@KM��yJU�OS�DD�IBClz[lMY�EC�
������ �������� ������������������������������� ������������� ������������������������ ������������ ��������������������� ��!"#��� ������$%&��������������������� �������� ������������������������������� ������������� ������������������������������ ������ ��������������������� '�# �'������$%&��������������� ���������������������������������������()*+*%*&(&,�(-*&-.(./*/�( 01*&2/�0(3.1�.44�*(./�/*(- �����/)����������������������������5678 9:;55<=7;>7?@=7A7B<CD5ECAF7>=@G<CB7@57HI(&J�&21�)01K03*/%L�*-)%�/.&,�.M*3*(./NAB7BD<7:O7P<CD5ECAF7QODEREBE@5S79TTU7VW;XRAE7Y5EZ<=[EB\7]5B<=C@FF<EAB<7F<Z<F_8 7a=ACBECAF7a=@G<CB7@57Hb2*3c�&2%)�*//&4d*(-�(%*�.K.%*3�104�*4K�/*(-efghfijkl mnnfofgpqjNAB7BD<7E5B<=C@FF<EAB<7r@;57sCE<5BE[B[7]55@ZABEZ<7a=@G<CB[S79TTt����� �������u����8 v;AFE?E<67w]aQ:79TTt7xEBD7�44�(M*0�0(c��'!8 v;AFE?E<67yPQ79TTt7xEBD7������.13.(%*4. �.)0�1*d.M*Wzsz7VaDA=Xz_S{E@B<CD5@F@\7|}S7~X7sA;=ARD7��szSWAD<[D7aA=�S7P;FE5G7:@A6SwAFFA[@>A=A7VQ_S7PAFz7�A[AES�E[B�PDA5<7�7�T|9TtzWADA=A[DB=AW@Rz7�7�t|7t�T|�79���|5<DA|}B� XAEFzC@X7�&&(0K�0K+.Wzsz7VaDA=Xz_S{E@B<CD5@F@\779��{S�s;XA5�S�E[D@=<7wAA=S:AGEZ7wAA=S:A5<7wAA=SwA[DE���99TTtWADA=A[DB=AW@Rz7�7�t|7t�9�|79�tTT>@@5AX�BAXR<�\AD@@zC@zE57�������������������������������������()*+*%*&(&,��K$)0(-*&-.(./*/*(�1.0/%�0(3.13.444*(.+� �����/)���7�������������������������8 s<C;=<67�E=[B7a=E�<7E57a@[B<=7�@X><BEBE@57@=A5E�<67A[7A7>A=B7@?7wABE@5AF7aDAXAC\7�<<�7�<F<R=ABE@57R\7]a7E57�<C79TT�8 :<ZE<x7aA><=7<5BEBF<67A[7H�*&%.3)(&4&-��%01%2$��1&K�.(3)%&�&�N7>=<[<5B<67E57]5B<=5ABE@5AF7s\X>@[E;X7D<F67AB7{7�7aAB<F7aQ:�7�<B=<S7DX<6ARA6����� �������u����8 v;AFE?E<67w]aQ:��QQ79TTt7xEBD7�44�(M*0�0(c�� 8 v;AFE?E<67yPQ79TTt7xEBD� ����.13.(%*4.8 v;AFE?E<67yPQ79TTU7xEBD7�'����.13.(%*4.
������ �������� ������������������������������� ������������� ������������������������ ������������ ��������������������� ��!"#��������$%&��������������������� �������� ������������������������������� ������������� �������������������������������������������������������� ������ ������������������������� ���������'(�)" ��(������$%&������������������������������������* ���&&+,-�.&/.$-%0/1232456789:2;<=>?@AB7C?D?EF44G<4HC:?D4IAJ>KACBF<4L8@A4C8E89<HF?K7F844M?D?CF<38N89O894C8E89<P8J7>OQ4RSSTUV2187898J7@981?W24X4YGU4GZS[U4S\TVT]8@>D]??9N8 F87??2B?2>C �������������������������������������_. &a.ba0%0a0bc�dd.e%&d�&,./���f�0b_0g0%&+a�������������������������LAD>NA9AK4JA:>C89J48@4Ph6iI4H7:8K8W8K45=2j268@AD46iIL4MAC@9A;4Xk i9F@79?]?>A@>C44Q484C?NAD48]]9?8B748J484CAl9?]9?@AB@>NAk m7A4lJA4?n4:?C?BD?C8D48C@>W?K>AJ4>C4@7A4@9A8@:AC@4?n4>CnAB@>?lJ4K>JA8JAJ CK469AJAC@AK4]8]A94?C4o�e&$.&d�&a$0%-/�_-+-ep0b�bq0-r48@4s334B?DDAEA4?n4]789:8BF4S 4>C@A9C8@>?C8D4B?CnA9ACBA48CK4hCK?QM8C8K>8C4J8@ADD>@A4JF:]?J>l:4?C46789:8BAl@>B8D4JB>ACBA<4mAB7C?D?EF<4698B@>BA48CK4P8@l98D469?KlB@JQSTTZ����� �������*����t ul8D>n>AK4Ph6iIQsii4STTG4v>@74�//�bq0-�-bf��((t ul8D>n>AK4wHmi4STTG4v>@74�#�'#�.+e.b%0/. 0a_-q�x$%-1232456789:;<=>?@AB7C?D?EF44SUS\Q=<4I8E7lC8@74M?D?CF<4y8D4Kv898<z8:lC8C8E89QUV[TTU<4{89F8C81?W24X4YGU4GGTG|4[TZTRN>J78KT E:8>D2B?:4 ������������������������������������}~��������}~�������.x+&$+&%.e%0,.�dd.e%&d���)�b%-c&b0a%0b�%+&f.-bq�%+&f.0bqxe.qa.0�x+.a������������������������� CKt 6?J@A94AC@>@DAK4o�,.+,0.���+xc�-%.b%�0bf-c.ar48BBA]@AK4>C4\S4hCK>8C46789:BAl@>B8D4M?CE9AJJ45h6M4STUT;4@?4WA47ADK48@418C>]8D4�C>NA9J>@F<418C>]8D4t H469?�AB@4AC@>@DAK48J4o�&,./a&/0qe-%0&b0eb-b&$-+%0e/.a.b_-be.qg-�c.b.q./0,.+p0b�xbc�-be.+r4v8J4JADAB@AK4>C4hCK>8C4HB8KA:F4?n43B>ACBAJ4STUT<4=8CED?9A4n?943l::A94IAJA89B74�ADD?vJ7>]453I�;����� �������*����t ul8D>n>AK4Ph6iI4STTG4v>@74�//�bq0-�-bf�(�(t ul8D>n>AK4wHmi4STTG4v>@74���''�.+e.b%0/.
���������������� ��������������� ��������������������������������� ����������������������
������������� ���������������
���������������� � � ������������������������������������������ �!����� "���#�� ���� ������������� ���!� �����$������%����� �������������������#���&���%���$�����������'����������$ �$��������%� �������%����$��������$ ���%���������(�������%�����&����!� ���� �����#)�������������������'�� ��������������������'��*��!��������$����)+ ,������#�!$����������������%� ����$����%�����������-��� ���%�����$������� ����"���$����!���������"����������� ����"�.�����������"�.�����%��������#"�.������&��� "�.����# �&� ������"�.���/01"�.��� �� ��"�.����#����������"�/���������� ����"�.���������������"�.������������"�.��������!� "�.����������� "�.����� ��&���"�.����������� �����.����-������� �������������&��� �����#�!$�����%�� ����������������!�������������������%�� ��������� ������%�������&����-��� ��)+ .����!$���#���������%����$����� �%%�����&#� ���� ���2�&�������%���������%������$ �����-� ��#�2������ ���� �����#)+ 3���$��������������������%� ����$�������'������� �$����-��� ���%�������&����%��������$���������$�� � ���!�������� �$���!�4��$ ��������5������������)+ 6����� �*����� ������&��������&�����#���$������%����&�����$!������%���$�������)+ 7���&������!��-��������8.98:�����������"� ���#��!��$�����&����#���$������%����&�����$!������%���$�������)+ 0����������%������$�����*��� ����$����$���!���%%�������� ���;$�����()"����������-��� ����"� ��$��� �������!����#"�������������/65:"�������������/6�5:)+ <��������!������� �������� ��������%������������(�������%� ���&�����$!�"����&����-��� ������� ���#���&���%���$�������)�����'��*��� �$�������������!����������%����������(����������%��� ������ �!����� ���������6�#�� ���� �������$�������%�/��&�����$!������%���$�������)�����'��*� ���������������������������� ���� ����(�������%�� ��������� ������9���*���� ����$�������������&������!���������%������� ;$����%� ��������%�����*��� ����$����$���!�/6�5:"�/65:���� 45:)+ <��������!���������%��� ��#�� ���� �������$������&#� ���*��� ����$�������#�������� %��!����������!��%����&�����$!��9� %���$��������%������&������$%� �$����)<��������%��#���&$������!���������) =>?@ABCD>E =>?@ABCDFGBHBGBAIB@CJCKHBGBAIB@CJCKKHBGBAIB@CJCKKKHBGBAIB@CJCKL =@BMNIADOJPQRDOJPSRT=JPQRT=JPQQO=JPURVWJPQRXYJPQRXYJPQQZXJPQRDOJ[QRDOJ[SRDOJ[\RDOJ[URDOJ[PRT=J[PRO=J[QQXYJ[QQZHJ[QRW]JP_W]JP CW]J[_W]J[ C abcdcefghijaklhfmnaopcendcqirdgsnkeotuvcofoigwixdnyizkefghbakedcqizhcq{ofo|la}geladcb{igwircdcofefkichsi~fkdg�fcqiuhwakefghovfgeaklhgqgy{ifhirlcd}ckanefkcqikfahkaovfgoecefoefkoa}fhcd�ahadcqi�c�i��badfahkaW>IF�C=@BMNIApcendcqirdgsnkeichsivfgtgdychfki|la}foed{pcendcqirdgsnkeotuuechscdsf�cefghigwipcendcqirdgsnkeixdnyoi�i�gd}nqcefghednkendai�qnkfscefgh~asfkfhcqirqcheivfgeaklhgqgy{i�i|nqef�cefghoirdgbcycefgheadagkla}foed{i�ixdnyizkefghrlcd}ckgqgyfcqikdaahfhyi�izooc{oa}fhcd�ahadcqi�c�i��badfahkaifhijlaizdacigwibakfcqf�cefghW>IF�C=@BMNIA{hgbofordaoahecefghW>IF�C=@BMNIAjlaofoxawahkaigwijlaofoW>IF�C=@BMNIAW>IF�C=@BMNIC�KCI>CKLCHBGBAIB@� ���������QP��_��QSPR���������QP��������������
������ �������� ��������������������������������� ������������� ������������������������ ���������������� �������������������� !"��#$"�!"����%&'��������������������� �������� ��������������������������������� ������������� ������������������������������� ������ �������������������� "����$(� �����%&'����������������������������������������������������)*&'+),-.+/0/12�.'0'3.+/0,4/05/&.'1'6789:;<=:>?=@=?;>�.11��������������������������ABCDEBFBGHIBJDKLFHLMHNOPQRHSTJBGLULGHVKW XMFBIIHMBIMDKYHLKGHDJZ[FDM\HZFV]DCDKYHV]HU[CHGF[YIHLKGHMTBDFH]VFJ[CLMDVKW SKMDHJLCLFDLCHL_MDEDM\HV]HDIVCLMBGHLCLCVDGHLKGHDMIHLKLCVYIH]FVJHabcdefghicagjkeHlDKKIMHPFBIBKMBGHLHZVIMBFHBKMDMCBGHm�/1'&,+)1'0'3*+5nn,1&n,350/&'n*%,no%,+&.4,opqHLMHrsHOPtHLMHSTJBGLULGu����� �������������W v[LCD]DBGHwSxQHyzz{H|DMTH ��##%,n+,1&.0,W v[LCD]DBGHDKHNOPQR}H~QQHyzz{H�00�12./�/1��( �������������������������������������'%.+/02,0.4,n*'6�,n�,n.1,/12.&o2,n.4/&.4,o6'n&),&n,/&-,1&'6������'o&�/0/�/�/n�,n-/0�,.o)-/1./o.o��������������������������ABCDEBFBGHIBJDKLFHLMHNOPQRHSTJBGLULGHVKW �BMLUVCVJD_IH]VFHPT\MVJBGD_DKBHFBIBLF_TH�HAF[YHGBEBCVZJBKMW NLKVEL__DKLMDVK�HRB_BKMHGBEBCVZJBKMIHDKHEL__DKLMDVK����� �������������W v[LCD]DBGHwSxQHyzz�H|DMTH #��"�,n+,1&.0,W NOPQRH~QQHyzz{H�00�12./�/1�� � �!��������������uXuH�PTLFJu�qNLM[FLCHPFVG[_MIHS�P�HSJUD�LCYLVKHxv�H�LF�LMHSTJBGKLYLF}H�s��zy�LTLFLITMFL�VUuH�H�{sH{�sz�Hz��yy\LKLFLIByzz{�YJLDCu_VJH����������������uXuH�PTLFJu�qHNLM[FLCHPFVG[_MIl��z�qHSUTDITBHSZZMuq�ZZuwLKBITH�DGT\LCL\Lq��TqH�\LIH|LGDqHNLELH|LGL�qHSTJBGLULG}��HzzHs��VUuH�HH�{sH{�sz�H���yyTBJLKYDUzys�YJLDCu_VJH
������������� �������� � ������������ ����� ����������������������� �������� ��� �� �������� �����������!���������� ��� �"������!��� #���#��$ %&�'�(������������ � ������������ ����� ����������������������� �������� ��� �� �������� ����������)*+,-./0-+,-01-��0,�23-0-�.45)0641�"������!��� #���#��� %&��'(��7&��������� ������������ #&������������������ �������������!����5-82-4�.�9�)20��0�)+45))99)+�96�*)6�)+494+6)+�./-01�)-:�84)6��� �������� ������������ ;<=>?<@<ABC<D>EF@BFGBHIJKLBMND<AFOFABPEBQR MBSTEGN<G>UB;<@>?FG>?<BPVBGN<BHFGW@F=BJ@PAWUGBLPUFX=FP=BICBFBJPG<EGBIEN>O>GP@BPVBYTGPZ>E<[\<A>FG<ABS>XEF=>EXBFEABSNP]CBH<W@P@PG<UG>?<BMUG>?>GTB_ab_cdeBFEAB>EBME>DF=B\PA<=CBPVBJF@Z>ECPEfCB;>C<FC<BFEABg@FWDFG>UBh@F>EBIEiW@TR KCC<EG>F=BP>=BV@PDBj_kl_mnnoao_pqkBNF?>EXBFEG>[<>=<G>UBFUG>?>GT����������� ��r��� R HIJKLBsKKBtuuvB�88�./4-�-.w'#'R xWF=>V><AByMgKBtuuvB]>GNB�$�'#�)0+).48) ����!����\zSzB{JNF@Dz|}HFGW@F=BJ@PAWUGCJ=PGBEPQB~tv�~}BS<UGP@QB�B�MfyFEAN>EFXF@zyWiF@FGzB��tuu�\POzBQB�v~Bvt���B�~�t�FCFFOP?<���XDF>=zUPD��!��������\zSzB{JNF@Dz|}BHFGW@F=BJ@PAWUGCh��}BsFTBMF@GD<EG}J@FG>ZBCPU><GT}BBBIEA>FBUP=PET}BhFWEFXF@}MND<AFOFA[��t��uz\POzBQB�v~Bv�t��B�~v�uXFi<@F����XDF>=zUPD������������������ �������������!��� +0)).4.��96�*)�./4-.*)/4+4.-8�8-.69�0�.4 �-.+)0-+4541��� �������� ������������ R ;<=>?<@<ABC<D>EF@BPEB�S]<@G>FDF@>EQBMB=<FABUPD PWEABV@PDB�_�epcmkkoan_ccedonmaBh=WD<zB�P@BFEG>[BNT<@=>>AF<D>UB<VV<UG�BFGBHIJKL[BMND<AFOFAR ;<=>?<@<ABC<D>EF@BPEB�B\>U@P]F?<[FCC>CG<ABN>XNBC<<ABUN<D>CG@TQMBE<]BG<UNE>�W<B>EBA@WXBA>CUP?<@T�BFGBHIJKL[BMND<AFOFA����������� ��r��� R HIJKLB[sKKBtuuvB�88�./4-�-.w7&#R xWF=>V><AByMgKBtuuvB]>GNB$��#%�)0+).48)
������ �������� ��������������������������������� ������������� ���������������������������������������������������� ��������������������������� !�"#$���%����&'(��������������������� �������� ��������������������������������� ������������� ������������������������ ������ ������)������� ��������������������! "$!�����*&'(��+,-�����������������������������������������������.,-/012-(3/4/01'/(5(4�,5'10602/0'7/',7&,5(/3+4(7,812*1'/(5(4�5'/�-60(910',7/1210'/8/'6������������������������:;<=>;?;@AB;C=DE?AEFAGHIJKALMC;@ENE@AODP QRSTUVUWXSYYZ[\]T[SXVU_Z RaYZbcUb][SXT[U]WYSVUWX[Wd[SbVUe[bWX]VUV\XV][dRWc[UV[fUV_[RYSeSXb[VW[ghijklmnlolpqjlrP sXSXVUWc R][SXT[b_URSY[]fUVb_UXat����� �������u����P vLwJxyzz{A|}E<=~=;@A�=FMA�����&,70,5'/2,P GHIJKx�JJAyzz{A|}E<=~=;@A�=FMA�22�53/1715������������������������������������������(-&171'/8,�.17-10(�/5,'/0+'*36(4�,79,7/5,153/'+4(7-*21'/(5+96*+/5��6+,7�(21+�/(,5.150,7�������������������������FM� I?;B;DF;@A�OBF;?AEFA�AHDF;?DEF=ODE<A��C�OB=}CAODAHDDO>EF=ODBA=DAIME?CE�;}F=�E<A��=;D�;AED@Aw;�MDO<O���AGO>;CN;?yz�z�ALM;C;@ENE@�A�DA��,8,2(&-,5'153 12/31'/(5(4������,'.(34(73,',7-/51'/(5(4�6+,7�(2/5�,,3+(4��������������������/55���10�����'710'������ �������u����� GHIJKA�JJAyzz{A�22�53/1�15��%�� }E<=~=;@AvLwJAyzz{A�=FMA���%��,70,5'/2, �!����������¡¢�¢A£IME?C¢¤�AGEF}?E<AI?O@}�FBAAK}�ED=�}?E�A¥MEDEBCE�:=BF¦AIEFED�Av}§E?EFxA©ªyyz¡ON¢A¦A«{�A{©¬{©Azª{©�@=�;D�EF;<zzz�CE=<¢�OC����)��������¡¢�¢A£IME?C¢¤�GEF}?E<AI?O@}�FBL®I¦x�}?}<�AwE<¢xE<�E�A:=BF¢¦x�ED�<=xAª�°Aªz¬¡EME?EBMF?E¡ON¢A¦AA«{�A{z��¬Ay{¬©{BM?=±EDF²�EF=<�{©�?;@=~~CE=<¢�OC
������ �������� ��������������������������������� ������������� ������������������������������� ������ ��������������������� �!"�� �#����$%&��������������������� �������� ��������������������������������� ������������� ������������������������������'($)* ��������������������� #+�,�-#�"����$%&��������������� ���������������������������������������./(01'12.3'4)'%(&1&5(1/(%)0.45&*6(10�7)4'*2*)02.4(3.*8/8/%.6&59:;<=><?@ABCDE?:BCFG?H?'0'(1/%�'%'*'7%������������������������ IJK LMNOPQJRSTURVPRWTPXTQYMVRXPUTYZT[T\XIRUX]IPYX]OT_ aYQPM TYXT\XXYV]IPYXQTPXTLJ]U]bRMIPb]OTbPRXbRQT]XSTcRbJXYOYd_eTfJ RS]N]STghihTRXIPIORSTj�k..%�82*&0.4(1l&)12�.'4(10m�1�$2'%.n����� �������l����K oM]OPZPRSTp\LqrTsqqTghhtK oM]OPZPRSTufcqTghht ��� ��������vwwTxLJ]UwyTp]IMU]OTLUYSMbIQzPOO{Tr]XdO]OTaMU]eTTcRJQPOT|TaYQI{TcYS]NJPTT}PQIUPbI{~]UYMOPxr]�]QIJ]XyvYNwT�T|tiTt[��tTgghh�QJPVXPaRU�_]JYYwbYwPX�����������vwwxLJ]Uwyep]IMU]OTLUYSMbIQ��YeTTJUPTr]XdO]O�Tr]X�]XT~M ]UT�]XQ_]�]UwTLYI{QROORU�Tv]JMUPTIYO]�T~]IU]TbJYW�}PQIw�TJRP�JaMU]{�iiih��PJ]UTvYNwT�T|tiTthi[�T�h[��U]�RQJ�M ]Uhgg�d ]POwbY�������������������������������������81%k./(/'12�1%(687&�'7%.*('4/7*..1(10&5��+��'$%k'�)(1&1.'1'4&)0)./������������������������� IJK j�1%(&�(2'1%'12�1%(%)6&)*'7%(3(%(./&5�=�<<A?�B?D;B��F�?DnYXT[hT\L�Tghh�TPXTpRWT}ROJP����� �������l����K oM]OPZPRSTufcqTghhtT�PIJT�#�!#�.*7.1%(4.K oM]OPZPRSTp\LqrTsqqTghhtT�44�12('�'1��+�,
������ �������� ��������������������������������� ������������� ������������������������������������ ������ ��������������������� ��!!"!������#$%��������������������� �������� ��������������������������������� ������������� ������������������������������ ������ ��������������������� &��!"!�'����#$%����������������������������������������������������()*+,($+%-(-.�/(01($+%-%2(34.+,($4.�5.*%6402+032%*7%1-.84(0+-6�������������������������9 :;<=>?@A;@B?C?D@E;F�GG4GG34-$%2)+%(,$+/+$5%2HIJKLMNOPJQRLIOSNJ��(#$(#(*-+�1G+-6)*+-4G8*+3#04$8(0+$5(GG(5TUV>;<A@>@B?@E;V?;WXY;:Z[@EV\VE;] _;;����� �������7����9 aVDCbC@E;cWXde;fdd;] _9 aVDCbC@E;g:hd;] _;UC?Z;�i�� �4*,4-$+04������������������������������������j�/(01($+%-%2�41*%64-4*($+/44224,$%2G404,$4.34.+,+-(0#0(-$G2*%3�-.+(-G5G$43%234.+,+-4�������������������������k XA@>@B?@E;<=>?@A;V?;:EC?lV;m=DD@n@;=b;<ZVA[Vmlo;:BEZAV;pBCq@A>C?lo;=B;m=Bn@>?Cq@;Z@VA?;bVCDaA@;VBE;UV>;VUVAE@E;bCA>?;<ACr@k s@DCq@A@E;t@[CBVA;=B;:uXcvwxyCE@;V>;V;B@aA=?A=<ZCm;[=D@maD@;CB;A=lVD;f@DDl;V?;cWXde;:Z[@EV\VEk s@DCq@A@E;t@[CBVA;=B;z;{|}~}�;W[VnCBn;w;V;e@q=Da?C=BCrCBn;bC@DE;�;V?;cWXde;:Z[@EV\VE����� �������7����k cWXde;fddw] _;�00�-.+(�(-��i��k aVDCbC@E;g:hd;] _;UC?Z;�i��'#4*,4-$+04 i��������������;;;;;;;;u�t�;�XZVA[��o;cV?aAVD;XA=Eam?>;;Yw��;fVl;YZV[aBEV;t=m�o�Z�;�Vq@ABVnVA;�a>w>?=<o�VnZ=ECV;e=VE�;�VE=EVAVw�_ v_u=\�;�;�_v;__]��;���ZCAVD>ZAC[VDC�lVZ==�m=[�������������u�t��XZVA[��ocV?aAVD;XA=Eam?>s�x;��;tCqVBVAVlVBVcVqV\<VD@[ohVE@<VDDCnaE@B;uVBEVDosC>?�;�@>?g=EVqVACw���v��:BEZAV;<AVE@>Zu=\�;�;�_v;_����;����>AC>@>ZV�\�n[VCD�m=[
������ �������� ��������������������������������� ������������� ����������������������������������� ��������������������� !� �"!��#����$%&��������������� '� �����(���������)*+*,-./01*234/560/78-09:6;5<88888888888;=98>?@78+@?A./78>BCD8>A0/E/784/A/038F/?A/G608H@5IJ@<5*B+/E/@8)/:.9G6038K/L/<5./?8MNNNOC)9P*8Q8RSC8STDSU8SCDVDW@?XX5*?@GX0TYZA1/@7*;91�������������������������������������[\]\%_&&abcdef_b%_gdaadg%&a&[d]���h�\g%_[\%&eb&�\i_&$e&%dg%_[ddaadg%&ab&jd�\%e\]$e&ig%b�������������������������k JX7@WX0X:8<X1@?/089?8l-/5.9G.I<@979AI3850X/51X?589m8>7n.X@1X0o<8:@<X/<X8/?:8<I?5.X<@<89m8<91X8?9WX78;91G96?:<p8/584q-rKB8>.1X:/P/:k JX7@WX0X:8<X1@?/089?8ls7;X08G095X;5@WX8XmmX;589m8t9<EX77@;8/;@:8m0918uvwxyzz{|}wy~~|�|p8/584q-rKB8>.1X:/P/:����� ������������k 4q-rK8�rr8NOOS8�]]�i_\�\h'� k �6/7@m@X:8F>�[email protected]������degd%_]d
������������� ������������
�������������������� ������������������������������������ !"#��$������$��%�����&�������$'����(�$�)���)*���&��++&$���+$&��,�-�.�����&$/�0����� !"���$����(��%��&�1��2�1�����&���������1$&1�$�����1&���%�3�$$��$�+&$�)$*%�)���(�$�/�4�&1��$����*���������&*%��1$&(�)��&�3���2�����������$�1�*��������3*���$��)�++��*����&�+&$�*�����)*���&�����$����3���������*��/�5*$�)�1�$������������%�%�)������$�*�(�����%�1$&3�����$�%�$)��%�)$*%�)���(�$��3��+&$�*�����%�!&�(����&��������������� &(���.$*%�.���(�$��6������� ..6#/�.�1�$������+&�*����&��+&��&���%�$����$����$���78 9$�+&$�*����&����*)����&+�(�$�&*��)$*%������*)��%�.$*%:�2��1��������&�1���3��������*)���8 9$&�&��1��+&$�*����&��)�(��&1�������*)���8 !������%���1�$������%��&���*)����&���&��);������&��)����)���<*�)��9$&)*���=1$&����8 �&���*��$��&�1��2����&���1$&(���<*�&*���&�*3������&+�1&&$�������$��&�*3���)$*%���&$�+&$�0��������'��%�&+�3����$�)$*%�/8 .�(��&1�����&+��2��1�������������1$&(�)�1$&1�$�����*���%��&:1$&�������%����$��%�������<*�>�8 ?�1�)�3���)�+&$�*����&���+&$�@�1$&(������&+�&$���3�&�(����3�����8 4*�����-��$���)�$����1�$�����&��������������&+�)$*%��3��1��������;���������������-��&�3�����&�����$�&+/8 ��&:3�&1��$����*����7�A&�*��&��)$*%���$%����%���)���, B�)���(�$�8 6��3��������*)��� .�1�$������&+�9��$����*���������<*�11�)�����������:&+��$��+��������+&$�+&$�*����&��)�(��&1����/�@������+�(����*)�����1*$�*��%�����$�)&��&$�����*)������&�%������CD��/6/��9��$�/#���*)����/�0���)�1�$����������)�(��&1�)�(�$�&*���&��$&���)���)��*������)�$�������+&$�*����&���-������&�&%������3�����$���+�$$�)��&�������)*��$���/�E����(��1��&��1�����+��������+&$��&�(����&����&$���-��$���)�$����)&��%��+&$���-����&���������)�$����$���&�������4�&����$�������)� ��&�����&�&%�/��&$�&(�$;�)�1�$�����������%�%�)��������$)����1����$��1$&F�����+&$�)���(�$��&+����$�1�*�����&+�3�&�����&�&%�����-����*$���&$�%��/0���)�������&+������3*��&+���/6/�9��$�/#�����������������$��%�(�����$�/ ��GHIJHKLMNOKPQRSTUVWXRY QRSTUVWXZ[V\V[VU]VTWW_\V[VU]VTWW__\V[VU]VTWW___\V[VU]VTWW_ QTVab]UcdefgcdehgiQefgiQeffXcefgjkefgldefgckemgldeffnlefgWcdmhgcdmogcdmpgcdmegcQmfgcQmffckmegldmffn\mfgkqerskqerrWkqmrskqmrrW tuvwxyz{u|}ztyv~x�z�w|w}y�y|v�~u��w|}w�y��~�vzw��z��w|}w�u�~�y�~�v�wv~vzu�zt|�xz���~u���y��|w�z��w��v~v�y�w|w�~u�z�y���~��yv�~u�y���u�ux�z~�z��w|}w�y��~�w�z��~y��yv�~uv�w�~v�~�v{���w}y��w�vzu�z���y��y���w�z�|u�y|��z����zw���y���u�ux�z�w�wxy}y���y}~�w|�y�y|w�z�w�u|w�u|�z���y|~y��ykR]Z�WQTVab]Ut|�xzty�~�y|�z��v�y}v��w|}w�y��~�w�z�|u����zty�y�u�}y������w|}w�y��~�w�z�|u����zty�y�u�}y������~u}w�y|~w�vt|�xz�y�w�u�~v}��w|}w�u�ux~�w�z��|yy�~�xzw��z�vvw�v�u�~�z��w�yz��w|}w�y��~�v�y}~�w|�y�y|w�z�w�z���y|~y��yz~�z��yz�|ywzu�z��y�~w�~�w�~u�kR]Z�WQTVab]U���u�v~v�|yvy��w�~u�kR]Z�WQTVab]U��yv~vty�y��yzu�z��yv~vkR]Z�WQTVab]Uk�k�nWQ�d _k\W¡fWk�W_W\did\kd�\¢ ££££¤¤¤¤£fp¥¦s§¦fheg¤£££¤¤£¤f¦fm
������ �������� ������������������������������� ������������� ��������������������������� ������� ��������������������� ���!"�# ����$%&��������������������� �������� ������������������������������������������������������ ������������� ��������������������������������������������������� ���������������������������������� ��������"�������$%&�������������� ������ ���� '#!���������������������������������������������()*+,-�(.(/&$0(,%&1�/+*,*2��3*%&)4,�*25&)$3(5()&1�,%*5(%5&.*54/�+(,%�������������������������678 9:;6;<7;=>?@67;:>A7>BC>D9E>F>GHHIF>JK;L=AMA=>@<>7K;>7@?NO>P�4,&%(23,&/&+QR2S55(,%5(+S/4%&5Q$(5)$(2%*.(T<=8 9:;6;<7;=>?@67;:>A7>BG>D9E>F>GHCHF>UA<N?AV>@<>7K;>7@?NO>P�(2%*&,W�X�&1�,X*4,$4%(,%)42%R4Y&&,%&�,X*4Z$5(.(,%*,+(.(5+5((,*,+&1$4%(,%)T7K8 9[MVN6K;=>:;\N;]>N<>6@[\;<N:>@>B>D<7;:<A7N@<AV>_L?@6N[L>@<>D<<@\A7N@<6>N<>9KA:LAO;[7NOAV>_ON;<O;6>A<=>a;OK<@V@bF>;<7N7V;=>P�(2(,%S$X4%(&,0*25&$45%*2S/4%(X5S+X(/*.(5Q)Q)%(0)1&5$&%(,%*4/X5S+4,X.422*,()2455*(5).*4$(Q(5c)$4%235&S%(T����� �������d����8 e[AVNN;=>fD9ghijgg>GHHI>]N7K>�//�,X*4�4,k#W Wl�������������Um_mn9KA:LmoF9KA:LAO;[7NO6piC>f;A:>qNV;6K]A:UA<=N:F>f;;L[OKF>rN67>sf;;L[OKF>Um9>9N<>i>tuvttC>U@Mm>w>xIC>>vHHHt>CHuCC>A:[<m<N?;:y AK@@mO@L��������������Um_m>n9KA:Lmo>9KA:LAO;[7NO6Gz{uIv>f;]>K@[6N<b>M@A:=F>|mDmrmEm>F}A?NF>rD_ai}AV6A=F>9N<i~IBCICF|[�A:A7F>U@Mm>w>xIC>IHCBB>Bvt~~=[:b;6K<N?;:=>ybLANVmO@L�������������������������������������(.(/&$0(,%4,X�34542%(5*�4%*&,&1�S2&4X3()*.(�4,&$45%*2/()1&5�2S/45�(/*.(5Q&1�&�*1/&�42*,�������������������������8 h;\N;]>A:7NOV;>;<7N7V;=>A6>��34//(,+()*,&$3%34/0*2X5S+X(/*.(5QR�S55(,%)2(,45*&T>7K?[MVN6K;=>N<>_@[\;<N:>@>B>D<7;:<A7N@<AV>_L?@6N[L>@:bA<N�;=>M>�m}m>9A7;V>9ghr>E;<7:;F>7K 7KJKL;=AMA=>=[:N<b>GB>iGv>f@\F>GHCH>����� �������d����8 e[AVNN;=>fD9ghijgg>GHHI8 e[AVNN;=>|Jag>GHHI>]N7K>"��l��(52(,%*/(8 e[AVNN;=>|Jag>GHHv>]N7K>�l����(52(,%*/(
������ �������� ������������������������������� ������������� ����������������������� ������� ��������������������� �!"#!�$%����&'(��������������������� �������� ������������������������������������������������������ ������������� ��������������������������������������������������� ���������������������������������� ��������!�)�����&'(�������������� ������ ���� )��$#�������� %$�������������������������������������*+,-./�*0*1(&2*.'(3�4+'5(��*'*.',0*�+2(',6�72&(34.�.',�89&*5'*.+,0*�57-������������������������� :;< =>?@AB;CDEFCGACHEAIEBJ>GCIAFEJKELEMI:CFIN:AJIN@EOPQRJBA>QEJIEMIIJGN:AJIBEAIE=;NFQNSC>SN@EOSACISCBENIDETCS;IJ@JUPVEW;QCDN?NDEXYZYECI:A:CDE[�541(+2(',6\57-\*1,0*59+9+'*2]4&('*.',41����(&',(.,.'*.'93,5+'6*.'759_IDE< WSSCR:CDERJB:CFEKJFERFCBCI:N:AJIEAIELX M=EXYZYEaNIARN@VECI:A:@CDE[�(52714',(.4.\�04174',(.(3�8*52(5*0*5+,b1*�76(4\8*+,0*�,65(*271+,(.�4+*\�.�+,'7�*1�������(34.�.',�(+'*(&(5(',6�-*.'_����� �������c����< d>N@AKACDEeM=fgEXYYhEHA:;E�11�.\,4�4.ij)% ��������������akOkEl=;NFQkmVE=;NFQNSC>:ASBno=ERN:INEpN@NVETN;BA@Eq>IN>FVrAB::kE=NIINVElakE=kmE=MeEsttYuYaJ?kEvEwhZEhLtxtEZuXXuEUNyCIDFNkIARCFzUQNA@kSJQE�468,.�847\845,akOkEl=;NFQkmV=;NFQNSC>:ASBWo=E{J@INI:;CETN@jEO;AFR>FErAB:jr;>@CElaN;NFNB;:FNmV=AIjEsXusstaJ?kEvEhZEhLtx|EXY|LLBNS;AIkIARCFXYYhzUQNA@kSJQ�������������������������������������*+,-.4.\�*0*1(&2*.'(3�*13�271+,39,.-\57-\*1,0*59+9+'*2(34.�.',�� �-*.'�������������������������IDE< =JB:CFERFCBCI:N:AJIEAIELXE=;NFQNSC>:ASN@EJIUFCBBEXYZYkEEfI:A:@CDE[�0*50,*]�57-�4'*.'�,.i4-*+} :;< =>?@AB;CDEFCGACHEAIEBJ>GCIAFEJKELEMI:CFIN:AJIN@EOPQRJBA>QEJIEMIIJGN:AJIBEAIE=;NFQNSC>:ASN@EOSACISCBENIDETCS;IJ@JUPVEW;QCDN?NDEXYZYECI:A:@CDE[�*6*.'7&\4'*(.2,65(&45',6714'*\57-\*1,0*59+9+'*2+3(5&('*.',41\57-4.\0466,.*+6455,*5+0,4&*9*5~+&4'68���276(+415(7'*_����� �������c����< d>N@AKACDEeM=fgEXYYhEHA:;E�11�.\,4�4.i$�< d>N@AKACDEqWTfEXYYhEHA:;E��� )�*56*.',1*
������ �������� ������������������������������� ������������� ������������������������������� ������ ��������������������� !��!"#����$%&��������������������� �������� ������������������������������� ������������� ����������������������'()*)%�+,-.*/,%0 ��������������������� 1�2"���1����$%&����������������������������������������������������./,3+4�.-.5&$6.+%&7�8%.+9.9*.5.)/./&5,99,/$.*/,&+&7�,/&59,$,+.�������������������������: ;<=>?@A?B>C>D?EAF�//'./)+9G&+%*&-.*/,./,+$)%.+%,+3�,&%.GH+&5&30I)/.9=>,++&-)%,&+/JKL=AM??BAN@?=?B>?EAL>A>K?AOPAQBECLBA;KL@RLS?T>CSLDAU<BV@?==AL>A>K?A=> =>WC@RLAXBCY?@=C>ZA<[A\SC?BS?ALBEA]?SKB<D<VZA_KR?ELMLEAET@CBVAPPPaAb?ScAdeef: g?YC?hAL@>CSD?A?B>C>D?EAL=F�6.*3,+3.*)&7$&506.*I)/.9�)+&%.GH+&5&30i>K�)+G.*�)*3.%,+3JNTMDC=K?EACBA\<TY?BC@A<[AOAQB>?@BL>C<BLDA\ZRN<=CTRA<@VLBCj?EA>K >KMZAkAL>Alcmc;L>?DA;ngbAU?B>@?A_KR?ELMLEAET@CBVAdO doAW<YAdePe����� �������p����: qTLDC[C?EAWQ;ngAdeefAhC>KA�55�+9,)�)+r2!: qTLDC[C?EAs_]nAdeefAhC>KA� �#��.*G.+%,5. t �����u������vc\cAw;KL@RcxA;KL@RLS?T>CS=AAAAAA;@LyL=KA]@LE?@=zNNcAlT=A=>LBEAA]KL@LEbC=>{AlLBL=yLB>KL;CBAao||O|AsT}L@L>AAAv<McA{A~fPAf�d|dAaf|f|AKL=RTyKcBCN?@�VRLCDcS<R���������� ���vc\cAw;KL@RcxA;KL@RLS?T>CS=l�|�AWCDyLB>KA\<SC?>Zl�KcAlL}@LBVA_=KL@LRA]KLyyL@MLNLBLVL@_KR?ELMLE�Aaoda|eAsT}L@L>v<McA{A~fPAf||ofAeO�|aARLBLDCcRcNKL@RL�VRLCDcS<R �������������������������������������./,3+)+9�.-.5&$6.+%&7G&+%*&55.9$&*&/,%0&/6&%,G$'6$7&*)+�+%,/$)/%,G)3.+%������������������������� BE: ;LN?@ALSS?N>?EA[<@AN<=>?@AN@?=?B>L>C<BAL>AOdAQBECLBA;KL@RLS?T>CSLDAU<BV@?==AdePeAK?DEACBAb?S?RM?@AdePeAvLBCNLDA<BAF�&*6'5)%,&+�.-.5&$6.+%)+9�%)%,/%,G)5�$%,6,�)%,&+&7�5.6.+%)*0�/6&%,G�'6$&7�,�)+,9,+.�09*&GH5&*,9.J>K: g?YC?hA_@>CSD?ANTMDC=K?EACBAOACB>?@BL>C<BLDA=ZRN<=CTRAK?DEACBAW<Y?RM?@AdePeA/%_KRLELMLEA<BAF�*)5&/6&%,G9*'39.5,-.*0/0/%.6i)$&%.+%,)5����&$%,&+,+��G.+%'*0J����� �������p����: qTLDC[C?EAWQ;ngAdeefAhC>KA�55�+9,)�)+r����: qTLDC[C?EAs_]nAdeefAhC>KA�#�!2�.*G.+%,5.
����������������������� ��� ��������������������������������������� ���!���������� ���"�"������������������"����"����#�$�%���&��"'������������(��%�������)*+,+-.+/0,+12-3*02-045)670896:;8<8;0=-0.>+0.=?2@,ABC ;+D+E=?1+-.0=F012@*=F2G+*021?E3-.0F=*0HE2=13,C )>3*13@=+@=-=12@,0��I��J�����(�K����C LM3E2F2+/045)67BN660OPPQ0C LM3E2F2+/0H8R60OPPQ0S2.>0TTUVW���"&������ XW����������������������� ��� ��������������������������������������������������"��&������"�������"$������"������������������(��%�������C )*+,+-.+/030?=,.+*0+-.2.E+/0Y������&Z�����$[��'""�������'����"$���"���&�����\]�3.0,.0_5-/23-0)>3*13@+M.2@3E0=-a*+,,b0;[email protected]>1+/3G3/C 8@@+?.+/030?=,.+*0+-.2.E+/0Y��&�����Xd�e��������������������&�[��� ������������]��"���������-/���"�"�����������������f0F=*0O05-/23-0)>3*13@+M.2@3E0=-a*+,,b0;+@c0OP_P03.0:3-2?3E��I��J�����(�K����C LM3E2F2+/045)67BN660OPPQ0S2.>0�������������#gWhC LM3E2F2+/0H8R60OPPQ0S2.>0TTUii���"&������ %�����I�����:cjc0k)>3*1clb0)>3*13@+M.2@,0)=,.A0m3-n3-073-@>>=/o3-n3*0F3E23b00;2,.p0o3E,3/HMn3*3.p0qQPrr:=Gc0A00sQ_0QQtQq0P_OquG*2n+,>c-2?+*va132Ec@=1J��I���� �:cjck)>3*1clb)>3*13@+M.2@,OB:cNc0)3*wb0=??c073.>2031*320bH3-a3?M*0*=3/0b43,>2w0B0xOOP_q:3>3*3,>.*30:=Gc0A0sQ_0QP_y0qyQQQ00D2,>3Ez1=a3EPtv{3>==c@=c2-������ %����(����J����|�U�Ud�I���Ue�I���������� |�����}������� ���������g�I����%����������J����| �~����������g�h���hhT V�Ui����U�W(�h�d������������Ue%U�I���������� %����(����J����|�U�Ud�I���Ue�I���������� |�����}������� ���������g�I����%�� ���������J����| �~����������g�h���hhT ����WU��(�hd������������Ue%U�I����
������ �������� ������������������������������� ������������� ����������������������������������� ��������������������� �!"�� �!"����#$%��������������������� �������� ������������������������������� ������������� ������������������������������� ������ ��������������������� !!& �"'����#$%����������������������������������������������������%(#)*)$+,-�.)/01+1%2�-34/)$%*01$*45$4*-).6�*)(-7%*8+.��9�4*%#-).6�)#).�������������������������:;< =>>?@A?;B@CDA?EBCFBGABHIBJ:;KG:B@LGEMG>?NAK>GOB>C:PE?DDBQLK>LBQGDBBL?O;BAL ALC:BRSBT?>BACBRUBT?>BIVRVBK:BWG:K@GOBX:KY?EDKAZ[BC:B\�%(#)*)$+,-).)/01+1*-34/)$%*01$*45$4*)/)##*%,)/#*%5-112%*(-6+5)/6-,+5-+.��).6������]AL< N_OKDL?;BE?YK?QBK:BDCNY?:KEBCFBHBJ:A?E:GAKC:GOBZM@CDKNMBC:BJ::CYGAKC:DBK:BLGEMG>?NAK>GOB>K?:>?DBG:;Ba?>L:COCPZ[B=LM?;G_G;BIVRVB?:AKA?;BbB�c)//-.3-1�.�#c$c)/(+5�*43�-/+,-*0d�4**-.$�5-.)*+%����� �������e����< fNGOKFK?;BgJhiBIVVUBQKALB�//�.6+)�).8jBk� < fNGOKFK?;Bl=ahBIVVUBQKALB���'k�-*5-.$+/- " m�����������BBWnnoLGEMnpBLGEMG>?NAK>DRVVqRRrU[sGtMKuEN@GBvOGAD[BGEGD:GPGE[BCOGBECG;[B=LM?;G_G;wxrVVHx[BlNyGEGAWC_nBzB{URBUHxrVBxr|I}uLNDL_N@GA?Orr~PMGKOn>CM����m�����WnnoLGEMnpBLGEMG>?NAK>D|xq=BPGZGAEKB:GPGEBDC>K?AZ[B:?GEBG;GEDLBYK;LZGOGZG[BWGL?DG:GBECG;[B;KDAzBWGL?DG:G[B�KD:GPGEwxr}xR|[lNyGEGABWC_nBzB{URBUrI}xBRVSUrB@GA?O;K@GunRUrr~PMGKOn>CMB��������������������������������������-/$�*).4/)$+%.)1).)##*%)5c2%*6-,-/%#(-.$%21$)�/-�)�-#*)�%/-1%6+4(�%*(4/)$+%.�������������������������< i?YK?QBGEAK>O?B?:AKAO?;BGDBb�%$$/-.-581$%�*43�+15%,-*0).6�-,-/%#(-.$�B@N_OKDL?;BALK:BCNY?:KEBCFBHBJ:A?E:GAKC:GOBZM@CDKNM< CDA?EB?:AKAO?;BGDBb�114-1).65%.$*%,-*1+-1+.#)$-.$+.3�+%$-5c.%/%30�)1-6+..%,)$+%.1�BDABLGDB_??:B@E?D?:A?;BGDB�CwGNALCEBGABAL?BHRJ�DA< �C:BRB@EK�?BK:BWC;?OB@E?D?:A?;B?:AKAO?;BGDB\�).%�4��/-d�.-(-*3+.3$*).12-5$+%.,-5$%*2%*/4.36+1-)1-1]BK:BWZEKG;BL?O;BGABlNyGEGABvCE?:DK>B>K?:>?BX:KY?EDKAZ����� �������e����< fNGOKFK?;BgJhiBIVVUBQKALB�//�.6+)�).8BwB"�< fNGOKFK?;Bl=ahBIVVUBQKALB����!�-*5-.$+/-
������ �������� ������������������������������� ������������� ������������������������������� ������ ��������������������� ��!"#�$$����%&'��������������������� �������� �����������������������������������������������������( ������������� ������������������������������������� �������������������������� �#�!����%&'�������)���)��������� ������ ���� *�"�������� +��������������������������������������,-./0102�,3,4'%5,0&'6�'3,4�17&.84,6'7����,4.3,79�������������������������:;< =>?@A@BCDEF@D?@GH?>IJFKL?>M>NO@PH:FQ@R>QFM@F?;D;MFQ@H:@S�10'TUTT4,V�0,5,7/.0/&710-6,8&.'03,8&'76'74U0/2.-,1-,-W@D?@ROCDHQIJLF@KMX:;FC:@>Y@FZF?;:@LFMQ@H;@[X\HCH;@;L]>CF?:DK@KDF?KF@_?DZFC:D;O@>?@a@G>ZFbcFC@dAde@[H?QLD?HNHCe@[X\HCH;?Q@< fHBFC@HKKFB;FQ@Y>C@B>:;FC@BCF:F?;H;D>?@H;@g hfie@>?@jkH;KL@=HlbH?@mK;@nk=mo@H?Q@D;:@:DN?DYDKH?;@FYYFK;@>?@h?QDH?@BLHCbHKFX;DKHM@D?QX:;CDF:p����� �������(����< qXHMDYDFQ@Ghfrs@dda@tD;L@�44�02.1�10u � ������(���Rvv@nfLHCbvoefLHCbHKFX;DK:k>X:F@G>v@wAdxa@FK;>C@@d@Pe@iLH?QDNHCLefD?@y@AgdddR>cv@z@aA@a{|}x@d|~{C\?:tHbD�NbHDMvK>b ���������RvvnfLHCbvoefLHCbHKFX;DK-fH;FMZH:em;I�DNHQDe@@JHI�HQDe@�D:;IRHLF:H?HefhGI|x}A{e[X\HCH;@R>cv@z@�aA@a}}x@|xx@BH;FMZDBXM�c�OHL>>vK>b@�������������������������������������,-./0�2,3,4'%5,0&102,314U1&.'0'6&�,8'0&7'44,27,4,1-,6'75U41&.'0'6&�,�'-U31-&1&.0�148.U5�������������������������� mBBMDKH;D>?@>Y@;LF@RFM;@NCH?XMH;D>?@JFKL?>M>NO@h?@;LF@:;HcDMDEH;D>?@>Y@;LF@R>D:;XCF@F?:D;DZF@QCXN� �>BD?N@H?Q@H?HMO;DKHM@bF;L>Q@QFZFM>BbF?;@Y>C@;LF@fC>LDcD;FQ@:Xc:;H?KF@����� �������(����� qXHMDYDFQ@Ghfrs@�rr@dda@�44�02.1�10u�$� qXHMDYDFQ@[mJr@dda@tD;L@������,78,0&.4,
������ �������� ������������������������������� ������������� ������������������������������� ������ ��������������������� ��!�"#�� ����$%&��������������������� �������� ������������������������������� ������������� ������������������������������� ������ ��������������������� '!�'!" �'����$%&����������������������������������������������������()(*&$+(,%-,.�)-*/-%0&,&1�2%(,.(.�(*(-3(4�&,��,150,60,6�&5+/*-%0&,&1�*1/7&30,89.5&:8*&50.(�������������������������;<= >?@ABACDEFGAE@AHI@?JKGLM@?N?OPAQI;GRAS?RGNAG@<E<NGRAI;AT�-,&U/UU*(V�,(+(560,6%5-,31(:%0&,)(:%&51&5*/,6.03(-3(3WAE@ASPDEIRJKMGALNX;<GD;A?YAGZG@<;A<MMGNRAI<A[X\IDI<A]?DG@;ELALEG@LGA_@EZGD;E<PA?@AaAH?ZGbcGDAdBdeA[I@RME@IOIDeA[X\IDI<= fGZEGgAID<ELNGAG@<E<NGRAI;AT�8-**(,6(30,&$8%8-*+0:.5/6.(*0)(59V�/55(,%<M3:(,-50&WACXcNE;MGRAE@A?XZG@EDA?YAhAi@<GD@I<E?@INAPbC?;EXbA?DOI@EFGRAcPAQjkjAlI<GNAlmfnAoG@<DG����� �������p����= qXINEYEGRAHilmfAddaAgE<MA�**�,.0-�-,r' = qXINEYEGRA[sKmAddaAgE<MAA����t�(5:(,%0*( !���������SjjAulMIDbjvelMIDbILGX<EL;owBeHGgA[EDRMIDAlIDxA?LjeAAyCCjeAojHjkERMPINIPIeAsbcIZIREeAmNNE;cDEROGeAsMbGRIcIRAzA{|dddhA[X\IDI<AS?cjA}A~aBAa�{�BAhd{ad@GMI;IDI<ME�ObIENjL?b�� �������SjjAulMIDbjvelMIDbILGX<EL;BB{wQAHGbE@I<MA?LEG<PeAHGIDeAkIREOIbA?LEG<PeAMIxASIDxG<efI@ECeAsMbGRIcIRz{|A�|deA[X\IDI<AS?cjA}A~aBAah�aAB{aDIZE�CMIDbILE;<�ObIENjL?bA�������������������������������������()(*&$+(,%-,.�)-*/-%0&,&1�/*3-%0*(�(*0)(59�93%(+&1 -*3-5%-,�������������������������= fGZEGgAID<ELNGAG@<E<NGRAI;AT�+(560,6(5-&1$&*9+(5U-3(.�-,&%(:8,&*&69V�-,:(5<M�-56(%%0,6WY?DA;?XZG@EDA?YAhAi@<GD@I<E?@INAPbC?;EXbA?DOI@E;GRAcPAI@RAMGNRAI<AQjkjlI<GNA<M <MlmfnAoG@<DGeAsMbGRIcIRARXDE@OAhJ|AAH?ZGbcGDedBd= nGNEZGDGRA;GbE@ID;AI<AHilmfAsMbGRIcIRAG@<E<NGRAI;}�,%5-,-3-*.(*0)(59&1�0$&3&+(3%&�5-0,�0&30+0*-53V�&$(-,.�9$(����� �������p����= qXINEYEGRAHilmfA�mmAddaA�**�,.0-�-,r'#= �XINEYEGRA[sKmAddaAgE<MA�#�#�(5:(,%0*(
��������������������� ������������������������������������������� ���������� ������������������������������������������� ����� �������!���������������������������������"��#����������������������������$�������������������%�����������&�'������"����'�(������������������$������������ �� �)#�����������������������$����������������������������� ���"����)�����������"����������"�����*����������������������� ������������� ����"������������� �� �)#�����%��%���������������������������������������������������������+�������� �����,�� ����������������"��$���������������������������������������������������� �� �)#�������������+������� ���������-����������������������"������������������������������ �������� ��)������������ ��������$������������������������� ������������������-���������������� ������������ ���������+������������������������� ����$. /0123452067834894:10938;5<=;>?9<6<:38@?>A7. B<>>8C05:27D<18?25=94:12324:<18544678C458E:3<5F2<G7. H0>>I8946J03<52K<184CC29<8. L21<4894:C<5<:92:M8C?92>23I82:87J<92?>89?7<7
��
������������������� ������������������������������� !" ��#�$�#�%��&�'���������(&�)&��������� '���������� ����*�+,-�.,�/.01,1.2�3�/.0-405,�67889�������*�������&���������:;����&����3������:���#������&����������������������������������������������������������<�$����*�===&�����!� ��#�$�#&����>?@AB>��CCD@EBF>CD��G�HIJK�L�MN�O=����(�#�����'�����P�#����� ��Q��R�#��S BTHU�TL����VUJH��W�XY��Z�[����\�;�� �"�������SS]F�?>_��CCD@EBF>CD���T�TJIUHJ��'�&�W��[Y�W�������$����:;����&����'�&�a����bY����W��#������#��[Y/55.:;����&����G�HIJK�L�MN�'�&��������� �Y ���������5-1:X� ��&��&���'�&�������� ��R����R�������� ��R����R�: ������&���SS BTHU�TL����VUJH��'�&�"�����W� �������������� ������:X����&�����'�&�O ������"���#[�=����#�� ���������#:X� ��&��&��SS�T�TJIUHJ��'Y�;�� �(�� ���� �R��OY� ���O�� ���� �Y# ����"�Y��� �Y# ��X�
CURRICULUM VITAE
Swati Yogesh Badatia M.S. (Pharm) Biotechnology
Present Address: National Institute of Pharmaceutical Education and Research, Ahmedabad, C/o B.V.Patel PERD Centre, S.G. Highway, Thaltej, Ahmedabad, Gujarat, 380054.
Career Objective:
To consistently learn & work with assets like team spirit, dedication, honesty in a challenging & competitive environment for the fulfillment of organization’s objectives & prove myself as a key factor for the growth of the organization Areas of Interest:
� Expression of recombinant proteins in expression systems � Research and Development in bioprocessing of recombinant proteins � Intellectual Property Rights
Academic Credentials:
Course School / College Year of passing Result
M. S. (Pharm) (Biotechnology) NIPER-Ahmedabad
Expected in May 2011
CGPA: 7.6/10
B.Pharm Sitabai Thite College of Pharmacy, University of Pune
2009 67.83 %
HSC Dr. S.K Junior College, Mahrashtra Board 2004 76%
SSC Andhra High School, Mahrashtra Board 2002 78.13 %
Awards/Achievements:
• Qualified NIPER JEE 2009 : 339 (AIR)
• Qualified GATE 2009 with 97.22% percentile.
• Successfully completed the distance learning course General Course on Intellectual Property from “World Intellectual Property Organization (WIPO) Wo rldwide Academy, Geneva, Switzerland” with 89%.
• Successfully qualified the Maharashtra State Certificate in Information Technology (MSCIT) exam with 82%.
Dissertation Project :
Enhancing the expression of therapeutic proteins inn mammalian cell line (CHO cell line) using different strategies
Recombinant therapeutic proteins (RTPs) produced in mammalian cells represent a major class of biopharmaceuticals and a majority of them are produced using CHO cell lines. A major limitation of CHO cell lines being the low yield of protein and hence the higher cost, the goal of current project is to decrease the production cost by increasing the recombinant therapeutic protein yield from CHO cell lines by increasing the cell specific productivity by using cell cycle growth arrest strategy (isolating cells at G1 phase) and also by increasing the cell viability by reducing factors responsible for apoptosis of cells. Technical Skills:
Molecular biology Methods: Techniques such as Transformation of plasmid, Plasmid/DNA/RNA isolation, Restriction and Ligation of plasmids, Gel electrophoresis and SDS PAGE, PCR, RT-PCR, Western blotting, etc.
Cell culture: Handling of primary and secondary animal cell cultures, transfection in mammalian cell lines using Electroporation.
Analytical Techniques: Techniques such as TLC, HPTLC, HPLC , Column chromatography, interpretation of UV , IR , NMR and MS spectrum
Bioinformatics skill : shRNA designing, primer designing, BLASTs, detection of SNPs and application of databases such as NCBI, ensemble, OMIM, PDB, NEB cutter etc. familiar with softwares such as DNA Club, etc.
Computer Skills: Well acquainted with Microsoft Office and Internet.
Extracurricular Activities:
Conferences Attended and Publications : • Presented poster entitled “Antidiarrhoael activity of Moringa oleifera” at the 61st
Indian Pharmaceutical Congress, Ahmedabad
• Paper entitled “A study on the prescription pattern in patients with Dysfunctional Uterine Bleeding (DUB) in Pune” selected for poster presentation in 62nd Indian Pharmaceutical Congress to be held at Manipal
• Attended 6th International Symposium on Innovations in Pharmaceutical Sciences and Technology at Ahmedabad, 2010.
Seminars delivered on:
• “Expression of Insulin in Arabidopsis thaliana” at NIPER-Ahmedabad, 2009.
• “Clinical Trials – An overview” at NIPER-Ahmedabad, 2010
Projects and Presentations: • A Practical Project on “Preparation and preliminary characterization of
mucodhesive microspheres of Norfloxacin” in partial fulfillment of 3rd year Bpharm 2008.
• A Practical Project on “Preparation and preliminary characterization of floating tablet of Dicyclomine”.
Industrial Work Experience:
Pursued one month industrial training in Cipla Pvt Ltd at Kurkumbh Personal Details: Date of Birth : 7th Nov, 1986. Marital status : Unmarried. Gender : Female. Language Known : English, Hindi, Marathi. Contact No. : +91-9601512889 E mail Address : [email protected] Permanent Address : Plot no-52, Survey no-88/4 Gujrat Colony Kothrud, Pune-411038, Maharashtra References:
Prof.Dr. Harish Padh Vice Chancellor, S P University Vallabh Vidyanagar Gujrat. Ph No: +91-9924452200 [email protected]
Dr Preeti Desai Research Associate NIPER Ahmedabad. Contact No - +91-9879205669 [email protected]
Declaration:
I hereby declare that the above mentioned statements are true to the best of my
knowledge and belief.
Regards, Swati .Y .Badatia
Mob. no. +91 9601527661 Email address: [email protected]
BACK to Previous Page
MINAL V. CHAUDHARI
M.S. (Pharm) Biotechnology
Correspondence Address
National Institute of Pharmaceutical Education & Research (NIPER), c/o – B. V. Patel PERD Centre, S.G. Highway, Thaltej, Ahmedabad, GUJARAT-380054
Career Objective
Intend to build a career in field of Pharmaceutical Biotechnology by exploring new facets of research for the benefit of organization and community
Areas of Interest
• Research and development in cancer therapeutics • Developing cell based Assays for screening potential Drug candidates • Intellectual properties rights and Regulatory affairs
Educational Qualifications
Course BOARD/UNIVERSITY Year of passing Result
M.S. (Pharm)
Biotechnology
NIPER-Ahmedabad Currently
pursuing
cGPA 7.77/10
(up to II sem)
B. Pharm M.S.University, Vadodara 2009 61.77 %
H.S.C C.B.S.E 2005 69.2 %
S.S.C C.B.S.E 2003 72.2 %
Other Qualifications
Successfully completed the distance learning course General Course on Intellectual Property from “ World Intellectual Property Organization (WIPO) World Wide Academy, Geneva, Switzerland”
M.S. Pharm. Project
In vitro and in vivo evaluation of some selected novel NF- ĸB activators as radioprotectors Ionizing radiation like gamma rays is used to treat many malignant neoplasms. The aim of radiotherapy is to destroy cancer cells with little damage to the normal cells.
Radioprotectants are a class of drugs that may selectively alleviate negative irradiation effects on normal tissue while allowing desirable negative effects on cancerous tissue. The main objectives for this study are:
• Evaluating in vivo the radioprotective effects of Novel Chemical Entities (NCEs) that have been shown to activate NF-κB in vitro
• Testing the selective effects of different compounds (radioprotectants) including NCEs on normal cells as well as cancer cells.
We aim to contribute to the development of a novel radioprotective compound so as to overcome the side effects of radiotherapy given to cancer patients.
Technical Skills
• Molecular and Cellular Biology:
� Mammalian Cell culture - Primary culture: Initiation and maintenance of Primary Cell culture (Bone marrow cells and Blood Lymphocytes)
Secondary Cell Culture : Initiation and maintenance of Cancer Cell lines
� Basic rDNA techniques- Initiation and maintenance of culture, Plasmid isolation, Vector construction, transfection and transformation
• Basic Cell Biology Techniques : Vital staining and fluorescence microscopy, Native and SDS PAGE, Western Blotting, Isolation of DNA, RNA and Proteins, PCR, RT-PCR, DNA Gel Electrophoresis, Comet Assay
• Pharmacology : Animal Handling and Dosing, Blood collection
• Bioinformatic Tools : Basic tools like BLAST, Clustal W, NEB Cutter, Primer designing
• Analytical : TLC, HPTLC, HPLC, UV-Vis spectroscopy, IR Spectroscopy, Column Chromatography
Achievements / Awards
• Qualified GATE in 2009 • Qualified NIPER - JEE in 2009
Presentations/Publications
Presented seminars at NIPER-Ahmedabad • Gene silencing with SnRNP: A Novel Technology • STATINS: Potential Therapeutic Role in Respiratory Diseases
Industrial Work Experience
One month summer training in KapTab Pharmaceuticals, Vadodara in June 2008
Conferences Attended
1. Attended 61st Indian Pharmaceutical Congress (IPC) held at NIRMA University, Ahmedabad (2009)
2. Attended 6th International Symposium held at B.V. Patel PERD Centre, Ahmedabad(Nov 2010)
Extra-curricular Activities
1. Participated in “Rasayanam” (Product launching event) in Foot-Prints, held at M.S.University, February 2008
2. Student Editor in “Pharmastir 08” – M.S.University, Pharmacy Department Annual Magazine
Personal Details
Date of Birth : July 29, 1987 Marital Status : Unmarried Father’s Name : Chaudhari Virambhai B. Languages known : English, Hindi, and Gujarati Contact no. : 09998710442 E-mail :[email protected] Permanent Address: At Nanicher, P.O. Ratania,
Tal: Mandvi, Dist: Surat - 394160 GUJARAT
RFERENCES
Prof. Harish Padh Dr. S Lakshmi Vice Chancellor, S.P. University, Research Associate Vallabh Vidyanagar, Gujarat NIPER- Ahmedabad,Gujarat Ph No: +91-9924452200 E-mail: [email protected]
Ph No: +91-9879845066
BACK to Previous Page
CURRICULUM VITAE
CChhaauuhhaann SSuunniill JJaayyaannttiibbhhaaii MM..SS.. ((PPhhaarrmm)),, BBiiootteecchhnnoollooggyy
Present Address: National Institute Of Pharmaceutical Education And Research (NIPER), Ahmedabad c/o – B.V.Patel PERD Centre, S.G.Highway, Thaltej, Ahmedabad, Gujarat Pin - 380054
Career Objective: To secure position in pharmaceutical R & D and contribute to organizations success. EDUCATIONAL QUALIFICATIONS
Dissertation Topic: Identification of genetic marker for breast cancer Aim: To establish the association between polymorphisms in breast cancer related genes MDM-
2 and p53 and breast cancer in Indian population. Association of polymorhism between breast
cancer related gene and breast cancer will be established which will be helpful in understanding
the disease etiology. Hence such association study will lead to identification of genetic marker
for breast cancer.
TECHNICAL SKILLS Biotechnological : DNA isolation, Real time PCR, Gel electrophoresis, Bacterial transformation, PAGE, Western blotting Analytical : UV & Visible spectrophotometer, IR spectrophotometer
Sr No Year Course Institute/ University % Marks Class
1 2010-11 M.S-Pharm National Institute of
Pharmaceutical Education And Research(NIPER), Ahmedabad
Appearing
2 2008 B.Pharm Gujarat University, Ahmedabad
61.50% First
3 2004 H.S.C G.H.S.E.B 68.46% First
Others : Familiar about Bioinformatic tools(BLAST,FASTA), Primer designing, NEB Cutter , Animal handling, Dosing in animals
Industrial work experiance:
• Worked as a trainee for one month at QUE PHARMA, Surendranagar(2007) • Worked as a trainee for two months at Indica Laboratories, Ahmedabad(2008)
Achievement:
• NIPER JEE 2009 All India Rank 404 • Qualified GATE 2009 with 92.06 Percentile.
Personal Details: Date of birth : 20th June, 1987 Marital status : Unmarried Gender : Male Languages known : English, Hindi, Gujarati Contact no. : 9725610970,9898034668 E-mail : [email protected] [email protected] Permanent address : B-203 silverline residency Opp, kirtan complex,New C.G road Chandkheda,Dist-Ahmedabad Pin - 382424 I hereby declare that the above written particulars are true to the best of my knowledge and belief.
Date: Chauhan Sunil.J.
Reference:
Dr. Aliasgar F. Shahiwala
Associate Professor NIPER, Ahmedabad Contact No - +91-9913764700 +97-1552563898 [email protected]
Dr. Neelam Chauhan Assistant professor, NIPER, Ahmedabad. Contact No.-9879855342 Email [email protected]
BACK to Previous Page
CURRICULUM VITAE
DDiippaann SShhiirriisshhbbhhaaii KKaaddiiaa MM..SS.. ((PPhhaarrmmaa)),, BBiiootteecchhnnoollooggyy..
Address 19 “Shekhar chhaya” Choksipark soc, Bhaduatnagar, Maninagar, Ahmedabad-08.
.
Career Objective To secure position in pharmaceutical R & D, contribute to organizations success and to enhance my professional skills in a dynamic and stable workplace. EDUCATIONAL QUALIFICATIONS
Other Qualification
• Successfully completed the distance learning course General Course on Intellectual
Property from “World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland.”
Sr No Year Course Institute/ University % Marks Class
1 2009-11 M.S(Pharma) National Institute of Pharmaceutical Education And Research(NIPER), Ahmedabad
pursuing Upto SEM-2 CGPA-7.65
2 2005-09 B.Pharm Shri Swaminarayan College of Pharmacy, Gandhinagar.
65.12 First
3 2003-05 H.S.C Gujarat Board 64.7 First
4 2001-03 S.S.C Gujarat Board 87.6 Distinction
Dissertation Topic Bioengineering Lactococcus lactis for the development of mucosal vaccine against Shigella Dysentraie Type-1. The primary aim of work is to transform Lactococcus lactis, an innocuous bacteria used in food industry since decades, with the plasmid carrying antigenic gene sequence of Shigella dysentraie type-1.The resultant recombinant strain of Lactoccocus lactis is confirmed for the heterologous protein formation at DNA, m-RNA and protein level by respectively performing PCR, RT-PCR and Western blot analysis. Achievement
• NIPER JEE 2009 All India Rank 135. • Qualified GATE 2009 with 98.2 Percentile (All India Rank 423).
Practical expertise In the entire course of my project work, I have developed proficiency
• In growing, maintaining and optimizing growth of bacterial cell culture, • Isolating plasmid from bacterial cell culture, performing its RE-ligation, • Transforming bacterial culture with the plasmid of interest, • And In Performing PCR, RT-PCR and Western blot analysis.
Area of Interest
� Process development of heterologous protein expression in bacterial cell.
Personal Details Date of birth : 04th Nov, 1987 Marital status : Unmarried Gender : Male Languages known : English, Hindi, Gujarati. Contact no. : +91 9979508861 E-mail : [email protected] Permanent address : 19 Shekhar Chhaya,
Chpoksipark soc, Bhaduatnagar, Maninagar, Ahmedabad-08. Gujarat,India.
Reference.
Dr. Preeti Desai Post Doctoral fellow, Pharmaceutical Education and Research Centre(PERD), NIPER-Ahmedabad. [email protected]
BACK to Previous Page
CURRICULUM VITAE
KKhhaann AAnnwwaarr AAhheemmaadd MM..SS.. ((PPhhaarrmm)),, BBiiootteecchhnnoollooggyy Present Address: National Institute Of Pharmaceutical Educationti And Research (NIPER), Ahmedabad c/o – B.V.Patel PERD Centre, S.G.Highway, Thaltej, Ahmedabad, Gujarat Pin - 380054
Career Objective: To work in Bio-Pharmaceutical industry in India & intend to build a growth oriented career in competitive corporate environment with full commitment & dedication. EDUCATIONAL QUALIFICATIONS
Other Qualification:
• Successfully completed the distance learning course General Course on Intellectual Property from “World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland.”
Dissertation Topic: Strategies to enhanace the protein expression level in CHO cell line The primary aim of the project is to analyze the correlation between transfection efficiency and expression level of the transfected gene, employing different transfection methods which includes electroporation, calcium phosphate mediated transfection, polyplex and liposome based transfection in CHO cells. Achievement:
• NIPER JEE 2008 All India Rank 247 • Qualified GATE 2008 with 91.73 Percentile.
Instrument Knowledge: Expertise in analyzing and interpreting data from various instruments like
� UV Spectrophotometer � Zeta sizer
Sr No Year Course Institute/ University % Marks
1 2009-10 M.Pharm NIPER, Ahmedabad Appearing
3 2006-09 B.Pharm Pune University 62.12 4 2004-06 D.Pharm MSBTE 83.3 5 2003-04 HSC Mumbai Board 50.17 6 2001-02 SSC Mumbai Board 73.4
Areas of Interest:
� Gene delivery and gene expression � Novel Drug Delivery System � Regulatory affairs and Intellectual Property Right(IPR)
Personal Details: Date of birth : 1st May, 1985 Marital status : Unmarried Gender : Male Languages known : English, Hindi,Urdu, Marathi Contact no. : +91 9016840001 E-mail : [email protected]
[email protected] Permanent address : A/4 Ramdhani Yadav Chawl,
Nr. Anjeli medical store, Mohilli village, Sakinaka ,
Mumbai- 400072 I hereby declare that the above written particulars are true to the best of my knowledge and belief. Date: Khan Anwar:
Reference:
Dr. Harish Padh
Vice Chancellor, S P University Vallabh Vidyanagar Gujrat. Ph No: +91-9924452200
Dr. Priti Desai Research Associate NIPER Ahmedabad. Contact No - +91-9879205669 [email protected]
Technical skills: Molecular and cell Biology Techniques:
� Basic rDNA technology: Initiation and maintenance of culture, Plasmid isolation,Vector construction, transfection and transformation
� Mammalian Cancer Cell Culture: culture maintenance, Transfection, RTPCR (Reverse Transcriptase Polymerase Chain Reaction) and Gel analysis.
Bioinformatics Tools: Basic tools like BLAST, OMIM, NEB Cutter, and sound knowledge of primer designing. Analytical: HPLC, TLC, HPTLC, UV-Vis Spectroscopy, IR spectroscopy, Column Chromatography.
IPR : Sound knowledge of Intellectual properties rights and Regulatory affairs.
BACK to Previous Page
CURRICULUM VITAE
PPrriiyyaannkkaa PPaannddeeyy MM..SS.. ((PPhhaarrmm)),, BBiiootteecchhnnoollooggyy
Present Address: National Institute Of Pharmaceutical Education And Research (NIPER), Ahmedabad c/o – B.V.Patel PERD Centre, S.G.Highway, Thaltej, Ahmedabad, Gujrat Pin - 380054
Career Objective: To secure position in pharmaceutical R & D and contribute to organizations success. EDUCATIONAL QUALIFICATIONS
Dissertation Topic: Identification of genetic marker for Diabetes
Aim:. To evaluate the frequency of variants of KCNQ1 gene for diabetes in Indian population
and To establish the association between polymorphisms in KCNQ1 gene and diabetes in Indian
population.Frequency of variants of diabetes related gene will help in identification of individual
susceptible to diabetes in near future.Association of polymorhism between diabetes related gene
and diabetes will be helpful in understanding the disease etiology.
Sr No Year Course Institute/ University % Marks Class
1 2009-11 M.S National Institute of
Pharmaceutical Education And Research(NIPER), Ahmedabad
Appearing
2 2009 B.Pharm RGPV,Bhopal
79.8% First
3 2004 H.S.C C..B.S.E 82% First
TECHNICAL SKILLS Biotechnological : DNA isolation, PCR, Gel electrophoresis, Bacterial transformation, PAGE, Western blotting Analytical : UV & Visible spectrophotometer, IR spectrophotometer Others : Familiar about Bioinformatic tools(BLAST,FASTA), Primer designing, NEB
Cutter.
Industrial work experience
• Worked as a trainee for one month at BRO-SHELL, Sagar(2008)
Achievement:
• NIPER JEE 2009 All India Rank 296 • Qualified GATE 2009 with 90.66 Percentile.
Personal Details: Date of birth : 18th July, 1985 Marital status : Unmarried Gender : Female Languages known : English, Hindi Contact no. : 9376466422, E-mail : [email protected] Permanent address : H.No 185 Tulsi Nagar Ward, Bhagwan Ganj,Sagar(M.P)-470002 I hereby declare that the above written particulars are true to the best of my knowledge and belief.
Date: Priyanka Pandey
Reference: Dr.Neeta Shrivastava, Project Director, NIPER-Ahmedabad. Contact no-9824250226 Dr. Neelam Chauhan Assistant professor, NIPER, Ahmedabad. Contact No.-9879855342 [email protected]
BACK to Previous Page
CURRICULUM VITAE
Poonam Chandrakant Tambe M S (Pharm) Biotechnology
Present Address: National Institute of Pharmaceutical Education and Research, Ahmedabad C/o B.V.Patel PERD Centre S.G. Highway, Thaltej, Ahmedabad, Gujrat, 380054
Carrer Objective:
Aim to work in Bio-Pharmaceutical industry and intend to build a growth oriented career in competitive corporate environment with full commitment & dedication.
Academic Credential:
Course Institute/University Year of Passing Result
M S (Pharma) Biotechnology
NIPER, Ahmedabad Expected in May
2011 cGPA – 9.17
(upto second sem)
B Pharmacy College of
Pharmacy,Nashik, Pune University
2009 71.83 %
HSC RYK College,Nashik,
Pune University 2005 79.17 %
SSC Sarda Kanya Vidya
Mandir,Nashik 2003 72.40 %
Other qualification:
Successfully completed the distance learning course General Course on Intellectual Property from “World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland.”
Area of Interest:
� Research and Development (R & D) specially in developing new biomolecules � Formulation and Development (F&D) of Biotechnology derived Drugs � Developing cell based assays for screening potential drug candidates
Dissertation Project: Inhibition of Lymphangiogenesis in Breast Cancer cell line by VEGF-C shRNA
The long term control over cancer can be best achieved by judicious combination of cytotoxic therapy and antiangiogenic therapy. Aim of the project is to develop an antiangiogenic agent. Metastasis poses the biggest problem to cancer treatment and is the main cause of death of cancer patients. The majority of studies identified Lymphangiogenesis and Lymph node invasion are critical steps in metastatic dissemination of solid tumors like breast tumor. The main objectives of this study are :
� Inhibition of VEGF-C, involved in the process of lymphangiogenesis, through the development of shRNA vector which is reported to give a site specific and long term inhibition of target mRNA.
� In vitro study of VEGF-C shRNA expressing vector on breast cancer cell line. We cannot replace chemotherapy by antiangiogenic therapy because latter therapy is
cytostatic and not cytotoxic but by the combination of two, we can definitely decrease the required dose of chemotherapeutic agent so that many of its side effects get ruled out.
Technical Skills:
� Molecular and Cell Biology � Bacterial Cell Culture: Initiation and maintenance of culture, Plasmid isolation,
Vector construction, Transformation � Mammalian Cancer Cell Culture: Secondary Cell Culture maintenance, Transfection � Techniques : Gel Electrophorèses,PCR,Western Blotting
� Bioinformatics Tools
shRNA designing, primer designing, BLASTs, application of databases such as NCBI, ensemble, OMIM, PDB, NEB cutter, familiar with softwares such as DNA Club, Primer3.
� Analytical Techniques
HPLC, TLC, HPTLC, UV-Vis Spectroscopy, IR spectroscopy, Column Chromatography
Awards and Achievements:
� NIPER JEE AIR 2009: 177 � Qualified GATE 2009 with percentile score 97.92 � Qualified GATE 2008 with percentile score 96.29
Presentation/Conference:
� Review Paper entitled as “Biotechnology Startup: From Bench to Box” presented in International Symposium held at B V Patel PERD Centre,Amedabad.
� Attended IPC 2009 at Ahmedabad
Seminars Presented at NIPER Ahmedabad:
� microRNA and AntagoMiRs:A Big World of Small RNAs � Telomerase Enzyme:EverReady Cell in Biological Clock
Extracurricular Activities:
� Secured First Prize in Poster Competition organized as a part of National Pharmacy Week Celebration by Indian Pharmaceutical Association in Dec 2006
� Active participation in The Bharat Scouts & Guide 14th National Jamboree, Raipur, Chhattisgarh in Jan 2002
Personal Details: Date of Birth : 2 April 1988 Marital Status : Unmarried Gender : Female Language known : English,Hindi,Marathi Contact no. : +91 9725125900 E. mail : [email protected] [email protected] Permanant address : 26/B,”Suman”,Kishore Nagar,Rajiv Nagar,Rane Nagar,Nashik-422009
Refrences: Dr.Neeta Shrivastava Guide and Project Director NIPER,Ahmedabd Contact no.- +91 9824250226 Email id - [email protected] Prof.Harish Padh Vice Chacellor Sardar Patel University, Vallabh Vidya Nagar,Gujrat Contact no. - +91 9924452200 Email id - [email protected]
I hereby declare that the above written particulars are true to the best of my knowledge and belief.
Date: Poonam Chandrakant Tambe
BACK to Previous Page
CURRICULUM VITAE
Neha Harendra. Trivedi
M.S. (Pharm) Biotechnology
Present Address: National Institute of Pharmaceutical Education and Research, Ahmedabad, C/o B.V.Patel PERD Centre, S.G. Highway, Thaltej, Ahmedabad, Gujarat, 380054.
Career Objective:
Working sincerely with maximum utilization of my talent, with a challenge to achieve the required targets and to become a successful professional in Bio - Pharmaceutical industry by utilizing my analytical, problem solving and fast learning abilities.
Areas of Interest:
� Formulation & Development (F&D) of Biotechnology derived Drugs
� Research and Development (R&D)
� Intellectual Property Rights
Academic Credentials:
Course School / College & University/ Board Year of
passing Result
M. S. (Pharm)
(Biotechnology) NIPER-Ahmedabad
Expected in May
2011
CGPA:
7.6/10
(upto 2nd
Term)
B.Pharm Saraswathi Vidya Bhavan’s College Of Pharmacy,
Mumbai University 2009 69.00 %
HSC Ramnivas Ruia Junior College, Mumbai,
Pune Board 2005 82.33 %
SSC K.M.P.D. High School, Pune Board 2003 89.86 %
Awards/Achievements:
• Qualified NIPER JEE 2009 : 268 (AIR)
• Qualified GATE 2009 with 90.92 percentile.
• Successfully completed the distance learning course General Course on Intellectual Property from “World Intellectual Property Organization (WIPO) Wo rldwide Academy, Geneva, Switzerland” with 80%.
• Successfully qualified the Maharashtra State Certificate in Information Technology (MSCIT) exam with 82%.
Dissertation Project :
Inhibition of Angiogenesis In Various Cancer Cell Lines Using VEGF-A shRNA
Members of the vascular endothelial growth factor (VEGF) family are important activators of
tumor angiogenesis which is a prerequisite for the growth of a tumor and its further metastasis.
VEGF-A , the most potent direct-acting angiogenic protein known. RNA interference is an
endogenous mechanism for the potent and specific inhibition of gene expression, which can be
diverted to act on unregulated expression of genes by introducing siRNA (short interfering RNA)
agents.
In this project, inhibition of angiogenesis and thereby reduction in tumor growth and survival is
being targeted in various cancer cell lines by inhibiting VEGF-A using shRNAs (short hairpin
RNAs) psNIPERD H1 A1 and psNIPERD U6 A2. The inhibition of VEGF-A will be screened by
in vitro cell based assays in prostate, lung and colon cancer cell lines.
Technical Skills:
Molecular biology Methods: Techniques such as Transformation of plasmid, Plasmid/DNA/RNA isolation, Restriction and Ligation of plasmids, Gel electrophoresis and SDS PAGE. Adept in PCR, RT-PCR, Western blotting, etc.
Cell culture: Handling secondary animal cell cultures, transfection in mammalian cell lines using Electroporation.
Analytical Techniques: Techniques such as TLC, HPTLC , HPLC , Column chromatography, Spectral interpretation by UV , IR and MS.
Bioinformatics skill : shRNA designing, primer designing, BLASTs, detection of SNPs and application of databases such as NCBI, ensemble, OMIM, PDB, NEB cutter etc. familiar with softwares such as DNA Club, etc.
Computer Skills: Well acquainted with Microsoft Office and Internet.
Extracurricular Activities:
Conferences Attended and Publications :
• Indian Pharmaceutical Congress at Ahmedabad, 2009. • 6th International Symposium on Innovations in Pharmaceutical Sciences and
Technology at Ahmedabad, 2010.
• Published Review in Souvenir of 6th International Symposium on Innovations in Pharmaceutical Sciences and Technology, Ahmedabad, 2010 entitled “Biotechnology: From Bench to Box”.
Seminars delivered on:
• “Tests Involved in Criminal Analysis” in third year B.Pharm, 2008.
• “Pharmacogenomics” at NIPER-Ahmedabad, 2009.
• “Microalgal Biodiesel” at NIPER-Ahmedabad, 2010.
Projects and Presentations:
• 2nd Runner up for a technical project on “Know Your Pharmacist – Right Use of Medicines” at the Rx Technical Exhibition, 2008 (Mumbai University Intercollegiate level).
• A Practical Project on “Quick Mouth Dissolving Anti-emetic Oral Film Using Zingiber Officinale” at the intercollegiate Young Scientists Innovative Projects, 2009.
• A poster on “Gene Silencing using RNA Interference” at the Rx Techfest and ExergyICT, 2009.
Industrial Work Experience:
Pursued one month industrial training at Twilight Litaka Ltd., Vasai Industrial Estate.
Personal Details:
Date of Birth : 11th June, 1987. Marital status : Unmarried. Gender : Female. Language Known : English, Hindi, Gujarati, Marathi. Contact No. : +91-9601527661. E mail Address : [email protected]
Permanent Address : 13, Om Saurabh CHS.,
Mahesh Park, Tulinj Road,
Nallasopara (E), Tal. Vasai,
Dist-Thane, Maharashtra - 401209.
References:
Dr.Neeta Shrivastava Prof. Harish Padh Project Director Vice Chancellor Sardar Patel University, NIPER, Ahmedabad Vallabh Vidya Nagar, Gujarat Contact no.- +91- 9824250226 Contact no.: + 91-9924452200, Email id : [email protected] Email id : [email protected]
Declaration:
I hereby declare that the above mentioned statements are true to the best of my knowledge and belief. Regards,
Neha H. Trivedi Mob. no. +91- 9601527661
Email id.: [email protected]
BACK to Previous Page
PPoooorrvvaa SSuubbhhaasshhcchhaannddrraa YYeeoolleeppaattiill MM..SS..PPhhaarrmm ((BBiiootteecchhnnoollooggyy))
Correspondense address : National Institute of Pharmaceutical Education & Research (NIPER), Ahmedabad c/o – B.V.Patel PERD Centre, S.G.Highway, Thaltej, Gujarat Pin code- 380054
Career Objective: Endeavor to work in Bio-Pharmaceutical industry in India & intend to build a growth oriented career in competitive corporate environment with full commitment & dedication
EDUCATIONAL QUALIFICATIONS
Other Qualification:
• Successfully completed the distance learning course General Course on Intellectual Property from “World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland.”
Areas of Interest: � Biotech Research and Development
Sr. No. Year Course Institute/ University % Marks
1. 2010 M.S.(Pharm) NIPER, Ahmedabad 8.9/10 (Up to
2nd sem)
2. 2009 B.Pharm N.D.M.V.P. Samaj’s college of pharmacy, Nashik, PUNE
University.
70.5 %
3. 2005 HSC R.Y.K. Junior college of Science, Nashik, Pune
University. 84.83 %
4. 2003 SSC Rachana Vidyalaya, Nashik,
Pune University. 84.93 %
Dissertation Topic: Chemosensitising Effect of Novel NF-kB inhibitors NF-κB is recognised as an important player in mediating resistance to an anti-cancer agents. Therefore it represents an attractive therapeutic target for treatment of cancer. The project involves evaluation of indigenously developed NF-κB inhibitor as chemosensitising agent in in vitro models of both acquired and innate chemoresistant cell lines. The project also includes analysis of effect of NF-κB inhibitor on expression of proteins such as IAPs, ABC transporters which are involved in mediating chemoresistance.
Publication/ Presentations:
• Delivered seminars at NIPER Ahmadabad (B.V.Patel PERD Centre): � Erythropoietin - a novel approach as a neuroprotective � The use of monoclonal antibodies in the treatment of infectious diseases
• JSS college of pharmacy 2nd international conference and indo-canadian satellite symposium on pharmaceutical science, technology, practice and natural products-2007
Technical Skills: Cell Biology Techniques:
� Mammalian Cell Culture: Initiation and maintenance of cancer cell culture � Basic rDNA techniques : Initiation and maintenance of culture, Plasmid isolation,vector
construction, Transformation
Protein and Molecular biology Techniques : Vital staining and florescence microscopy, Native and SDS PAGE , Western blotting, Isolation of DNA , RNA and proteins, PCR, RT-PCR, DNA gel electrophoresis, comet assay, clonogenic assay, cytotoxicity assays
Bioinformatics Tools: Basic tools like BLAST, ClustalW, OMIM, NEB Cutter, RASMOL and sound knowledge of primer designing Analytical: HPLC, TLC, HPTLC, UV-Vis Spectroscopy, IR spectroscopy, Column Chromatography
Conferences attended:
• Attended 61st Indian Pharmaceutical Congress held at NIRMA University, Ahmedabad
• Attended 6th International Symposium On innovations in Pharmaceutical Sciences and Technology at Ahmedabad
Awards / Achievements:
• NIPER JEE 2009 All India Rank: 133 • GATE 2009 Percentile: 98.68 • GATE 2008 Percentile: 93.78
Personal Details: Date of Birth : 23rd May, 1987
Marital status : Unmarried Gender : Female Languages known : English, Hindi, Marathi Contact no. : +91-9725126030.
E-mail : [email protected] Permanent Address : 9, Anmol Residency, Date nagar, Ayodhya Colony, Savarkar nagar, Gangapur road,Nashik, Maharashtra.
Pin code : 422013.
References :
1. Dr. Milee Agarwal,
Research associate, NIPER- Ahmedabad. [email protected]
2. Dr. S. Lakshmi, Research Associate, NIPER-Ahmedabad.
BACK to Previous Page
Present Address: Dept. of Biotechnology, National Institute of Pharmaceutical education and Research (NIPER), C/O B.V.Patel PERD Centre, S.G. Highway, Thaltej Ahmedabad-380054 Gujarat, India
Mobile No: +919909850704 Email ID: [email protected] [email protected]
Vishad Gupta
CAREER OBJECTIVE:
To consistently learn & work with assets like team spirit, dedication, honesty in a challenging & competitive environment for the fulfillment of organization’s objectives & prove myself as a key factor for the growth of the organization
AREA OF INTEREST:
� Research & Development (R&D) � Formulation & Development (F&D) � Intellectual Property Rights � Regulatory Affairs � Quality Assurance
PROFESSIONAL ACHIEVEMENTS:
M.Pharm RESEARCH PROJECT:
In vivo & In vitro Neuroprotective Effect of TLR4 Antagonist in Stroke and Stroke induced seizures
Stroke is the leading cause of death after cardiovascular disease and cancer. It involves rapidly developing loss of neurological function due to disturbance in the blood supply to the area of brain. But the pneumbra, surrounding that area remains active for some period due to the supply of blood by the collateral arteries and TLR4 antagonist will help to stop the further worsening and assist in the survival of pneumbral area. This project involves the neuroprotective effect of TLR4 antagonist on “in vivo middle cerebral carotid artery occlusion (MCAO) model of stroke.” But there is possibility of occcurence of seizures in recovered cells due to increase in the level of glutamate in the brain. Hence to study the effect of TLR4 antagonist on seizure, it also involves “ in vitro model of glutamate induced seizures” in the hippocampal neurons.
SUMMER TRAINING:
One month summer training on project entitled “Development & characterization of calcium phosphate Nanoparticles of colchicine” in Delhi University (DU) under Dr. Rakesh Kumar Sharma, Dept. of Chemistry.
CONFERENCES ATTENDED:
� Poster entitled “Overview: Drug Patent Linkages” accepted in 62nd Indian Pharmaceutical Congress (IPC 2010) to be held at Manipal University, Manipal
� Attended 61st Indian Pharmaceutical Congress (IPC 2009) as delegate, held at NIRMA University, Ahmedabad
� Attended 6th International Symposium on Innovations in Pharmaceutical Sciences & Technology at PERD Centre in 2010, Ahmedabad
PUBLICATIONS/PRESENTATIONS:
� Project entitled as “Novel solid cationic nanoparticles enhanced bax ge ne delivery in Lung Cancer” was selected in Indian Academy of Sciences 2010, Banglore for Summer Research Fellowship (SRF).
SEMINARS PRESENTED DURING MASTERS COURSE:
� P53 Gene transfer to Lung Cancer Through Solid Lipid Nanoparticles. � Bioisosterism: A Rational Approach in Drug Design.
ACADEMIC CREDENTIALS:
TECHNICAL SKILLS:
Molecular biology Methods: Techniques such as Transformation of plasmid, Plasmid/DNA/RNA isolation, Restriction and Ligation of plasmids, Gel electrophoresis and SDS PAGE, PCR, RT-PCR, Western blotting, ELISA etc.
Analytical Techniques: TLC, HPTLC, UV-Vis Spectroscopy, IR spectroscopy
In vivo studies : Animal handling in preclinical studies (dosing by oral, im, ip, sc routes) and surgery in rats
Bioinformatics skill : BLAST, detection of SNPs and application of databases such as NCBI, ensemble, OMIM, PDB, NEB cutter etc.
IPR: Concepts related to Intellectual Property Management and Regulatory Affairs
Computer Skills: Proficient in MS-Power Point, Excel, Word; Internet browsing; scientific data retrieval from Internet portals like Sci-Finder®, Sciencedirect, Pubmed, Scopus etc.
Sr.No Description Board/University Year Percentage/CGPA
1 M.S.(Biotechnology)
National Institute of Pharmaceutical Education And Research (NIPER),
Ahmedabad 2009-11
7.03 (till 2nd Sem)
2 P.G. Diploma in Patents Law
National Academy of Legal Studies And Research (NALSAR), Hyderabad
2010-11 Appearing -
3 B.Pharm Maharshi Dayanand University,
Rohtak 2009 63.4%
4 H.S.C. C.B.S.E. 2004 73.2% 5 S.S.C. Haryana Board 2002 81.00%
AWARDS & ACHIEVEMENTS:
� Qualified GATE 2009 with 90.66 percentile � Qualified NIPERJEE 2009: 313 (AIR) � Passed General course on Intellectual property conducted by WIPO with score of 89
PERSONAL DETAILS:
� Date of Birth: March 5,1987 � Marital status: Unmarried � Father’s name: Anil Kumar Gupta � Languages Known: English, Hindi � Interests: Listening Music, Net surfing & playing volleyball � Permanent Address: 2126-B, Raghunath Colony, Lal dwara, Yamunanagar-135001, Haryana
REFERENCES:
Dr. S. Lakshmi
Research associate
Dept. of Cell Biology
NIPER Ahmedabad
B.V.Patel PERD Centre
Ahmedabad
Cell no. +91 9879845066
Dr. Manish Nivsarkar
Dean NIPER Ahmedabad
Dept of Pharmacology
B.V.Patel PERD Centre
Ahmedabad
Cell no. 07927439375
BACK to Previous Page
CURRICULUM VITAE
YYooggeesshh AAjj iinnaatthh AAnnaarr aassee MM ..SS.. ((PPhhaarr mm)),, NNaattuurr aall PPrr oodduucctt
Present Address:
National Institute Of Pharmaceutical Education And Research (NIPER), Ahmedabad c/o – B.V.Patel PERD Centre, S.G.Highway, Thaltej, Ahmedabad, Gujrat Pin - 380054
Career Objective: To pursue a challenging career in pharmaceutical R & D which enables me to actively participate and provide an ample scope to enhance my knowledge and technical skills, and be recognized for the service to the company. And contribute to organizations success. EDUCATIONAL QUALIFICATIONS
Other Qualification:
• Successfully completed the distance learning course General Course on Intellectual Property from “World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland.”
Dissertation Topic: “Phytochemical and Biological Evaluation of Physalis minima Linn.” Aim: To identify and isolate the new compounds by using different chromatographic techniques and evaluate the in vitro cytotoxic activity on different cell lines and anti- microbial activity of the isolated compounds The primary aim of work was to finding the new compound from plants to reduce the side effect and improve the efficacy. Also I was established the microscopy of P.minima linn. which is important for authentification in herbal drugs . We pay attention towards the finding new species of herbs for the development of new drugs. Current therapy for cancer and infectious diseases
Sr No Year Course Institute/ University % Marks Class
1 2009-11 M.S.(Pharm) NIPER- Ahmedabad (GJ) GPA: 7.67 (Updated up to IInd Sem.)
-
2 2009 B.Pharm University of Amravati (MS)
67.25 First
3 2006 D.Pharm MSBTE, Mumbai (MS) 81.20 Distinction 4 2004 H.S.C. 66.00 First 5 2002 S.S.C. 67.66 First
produces MDR by different mechanisms and some enzymes present in micro-organisms so the desired effect of drug are not produced in such cases. There is a need to develop new cytotoxic and anti-microbial agents from Natural Products this will reveal the potential natural anticancer and anti-microbial agents with improved efficacy and least side effect. Achievement:
• NIPER JEE 2009 All India Rank 389 • Qualified GATE 2009 with 92.55 Percentile.
Relevant Scientific Skills Learnt: � Separation and isolation Techniques � Synthesis and Structure elucidation � Animal handling � Maintenance of cell lines � Maintenance of cell culture � Cytotoxic assay
Instrument Knowledge: Expertise in analyzing and interpreting data from various instruments like
� HPTLC � UV Spectrophotometer � HPLC � IR � NMR
Extra Curricular Activities:
• Presented a poster entitled “Nanotechnology: current regulatory perspectives”, at 61st Indian Pharmaceutical Congress at Ahmedabad.
Area of Interest:
� Drug discovery and Development � Isolation and characterization of single compound from crude extract � Quality Assurance and Control (QA/QC) � Mechanistic study of isolated compounds � Regulatory affairs
Computer Proficiency: Experience in computer software such as Windows, MS office, Win Cats Data retrieval from various databases such as Pub med, Springer link, Wileyinterscience, American Chemical Society, Science Direct, Inform world,
Personal Details: Date of birth : 21st June, 1986 Marital status : Unmarried Gender : Male Languages known : English, Hindi, Marathi Contact no. : +91 9510505722, +91 9405271539. E-mail : [email protected] [email protected] Permanent address : A/P Ambijalgaon, Tal. Karjat, Dist. Ahmednagar. Pin. 414402 Maharashtra. I hereby declare that the above written particulars are true to the best of my knowledge and belief. Date: Yogesh A. Anarase
Reference:
Dr. Neeta Shrivastava Project Director, NIPER-Ahemdabad Phone: +91-9824250226 E-mail:- [email protected] Dr. Sheetal Anandjiwala Senior Lecturer, NIPER-Ahmedabad Phone: +91 9426524080 E-mail:- [email protected]
Dr. Laxmi Srihasam Research associate NIPER-Ahmedabad Phone: +91-79 27439375, +91 9879845066 E-mail: [email protected]
Dr. Jyoti Paliwal Director, B.V. Patel Perd centre Ahemdabad
BACK to Previous Page
CURRICULUM VITAE
Bagadiya Hemangi J. MM..SS.. ((PPhhaarrmmaa)),, NNaattuurraall PPrroodduuccttss
Present Address:
National Institute of Pharmaceutical Education
and Research (NIPER), Ahmedabad
c/o – B.V. Patel PERD Centre
S.G.Highway, Thaltej, Ahmedabad, Gujarat
Pin - 380054
Career Objective:
To strive for a growth oriented career in Pharmaceutical industry with full commitment and
dedication
Area of Interest:
� Drug Discovery and Development
� Formulation & Development (F&D) and Novel Drug Delivery Systems (NDDS)
� Quality Assurance and Control (QA/QC)
� Analytical Method Development
� Regulatory Affairs and Intellectual Property Rights
Educational Qualifications:
Other Qualification:
• Successfully completed the distance learning course General Course on Intellectual Property from “World Intellectual Property Organization (WIPO) Worldwide Academy,
Geneva, Switzerland.”
• Extra credit course of IPR (at NIPER-Ahmedabad) is being pursued (expected in Jan.
2011).
Sr
No Year Course Institute/ University % Marks Class
1 2010-11 M.S.(Pharma) NIPER- Ahmedabad
cGPA: 8.91
(updated upto
IInd Sem)
---
2 2009 B.Pharm Gujarat University 71.21 Distinction
3 2006 D.Pharm Gujarat University 74.00 Distinction
4 2004 H.S.C GHSEB 80.00 Distinction
5 2002 S.S.C GSEB 89.14 Distinction
Dissertation Topic:
“Topical Delivery of Berberine & its Derivatives for the treatment of PKDL” (Post Kala-
Azar Dermal Leishmaniasis)
Leishmaniasis is a neglected infectious disease. One of its clinical manifestations, Visceral
Leishmaniasis (VL) is caused by Leishmania donovani complex. PKDL is seen as a sequel to
VL. No topical formulations are available for the lesions that occur in PKDL. Earlier, we
developed a topical gel of Berberine (a polar molecule with log P = - 0.45) using 10% DMSO as
penetration enhancer which gave 85-90% drug release. This high amount of DMSO might be
toxic and irritant to skin. Hence, this project aims at synthesising and characterising lipophilic
derivatives of Berberine, evaluating its anti leishmanial activity, developing its optimized topical
delivery system and conducting its open clinical trials. This study will help in developing a
topically active formulation that would be effective in preventing the spread and curing the skin
lesions developed in PKDL.
Relevant Scientific Skills Learnt:
� Separation and isolation Techniques
� Synthesis and Structure elucidation
� Development and Optimization of various formulation parameters
� Animal handling
� Designing and conductance of clinical trials
Analytical Expertise:
Expertise in analyzing and interpreting data from various instruments like
� HPTLC
� HPLC
� UV Spectrophotometer
� IR spectrophotometer
� LC-MS
� NMR Spectrophotometer
� DSC
� Franz Diffusion cell
Academic Achievements:
• NIPER JEE 2009 All India Rank: 394
• Qualified GATE 2008 with 95.47%
Presentations delivered at NIPER-Ahmedabad:
I) Metabolomics for phytomedicine research & Drug development
II) Nanovaccination: Recent developments in vaccination
Extra Curricular Activities:
• Attended 6th International Symposium on “Innovations in Pharmaceutical Sciences and
Technology” held by B.V.Patel PERD Centre (2010), Ahmedabad.
• Participated as a delegate in 61st “Indian Pharmaceutical Congress”(2009) at Ahmedabad.
Personal Details:
Date of birth : 2nd
June, 1987
Marital status : Unmarried
Gender : Female
Languages known : English, Hindi, Gujarati
Contact no. : +91 9510458322, +91 9429901254.
E-mail : [email protected]
Permanent address : L/504, Abhishek Appt.,
Opp.Ganesh Vidhyalaya,
B/h, Vyas wadi, Nava wadaj,
Ahmedabad-38 00 13
Gujarat.
I hereby declare that the above written particulars are true to the best of my knowledge and
belief.
Date Bagadiya Hemangi Jitendrakumar
References:
Dr. Sheetal Anandjiwala
Senior Lecturer
NIPER-Ahmedabad
Contact No.: +91 9426524080
Dr. Manish Nivsarkar Dean, NIPER-Ahmedabad
Joint Director
B.V.Patel PERD Centre,Ahmedabad
Contact No.: +91 9979887931
Dr. Neeta Shrivastava
Project Director
NIPER-Ahemdabad
Contact No.: +91 9824250226
Email:- [email protected]
Dr. Anita A. Mehta
Assistant Professor in Pharmacology
L.M. College of Pharmacy
Ahmedabad
Contact No.: +91-9428418611
Email: [email protected]
Back to Previous page
CURRICULUM VITAE
GGaajj eerr aa MM aayyuurr HHaarr iibbhhaaii MM ..SS.. ((PPhhaarr mm)),, NNaattuurr aall pprr oodduuccttss
Present Address: National Institute Of Pharmaceutical Education And Research (NIPER), Ahmedabad c/o – B.V.Patel PERD Centre, S.G.Highway, Thaltej, Ahmedabad- 380054, Gujarat.
Career Objective: To secure position in pharmaceutical R & D, contribute to organizations success and to enhance my professional skills in a dynamic and stable workplace. EDUCATIONAL QUALIFICATIONS
Other Qualification:
• Successfully completed the distance learning course General Course on Intellectual Property from “World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland.”
Dissertation Topic: “ Screening of some Indian Medicinal Plants for Anti-cancer Activity ” . My present project work include preparation of Methanolic extracts from six different parts of the three Indian medicinal plants, with cancer-related ethnobotanical uses, testing for their cytotoxic ability in vitro against human cancer cell lines: prostate cancer cells, lung cancer cells, breast cancer cells, PC- 12 cells, MIA Paca-2 cells,and colon adeno carcinoma cells, the plants are Madhuca indica, Crataeva nurvala, and Diospyros melanoxylon. Of these plant extracts, the extract which shows lowest IC50 value are further fractionated. The active molecule will be isolated and characterised using different spectroscopic methods. The mechanism of action of the active molecule will be determined using different In vitro assays.
Sr No Year Course Institute/ University % Marks Class
1 2009-11 M.Pharm National Institute of
Pharmaceutical Education And Research(NIPER), Ahmedabad
Appearing CGPA 8.85
(up to 2nd sem.)
3 2006-09 B.Pharm RPCP, Gujarat University, 67.41 First
4 2004-06 D.Pharm ARCP, S.P. University, V.V. Nagar
68.71 First
5 2004 H.S.C. Gujarat board 66.92 First
6 2002 S.S.C. Gujarat board 88.14 First with
Distinction
Achievement:
• NIPER -JEE 2009 All India Rank 372 • Qualified GATE 2009 with 91.26 Percentile.
Instrument Knowledge: Expertise in analyzing and interpreting data from various instruments like
� HPTLC � UV Spectrophotometer � Rota vapour
Extra Curricular Activities:
• Delivered seminar on “Swertiamarin: A lead compound from Enicostemma littorale Blume. For anti- hyperlipidaemic effect” at NIPER- Ahmedabad.
• Delivered seminar on “ Microwave-assisted high speed chemistry:A new technique in drug discovery” at NIPER- Ahmedabad.
Area of Interest:
� In vitro Screening and isolation of active moieties from herbal drugs. � Drug Discovery, Research and Development
� Maintenance of cell lines
� Regulatory Affairs and Intellectual Property Rights
Personal Details: Date of birth : 7th August,1986 Marital status : Unmarried Gender : Male Languages known : English, Hindi, Gujarati Contact no. : +91 9725761980 E-mail : [email protected] [email protected] Permanent address : B/4, Jay appartment, Pratik society, India colony, Bapunagar, Ahmedabad-382350, Gujarat
I hereby declare that the above written particulars are true to the best of my knowledge and belief.
Date: Gajera Mayur H.
Reference: Dr. S. Lakshmi Pharmaceutical Education and Research Centre(PERD), NIPER-Ahmedabad. Email: [email protected] Contact no: 9879845066 Dr. Anita Mahapatra Asst. professor, National institute of pharmaceutical education and research, Ahmedabad Email : [email protected] Contact no: 9601087313
BACK to Previous Page
CURRICULUM VITAE
DDiippeenn RR PPaatteell MM..SS.. ((PPhhaarrmm)),, NNaattuurraall PPrroodduuccttss
Present Address: National Institute Of Pharmaceutical Education And Research (NIPER), Ahmedabad c/o – B.V.Patel PERD Centre, S.G.Highway, Thaltej, Ahmedabad, Gujrat - 380054
Career Objective: To secure position in pharmaceutical R & D and contribute to organizations success. EDUCATIONAL QUALIFICATIONS
Dissertation Topic: Title: Chemical modification of pentacyclic triterpenoids for evaluation of anti Mycobacterial activity
Objectives:
• Selection of Natural Scaffold and Isolation of the oleanolic acid from high yielding natural sources
• Synthesis of analogues of oleanolic acid and Structure elucidation by spectroscopic analysis
• Antimycobacterial screening of analogues against virulent strain of Mycobacterium bovis. • Determination of cytotoxicity of the analogues on the mammalian cell lines. • Screening of the potent analogues, further on the more virulent strain of Mycobacterium
tuberculosis.
Sr No.
Year Of Passing Course Institute/ University % Marks Class
1 2011 M.S.(Pharm) National Institute of
Pharmaceutical Education And Research(NIPER), Ahmedabad
Appearing -
2 2009 B.Pharm Hemchandracharya North
Gujarat University 68.54 First
3 2005 12th Gujarat Secondary and Higher
Secondary Board 76.31 Distinction
4 2003 10th Gujarat Secondary and Higher
Secondary Board 88.86 Distinction
Achievement:
• NIPER JEE 2009 All India Rank-333 • Qualified GATE 2009 with 91.22 %
Instrument Knowledge: Expertise in analyzing and interpreting data from various instruments like
� HPTLC � UV Spectrophotometer � Rotavapour � Column Chromatography
Area of Interest:
� Spectroscopy � Quality Standard of Natural Products
Personal Details: Date of birth : 19th-Feb-1988 Marital status : Unmarried Gender : Male Languages known : English, Hindi, Gujarati Contact no. : 09879804981. E-mail : [email protected] Permanent address : Rupanipura, Chanasma, Dist: Patan, Gujarat- 384220 I hereby declare that the above written particulars are true to the best of my knowledge and belief.
Date: Dipen R Patel
Reference:
Dr. Anita Mahapatra Associate Professor, NIPER, Ahmedabad. Mo-9601087313 E mail [email protected]
Dr. Neelam Chauhan Assistant professor, NIPER, Ahmedabad. Contact No.-9879855342 Email [email protected]
BACK to Previous Page
CURRICULUM VITAE
Shrikant J. Patil MS (pharm.), Natural Products
National Institute of Pharmaceutical Education and Research
C/o B.V.Patel PERD Centre, S.G.Highway,
Thaltej, Ahmedabad-380054
Contact No.: +91-9016729789
E. Mail: [email protected]
Career Objective:
To build up a career in a reputed pharmaceutical industry with an aim to work
creatively in a competitive and challenging environment by applying adopted knowledge and
skills.
Areas of Interest:
� Quality Assurance and Control (QA/QC)
� Analytical Method Development
� Drug Discovery, Research and Development
� Regulatory Affairs and Intellectual Property Rights
Academic Credentials:
Course School / College Year of
passing Result
M. S. (Pharm.)
(Natural Products) NIPER-Ahmedabad Pursuing
CGPA: 8.1/10
(upto 2nd
semester)
B.Pharm.
Bharati Vidyapeeth College of
Pharmacy Kolhapur, Shivaji
University, Kolhapur
2008 64.83%
H.S.C Vidyamandir Junior College,
Miraj, Kolhapur Board 2004 65.83%
S.S.C Vidyamandir Prashala, Miraj,
Kolhapur Board 2002 69.73%
Achievements:
• Qualified NIPER JEE 2009 : 373 (AIR)
• Qualified GATE 2009 percentile : 93.73 AIR: 1613
• Awarded Certificate for completion of General Course on Intellectual Property Rights
(IPR) held by World Intellectual Property Organisation (WIPO) (2009)
Research Experience:
M.S. (Pharm.) desertation topic:
“Comparative Pharmacokinetic Study of Berberine and Its Formulations by Using Lysergol as
Bioenhancer”
Summary: The primary aim of work is to determine comparative pharmacokinetic profile of
different formulations of berberine with berberine to find which formulation gives better
bioavailability. The formulations will be marketed formulation and Ayurvedic formulation. It is
already reported that bioavailability of berberine is very low. So, enhancement of bioavailability
will be another aspect of this study using lysergol as bioenhancer.
In this we will be developed and validated bioanalytical method for both berberine and lysergol
simultaneously using HPLC. Method will be validated as per ICH guidelines. By using this
bioanalytical method pharmacokinetic profile will be developed in Sprague Dawley rats.
Instruments Handled:
• HPTLC
• HPLC
• UV-Visible Spectrophotometer
• IR Spectrophotometer
• Lyophilizer
• Flame Photometer
Technical Skills:
• Analytical Method Development: Having good hand on developing validated analytical
methods as per ICH guidelines in HPTLC, HPLC, UV spectrophotometer, etc.
• Data Interpretation: Proficient at spectral data interpretation by 1H-NMR,
13C-NMR, 2D-
NMR, COSY, HETCOR, IR, UV, MS, HRMS, IR, etc.
• Drug Isolation and Purification: Expertise in various extraction, isolation and
purification techniques viz. Silica gel CC, TLC, HPLC, GC, Solvent extraction, etc.
• In vivo experimentation: Handling of animals in preclinical studies (dosing by oral, IV, IP,
SC routes)
• Statistical Analysis: Good hands on Statistical softwares like Graphpadprism, MS
Excel,SPSS, etc.
• Pharmacoinformatics: Well versed in application of molecular modeling softwares like
CHEMDRAW, CHEMSKETCH etc.
• Data retrieval from various scientific databases such as Pubmed, Highwire, Google
scholar, Sciencedirect, Nature, Research Gate, Scopus, SciFinder, MDL Crossfire etc.
• Computer Skills: Programming Languages: Foxpro; Microsoft Office; DBMS; Internet
browsing, etc.
Work Experience:
• Worked as a Trainee for six weeks at Uni-Sankyo LTD, Chiplun, Maharashtra (2007)
Publications/Presentations:
• Presented Poster on “Development and Validation of HPTLC Method for determination
of Lysergol in Seeds of Ipomoea muricata (Linn.) Jacq. Extract” in 6th
International
Symposium on Innovations in Pharmaceutical Science and Technology, November2010,
Ahemedabad.
• Seminars delivered at NIPER-Ahmedabad (2010) on:
• “PHYTOSOME® Strategy to Improve the Bioavailability of Phytochemicals”
• “Hepatoprotective Activity of Dehydrocavidine from Corydalis saxicola”
Personal Details:
• Date of Birth : 1st
July, 1986
• Marital status : Unmarried
• Gender : Male
• Language Known : English, Hindi, Marathi, kannad
• Contact No. : +91-9016729789
• E mail Address : [email protected]
• Permanent Address : A/P-Surul, Tal-Walwa
Dist-Sangli, Maharashtra
PIN-415 407
References:
Dr. Sheetal Anandjiwala
Senior Lecturer,
NIPER-Ahmedabad
Dr. Neeta Shrivastava
Project director,
NIPER-Ahmedabad
,
Dr. Manish Nivsarkar
Joint Director,
NIPER-Ahmedabad
B.V.Patel PERD Centre, Ahmedabad
Dr. Yogesh Biradar
Scientist, R&D,
Orchid Chemicals & Pharmaceuticals
Limited,
Declaration:
I hereby declare that the above mentioned statements are true and correct.
Yours sincerely,
Shrikant Patil
BACK to Previous Page
CURRICULUM VITAE
NNIIRRAAJJ SS.. MMOODDII MM..SS.. ((PPhhaarrmm)),, NNaattuurraall PPrroodduuccttss
Present Address: PLOT NO: 129/1, Sector: 3 ‘A’; GANDHINAGAR. GUJARAT. 382006
Career Objective: To gain professional knowledge through experience and build up carrier with the challenging opportunities in the field related to research. EDUCATIONAL QUALIFICATIONS
Dissertation Topic: Title: Evaluation of neuroprotective effect of some specific secondary metabolites. Project includes,
• Isolation of target compounds.
• Identification of isolated compounds using various spectroscopic methods.
• Screening for their neuroprotective activity on cell lines with and without neurotoxic insults.
• Screening for their neuroprotective activity on primary neuronal culture.
Sr No.
Year Of Passing
Course Institute/ University % Marks
1 2011 M.S.(Pharm) National Institute of Pharmaceutical Education And Research(NIPER),
Ahmedabad Appearing
2 2008 B.Pharm Hemchandracharya North Gujarat
University 67.84
3 2005 D.Pharm Gujarat University 66.2
4 2003 12th Gujarat Secondary and Higher Secondary
Board 56.92
5 2001 10th Gujarat Secondary and Higher Secondary
Board 92.14
Achievement:
• NIPER JEE 2009 All India Rank-424 • Qualified GATE 2009 with 89.42 %
Instrument Knowledge: Familiar in analyzing and interpreting data from various instruments like
� HPTLC � UV Spectrophotometer � Column Chromatography
Area of Interest:
� Spectroscopy � Quality Standard of Natural Products � Research And Development
PERSONAL DETAILS
Date of birth : 21st june 1986 Marital status : Unmarried Gender : Male Languages known : English, Hindi, Gujarati Contact no. : 09276831425 E-mail : [email protected] Permanent address : plot no: 129/1; Sector: 3 A Gandhinagar. Gujarat. 382006 I hereby declare that the above written particulars are true to the best of my knowledge and belief.
Date: 23/11/2010 NIRAJ S. MODI Place: Ahmedabad
Reference:
Dr. Anita Mahapatra Associate Professor, NIPER,
Ahmedabad. Contact No - 09601087313 E mail [email protected]
Dr. Mukesh Patel Assistant professor, HOD, Pharmaceutics Department, B.M.C.P.E.R. Modasa. Contact No.- 9998360205 E mail- [email protected]
BACK to Previous Page
CURRICULUM VITAE
RRaakkeesshh KK uummaarr .. MM ..SS.. ((PPhhaarr mm)),, NNaattuurr aall PPrr oodduuccttss
Present Address: National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad C/O B.V.Patel PERD Centre, S.G.Highway, Thaltej, Ahmedabad (Gujarat). Pin - 380054
Career Objective: To enrich my knowledge in Pharmaceutical R&D and Production and thus shape myself to be a competent and an efficient employee and excel with time. My ambition is to be a value adder and a value transformer to my company. Area of Interest:
� Spectroscopy data analysis � R&D and Production � Natural Product Chemistry � Quality Assurance and Control (QA/QC)
EDUCATIONAL QUALIFICATIONS
Course School / College Year of passing Result
M. S. (Pharm.) (Natural Products)
NIPER-Ahmedabad Pursuing CGPA: 8.60/10
(upto 2nd semester) Diploma in Clinical
Research Catalyst Clinical Services Pvt. Ltd,
Delhi 2009 Qualified
B. Pharm. Manipal University, Manipal
(Karnataka) 2009 CGPA: 8.75/10
Other Qualification: • Successfully completed the distance learning course General Course on Intellectual
Property from “World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland.”
Dissertation Topic: “Synthesis and Antimycobacterial Screening of 1, 4- Naphthoquinone Analogues.” As Tuberculosis is a highly infectious and dangerous disease, it requires multidrug treatment for a long period of time to cure. Such types of treatment also lead to the emergence of MDR & XDR TB. So, it is necessary to search a better drug having potent and specific Antimycobacterial activity with less toxicity. As 1, 4-Naphthoquinone pharmacophore is known to impart pronounced biological effects including Antimycobacterial property, synthesizing different analogues may lead to development of better drugs with potent Antimycobacterial activity. It included mainly analogues synthesis of 2, 3- dichloro 1, 4- naphthoquinone. Since, few naphthoquinone derivatives like 7- methyljuglone show better Antimycobacterial activity with undesired toxicity. Hence, some structural modification in 7- methyljuglone is done to reduce its toxicity. All the analogues are characterized by chemical and spectral analysis along with Antimycobacterial screening of analogues against strains of Mycobacterium sp. Determination of cytotoxicity of the analogues are also done on mammalian cell lines. . Achievements: • Training as pharmacist at Kasturba Medical College, Manipal for one month. • Student member of “Association of Community Pharmacists of India.” • NIPER JEE 2009 All India Rank 423. • Qualified GATE 2009 with 96.76 Percentile.
Conference attended:
• 60th Indian Pharmaceutical Congress (IPC), December 2008, New Delhi • “Pharmfest 09” On “Pharmaceutical Science and Business: The Next 20 Years”
organized by the Students Council of MCOPS in association with IPA, ACPI and IHPA on February, 09.
• 6th International Symposium On “Innovations in Pharmaceutical Sciences & Technology” at PERD Centre 2010, Ahmedabad.
Instrument Knowledge:
� HPTLC � UV-Visible Spectrophotometer � IR Spectrophotometer � LC-MS, LC-MS-MS � Microwave � Rotavapour
Technical Skills:
• Data Interpretation : Knowledge of spectral data interpretation by 1H-NMR, 13C-NMR, 2D-NMR, COSY, HETCOR, IR, UV, MS, HRMS
• Drug Isolation and Purification: Knowledge in various extraction, isolation and purification techniques viz. Silica gel CC, TLC, Solvent extraction etc.
• Pharmacoinformatics: Well versed in application of molecular modeling softwares like Auto dock, CHEMDRAW, CHEMSKETCH etc.
• Data retrieval from various scientific databases such as Pub med, Google scholar, Science directs, Nature, Research Gate, SciFinder, etc.
• Computer Skills: Programming Languages: C++; BASIC; Microsoft Office; Adobe Photoshop; Adobe Audition; Software installations and troubleshooting; Internet browsing; etc.
Publications/Presentations:
• Presented poster at 60th Indian Pharmaceutical Congress (IPC), December 2008, New Delhi, On
“Antioxidant and Antitumour activities of Boerrhavia diffusa.” • Seminars delivered on:
� “Processing pharmaceutical grade microcrystalline cellulose from groundnut
husk: extraction methods and characterization” at NIPER-Ahmedabad (2009).
� “Antiosteoporotic Activity of phenolic compounds from Curculigo orchioides ” at
NIPER-Ahmedabad (2009).
� “BL-1020: A novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia” at NIPER-Ahmedabad (2010).
Personal Details: Date of birth : 12nd January, 1978 Marital status : Unmarried Gender : Male Languages known : English, Hindi. Contact no. : +91 9016730674, +91 9234144911. E-mail : [email protected] [email protected] Permanent address : C/O Shri Ranglal; Ranjan Kumar kansyakar. Pot- seller; Mahuri tola; Katra chowk P.O. + Dist. - Sheikhpura- 811105 Bihar.
Declaration: I hereby declare that the above written particulars are true to the best of my knowledge and belief. Date: 24-11-10 Rakesh Kumar.
Reference:
Dr. Anita Mahapatra Associate Professor, NIPER- Ahmedabad. Mob.- +91- 9601087313 Email: [email protected]
Dr. Neeta Shrivastava Project Director, NIPER- Ahemdabad. Mob.- +91- 9824250226 Email: [email protected]
Dr. Neelam Chauhan Assistant professor, NIPER- Ahmedabad. Mob.- +91- 9879855342 Email: [email protected]
Dr. Sheetal Anandjiwala Senior Lecturer, Course Coordinator NIPER- Ahmedabad. Mob.- +91- 9426524880 Email: [email protected]
BACK to Previous Page
CURRICULUM VITTAE Shivraj Meena M. S. (Pharm.), Natural Products Village- Ranglal pura Tehsil + Post -Todabhim District- Karouli Rajasthan. Contact No.: +91-9638922007, +91-9887173815 E. Mail: [email protected] [email protected] Career Objective:
To build up a career in a reputed pharmaceutical industry with an aim to work creatively in a competitive and challenging environment with strong responsibility and commitment, where job satisfaction and career development is provided.
Areas of Interest:
� Quality Assurance and Control (QA/QC) � Analytical Method Development � Formulation & Development (F&D) and Novel Drug Delivery Systems (NDDS) � Regulatory Affairs and Intellectual Property Rights
Academic Credentials:
Course School / College Year of passing
Result
M. S. (Pharm.) (Natural Products)
NIPER-Ahmedabad Pursuing CGPA: 6.5/10
(upto 2nd semester)
B.Pharm.
Apex Institute of Management & sciences,
Mansarovar, Jaipur (R.U.H.S)
2008 64.31 %
Awards/Achievements:
• Qualified NIPER JEE 2009.
• Qualified GATE 2009.
Research Experience:
Design and evaluation of novel in situ gel forming Ocular Drug Delivery System (ODDS) of Andrographis paniculata aqueous extract for sustained pharmacological response against Cataract Polymer based ophthalmic delivery system of Andrographis paniculata aqueous extract of whole plant will be prepared having in situ gelling capabilities and sustaned release property. The prepared formulation will be characterized by pH, in-situ gelling capacity, viscosity, in-vitro drug release study, assay, sterility test, accelerated stability study etc. Therapeutic efficacy of the formulation would be tested by ocular irritation study, pharmacodynamics study in animal model. Thus sustained release in-situ gel formulation containing aqueous extract of Andrographis paniculata would be prepared to treat Cataract.
Instruments Handled:
• HPTLC • HPLC • IR Spectrophotometer • UV-Visible Spectrophotometer • Brookfield Viscometer • Dissolution Test Apparatus • Franz Diffusion Cell • Differential Scanning Calorimeter (DSC) • Lyophilizer • Polarimeter • Flame Photometer • Schiotz Tonometer
Technical Skills:
• Analytical Method Development: Having good hand on developing validated analytical methods as per ICH guidelines in HPTLC, HPLC, LC-MS, LC-MS-MS, etc.
• Formulation & Development (F&D): Adept in Ocular Drug Delivery Systems (ODDS) and other Novel Drug Delivery Systems (NDDS); insightful knowledge of formulation development aspects; stability studies, sterility testing, etc.
• Data Interpretation: Proficient at spectral data interpretation by 1H-NMR, 13C-NMR, 2D-NMR, IR, UV, MS, HRMS
• Drug Isolation and Purification: Expertise in various extraction, isolation and purification techniques viz. Silica gel CC, TLC, HPLC, GC, Flash chromatography, Solvent extraction, etc.
• In vivo experimentation: Handling of animals in preclinical studies (dosing by oral, IV, IP, SC IM routes) and expertise in animal model development of glaucoma in New Zealand White Rabbits.
• Data retrieval from various scientific databases such as Pubmed, Highwire, Google scholar, Sciencedirect, Nature, Research Gate, Scopus, SciFinder, MDL Crossfire etc.
• Computer Skills: Microsoft Office; DBMS; Internet browsing; etc.
Work Experience:
• Worked as a Trainee for six weeks at SMILAX Pharmaceutical Pvt. Ltd. Sanganer Jaipur, Rajasthan (2008)
Publications/Presentation
• Seminars delivered on:
� “ Potential use of hirudin in diabetic cataract” at NIPER-Ahmedabad.
� “Formulation of an Ocular Drug Delivery System (ODDS) of a natural product” at NIPER-Ahmedabad (2009).
• Published review in souvenir of 6th International Symposium on Innovations in Pharmaceutical Sciences and Technology, Ahmedabad 2010 entitled “Sheet Hydrogel in Wound Healing: An Update.”
Personal Details: • Date of Birth : 15 Aug, 1985 • Marital status : Unmarried • Gender : Male • Language Known : English, Hindi, Rajasthani. • Contact No. : +91-9638922007 , • E mail Address : [email protected]
[email protected]. • Permanent Address : Village- Ranglal pura; Tehsil + Post-
Todabhim; District- Karouli, Rajasthan Pin- 321611
Declaration:
I hereby declare that the above mentioned statements are true and correct. . Date: Shivraj Meena.
References:
Dr. Neeta Shrivastava Project Director, NIPER-Ahmedabad B.V. Patel PERD Centre, Ahmedabad [email protected] Dr. Sheetal Anandjiwala Senior Lecturer, NIPER-Ahmedabad [email protected]
Dr. Uttam Kumar Mandal Asszit. Professor, NIPER-Ahmedabad, B.V. Patel PERD Centre, Ahmedabad [email protected] Dr. Manish Nivsarkar Dean, Joint Director, NIPER-Ahmedabad B.V. Patel PERD Centre, Ahmedabad [email protected]
BACK to Previous Page
CURRICULUM VITTAE Hiral R Shrimali M. S. (Pharm.), Natural Products C-88 Jay Chamunda Society, Bh.Zavernagar Bus –stop, Waghodia Road. Vadodara-390019.Gujarat. Contact No.: 9924340806, 0265-2517665 E. Mail: [email protected] Career Objective:
To excel in the field of pharmaceutical research and be a key team player in a growth oriented research team within a challenging environment with strong responsibility and commitment, and to provide best of my skills for the organization Area of interest:
� Quality Assurance and Control (QA/QC) � Analytical Method Development � Formulation & Development (F&D) � Regulatory Affairs and Intellectual Property Rights
Academic Credentials:
Course School / College Year of passing Result
M. S. (Pharm.) (Natural Products)
NIPER-Ahmedabad Pursuing CGPA: 8.2/10
B.Pharm. Veer Narmad South Gujarat
University,Surat 2009 70.88 %
H.S.C Gujarat Secondary and
Higher Secondary Education Board, Gandhinagar
2005 53.69 %
S.S.C Gujarat Secondary and
Higher Secondary Education Board, Gandhinagar
2003 86.14 %
Awards/Achievements:
• Qualified NIPER JEE 2009
• Qualified GATE 2008 percentile : 93.97
Other Qualification:
• Awarded Certificate for completion of General Course on Intellectual Property Rights (IPR) held by World Intellectual Property Organisation (WIPO) (2010)
Dissertation Topic:
Fabrication and Evaluation of Medicated Hydrogel film for wound healing A medicated hydrogel containing embelin isolated from Embelia ribes Burm. which has both wound healing as well as antimicrobial activity would be formulated, so as to enhance healing and also prevent the infection in chronic wounds which is a major and essential concern in chronic wound therapy. The formulation will be characterized by various evaluation parameters like tensile strength, swelling ratio, gel fraction, in-vitro drug release, assay, sterility test etc. Finally, therapeutic efficacy of the formulated hydrogel sheet would be evaluated in animal model. Thus the primary aim is to formulate patient compliant hydrogel sheet formulation for chronic wound healing.
Instruments Handled:
• Dissolution Test Apparatus (USP Type I & II) • Franz Diffusion Cell • Polarimeter • Flame Photometer
Technical Skills:
• Analytical Method Development: Having good hand on developing validated analytical methods as per ICH guidelines in HPTLC, HPLC, etc.
• Formulation & Development (F&D): Insightful knowledge of formulation development aspects; stability studies, sterility testing, etc.
• Data Interpretation: Proficient at spectral data interpretation by 1H-NMR, 13C-NMR, IR, UV, MS,
• Drug Isolation and Purification: Expertise in various extraction, isolation and purification techniques viz. Silica gel CC, TLC, HPLC, Solvent extraction, etc.
• Pharmacological experimentation: Handling of animals and dosing(oral, ip,im,sc)
• Data retrieval from various scientific databases such as Pubmed, Google scholar, Sciencedirect, etc.
• Computer Skills: Microsoft Office; Internet browsing; etc.
Work Experience:
• Worked as a Trainee for three months at Alpha Labs, Vadodara (for six weeks in 2008 and six weeks in 2009)
Publications/Presentations:
• Dissertation work entitled “Bioactivity of Alstonia scholaris(Saptaparni)” submitted to Veer Narmad South Gujarat University, Surat and Sigma Institute of Pharmacy, Baroda (2008) under the guidance of Dr.U.M.Upadhyay
• Presented poster at 61th Indian pharmaceutical congress, 2009, Ahemdabad on the topic “Assessment of bioactivity of Alstonia scholaris (Saptaparni)”.
• Published review in souvenir of 6th International Symposium on Innovations in Pharmaceutical Sciences and Technology, Ahmedabad 2010 entitled “Sheet Hydrogel in Wound Healing: An Update”
Personal Details: • Date of Birth : 23rd August, 1987 • Marital status : Unmarried • Gender : Female • Language Known : English, Gujarati,Hindi,Marathi • Contact No. : +91-9924340806 • E mail Address : [email protected] • Permanent Address : C-88 Jay Chamunda Society,
Bh.Zavernagar bus-stop, Waghodia Road, Vadodara-390019 Gujarat.
I hereby declare that the above written particulars are true to the best of my knowledge and belief.
DATE: HIRAL R SHRIMALI
References:
Dr.Neeta Shrivastava Dr. Uttam Kumar Mandal Project Director, Assistant Professor, NIPER-Ahmedabad NIPER-Ahmedabad [email protected] [email protected] Dr. Sheetal Anandjiwala Dr. Manish Nivsarkar Senior Lecturer Dean, NIPER-Ahmedabad NIPER-Ahmedabad [email protected] Joint Director, B.V.Patel PERD Centre,Ahmedabad [email protected]
BACK to Previous Page
CURRICULUM VITAE
SRISESHA BANDI M.S (Pharm) , Natural products Present Address:
National Institute Of Pharmaceutical Education and Research (NIPER), Ahmedabad c/o – B.V.Patel PERD Centre, S.G.Highway, Thaltej, Ahmedabad, Gujrat Pin - 380054 Career objective: To strive for a growth oriented career in Pharmaceutical industry in India with full commitment and dedication Education:
Sr.no
Year Course University/Institute Percentage Class
1 2009-11 M.S.Pharm National Institute of Pharmaceutical Education And
Research(NIPER), Ahmedabad
Appearing 8.5 (till 2nd sem)
2 2005-09 B.Pharm Aditya Institute of Pharmaceutical Education and
Research, Andhra University
76.18 FIRST CLASS
(Distinction)
3 2002-04 Intermediate Andhra Pradesh board of Intermediate Education
89.00 FIRST CLASS
4 2003-04 S.S.C Andhra Pradesh board 86.00 FIRST CLASS
Other Qualification: • Successfully completed the distance learning course General Course on Intellectual Property from
“World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland Dissertation topic: “ Evaluation of neurogenerative effect of selected medicinal plants from Indian system of medicine” As the current medications cannot cure the progressive loss of neurons, there is no suitable allopathic drug for these diseases. The neural tissue repair in the neurodegenerative diseases is not robust enough to promote a functional and stable recovery of the CNS architecture. Therefore, one of the promising strategies for the treatment of neuronal loss could be to induce or to enhance the neurogenic potentials in situ. The studies till now did not give an overall mechanistic as well as functional perspective of the compounds that is very vital for their
credibility as neuromodulatory agents that can be used to treat diseases Therefore, the aim of the project is to screen the plants with neuroregenerative activity, detailed phytochemical evaluation of the plants ,observe neuritogenesis on PC12 and IMR -32 cells ,observe neurogenesis and differentiation of hippocampal cells ,observe the neuroprotective effect of the plant extracts Technical skills learnt: Separation and Isolation Techniques: Having good knowledge of various methods like HPTLC, HPLC, Column chromatography, Crystallization, Solvent extraction etc. for the isolation of active compounds
Structure Elucidation: Good practice of structure elucidation using UV, IR, MS, NMR for novel Molecules Cell Biology : � Mammalian cell culture: Culture maintenance, RT-PCR (Reverse Transcriptase Polymerase
Chain Reaction), western blot , SDS PAGE ,Vital staining and Fluorescence microscopy
� Primary culture : Initiation and maintenance of neuronal culture from embryonic mice brain Pharmacology: Animal handling and dosing Areas of interest : � Research And Development (R & D) � Analytical method development � Quality assurance and Control Conferences attended: � Attended 6th International symposium on innovations in pharmaceutical sciences and technology at
B.V. Patel PERD centre 2010 , Ahmedabad � Attended 61st Indian pharmaceutical congress (Ipc 2009) held at NIRMA university , Ahmedabad Seminars delivered on: � AMP-N1 oxide in royal jelly as neurotrophic molecule at NIPER Ahmedabad-2009 � In vivo imaging: A revolutionizing field at NIPER Ahmedabad-2009 Presentation: Presented poster at Aditya college of pharmacy, Andhra University, on congestive heart failure and was awarded first prize Achievements: NIPER JEE-2009 All India Rank : 300 Qualified GATE 2009 with percentile 93.25
Personal details: Date of birth : 13 AUG 1987 Marital status : Single Gender : Female Languages known : English, Telugu, Hindi Contact no. : +91 9537537033 E-mail : [email protected] Permanent address : D/O B. Sivanarayana Jaya residency-2, C-4 Near R.T.C complex, Syamala Nagar, Rajahmundry-533101 ANDHRA PRADESH
REFERENCES:
Dr. Sheetal Anandjiwala Dr. S. Lakshmi Senior Lecturer Research Associate, Dept. of Natural Products NIPER-Ahmedabad NIPER-Ahmedabad Email id : [email protected]
Email id: [email protected] Ph .no : +91-9879845066
Ph. no : +91-9426524080
BACK to Previous Page
CURRICULUM VITAE
VViinneeeett KK uummaarr GGuuppttaa MM ..SS.. ((PPhhaarr mm)),, NNaattuurr aall pprr oodduuccttss
Present Address: National Institute Of Pharmaceutical Education And Research (NIPER), Ahmedabad c/o – B.V.Patel PERD Centre, S.G.Highway, Thaltej, Ahmedabad- 380054, Gujarat.
Career Objective: To become a part of R&D team and to make best use of my knowledge and skills in the growth and development of an organization and society.
Other Qualification:
• Successfully completed the distance learning course General Course on Intellectual Property from “World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland.”
Dissertation Topic: “Evaluation of synergistic effect of novel NF-ĸB activators on Radioprotective effect of some Natural products”.
Radioprotection is very important for the cancer patient undergoing radiotherapy and also to the person exposed to unwanted radiation. The objectives of my work include isolation of the selected compounds of natural origin and their characterization. The isolated compounds were screened for their radioprotective activity using various assays. The compound showing promising activity was further evaluated for synergistic effect with novel NF-ĸB activators for the radioprotective active
Sr No Year Course Institute/ University % Marks Class
1 2009-11 M.Pharm National Institute of
Pharmaceutical Education And Research(NIPER), Ahmedabad
Appearing CGPA 8.15
(up to 2nd sem.)
2 2006-09 B.Pharm BNCP, Rajasthan University of
Health Sciences, Jaipur 65.68 First
3 2001-02 H.S.C. Rajasthan board of Sec. Education, Ajmer
68.62 First
4 1999-2000 S.S.C. Rajasthan board of Sec.
Education, Ajmer 80.18 First
Achievement:
• NIPER JEE 2009 All India Rank 376 • Qualified GATE 2009 with 92.42Percentile.
Relevant Technical Skill Learnt:
• Separation and Isolation Techniques: Having good knowledge of various methods like HPTLC, HPLC, Column chromatography, Crystallization, Solvent extraction etc. for the isolation of active compounds
• Structure Elucidation: Good practice of structure elucidation using UV, IR, MS, NMR for novel Molecule
• Biotechnological: Various In vitro assays, RT-PCR, Western blotting, Gel electrophoresis, Fluorescence microscopy, Primary cell culture, Comet Assay, Cytotoxicity Assay, Clonogenic Assay
• Pharmacological: Animal handling, Oral dosing, Blood collection Extra Curricular Activities:
• Delivered seminar on “Pathophysiology, treatment of Alzheimer’s disease and synthesis of some novel compounds” at NIPER- Ahmedabad.
• Delivered seminar on “Ulcer protective effect of Boswellic acid from Boswellia serrata” at NIPER- Ahmedabad.
Conferences Attended
1. Attended 61st Indian Pharmaceutical Congress (IPC) held at NIRMA University, Ahmedabad (2009)
2. Attended 6th International Symposium held at B.V. Patel PERD Centre, Ahmedabad(Nov 2010)
Area of Interest:
� Extraction, isolation and characterization of active moieties from herbal drugs. � Drug Discovery, Research and Development � Pharmaceutical analysis and Bioanalysis � To develop various cell based assays for screening of natural and synthetic molecules � Regulatory Affairs and Intellectual Property Rights
Personal Details: Date of birth : 20th June,1984 Father’s name : Laxmi Narayan Gupta Marital status : Unmarried Gender : Male Languages known : English, Hindi, Rajasthani Contact no. : +91 9879591767 E-mail : [email protected] Permanent address : c/o Anil Singhal A-17 Agrawal Nagar, Gangapur City Dist.-Sawai Madhopur, Rajasthan 322201 I hereby declare that the above written particulars are true to the best of my knowledge and belief. Date: Vineet Kumar Gupta
Reference:
Dr. Sheetal Anandjiwala Dr. Lakshmi Srihasam Lecturer (Senior) Research Associate Dept. of Natural Products Dept. of Cell Biology & Neurology NIPER- Ahmedabad NIPER- Ahmedabad Phone: +91-9426524080 Phone: +91-9879845066 E-mail: [email protected] E-mail: [email protected]
BACK to Previous Page
Arun kumar choudhary Mob: +918000410511 Email: [email protected] Page 1
ARUN KUMAR CHOUDHARY Contact No. # +918000410511 Email: [email protected] CAREER OBJECTIVE: To secure position in pharmaceutical R & D and contribute to organizations success. EDUCATIONAL QUALIFICATIONS:
COLLEGE: SGSITS, Indore. NIPER, Ahmedabad ACHIEVMENT:- Qualified GATE 2008 with 94.10 Percentile Qualified GATE 2009 with 89.42 Percentile Class topper in B. Pharm DISSERTATION TOPIC:- Development and Characterization of Mucoadhesive Nanoparticles for Ocular Delivery of Moxifloxacin Aim:To prepare the mucoadhesive nanoparticles of different polymer for ocular delivery.The primary aim of work is to prepare mucoadhesive nanoparticles of different polymer and screen them on the basis of different properties such as mucoadhesion, biocompatibility etc .Also permeation is studied using goat’s cornea.
Sr No Year Course Institute/ University % Marks Class
1 20010-11 M. Pharm National Institute of
Pharmaceutical Education And Research(NIPER), Ahmedabad
8.57(till 2nd sem) -
2 2009 B. Pharm R.G.P.V. Bhopal 70.09 First 3 2003 H.S.S.C. M.P. Board 80.22 First 4 2001 S.S.C. C.B.S.E. 68.00 First
Arun kumar choudhary Mob: +918000410511 Email: [email protected] Page 2
Publication:
• Review article entitled as “Challenges in ophthalmic drug delivery: Current scenario” published in Souvenir of 6th International Symposium organized by B.V. Patel PERD Centre, Ahmedabad during 26th -28th Nov, 2010.
INDUSTRIAL TRAINING:
Completed 15 days training at RANBAXY Dewas INSTRUMENT KNOWLEDGE:- Expertise in analyzing and interpreting data from various instruments like
Zeta Sizer Homogeniser Franz diffusion cell HPLC UV Spectrophotometer DSC Iontophoresis
EXTRA CURICULLAR ACTIVITIES:
School vice President Played Football at District level Completed NCC A certificate
PERSONAL SKILLS:
Analytical and logical problem solving abilities Good at planning, organizing events Willing to learn and apply my knowledge to practical situations Team facilitator with good communication and interpersonal
PERSONAL DETAILS: Date of birth : 16th June, 1985 Marital status : Unmarried Gender : Male Languages known : English, Hindi Contact no. : +918000410511 E-mail : [email protected]
Arun kumar choudhary Mob: +918000410511 Email: [email protected] Page 3
Permanent address : F-1 Near Kileshwar Mandir Neemuch, Dist –Neemuch, M.P. Pin - 458441 I hereby declare that the above specified information is true to the best of my knowledge and belief. Date: Arun kumar choudhary
REFERENCES:-
Dr.Manju misra Assistant Professor NIPER, Ahmedabad
Contact No - 09099069333
Dr. Uttam mandal Assistant Professor
NIPER, Ahmedabad Contact No - 07567738836
BACK to Previous Page
1
DDuurrggeesshh AA BBaarrhhaattee
MM..SS.. ((PPhhaarrmmaa)),, PPhhaarrmmaacceeuuttiiccss
Present Address:
National Institute Of Pharmaceutical Education
And Research (NIPER) .
c/o – B.V.Patel PERD Centre, S.G.Highway, Thaltej,
Ahmedabad, Gujarat ,Pin code -380054
CAREER OBJECTIVE:
Aspiring for a job wherein my qualification and acquired skills are put to best use for success
of my organization & which would provide me an opportunity to learn and grow professionally to my
full potential and perform task assigned to me with the best of my ability and to work dedicatedly
towards the success of the organization.
ACADEMIC CREDENTIALS:
Course School /
College/university
Year of passing Result Class
M.S. (Pharm.)
pharmaceutics
NIPER, Ahemdabad Expected on July
2011
GPA- 8.29/10 -
Pharma Regulatory Affairs Bioinformatics institute
of India
Expected on July
2011
Pursuing -
B. Pharm Pune University, Pune 2009 65% First
HSC Maharashtra state board 2005 63 First
SSC CBSE 2003 80.12 Distinction
Other qualifications:-
• Successfully completed the distance learning course General Course on Intellectual Property from
“World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland.”
RESEARCH EXPERIENCE:
UNDERGOING PROJECT:
Design & Development of Alginic-Chitosan Microspheres of Antiretroviral Agent.
Aim: To optimize various formulation parameters such as drug to polymer ratio, size, zeta potential,
amount of cross linking agent for preparations of nano/microspheres of antiretroviral agent & to
study the uptake of nano/microspheres of antiretroviral agent by peyer’s patches.
The primary aim of work was to enhance the uptake of nano/microspheres of antiretroviral agent by
peyer’s patches to increase drug concentration in GALT.
[ Curriculum vitae Curriculum vitae Curriculum vitae Curriculum vitae ]
2
AREA OF INTEREST:
� Formulation Development
� Research & Development
� Novel Drug Delivery System
� Regulatory affairs
� Intellectual property rights
AWARDS / ACHIVEMENTS:
• NIPER JEE 2009 All India Rank 53
• Qualified GATE 2009 with 98.73 Percentile.
• Qualified GATE 2008 with 96.04 Percentile.
Technical skills :-
Expertise in analyzing and interpreting data from various instruments like
� UV Spectrophotometer
� Dissolution Test Apparatus
� DSC
� Zeta sizer
� Brookefield viscometer
� HPLC
� Tablet punching machine
� Tablet coater
� Franz diffusion cell
� FBD
PUBLICATIONS / PRESENTATIONS:
• Presented poster at 61th Indian pharmaceutical congress, 2009, Ahemdabad on the
topic “Nanotechnology: current regulatory perspective”.
• Presented poster at 62th Indian pharmaceutical congress, 2010, Manipal on the topic
"Section 3(d) of Indian patents act: a boon to India, preventing evergreening
of patents".
• Published review in souvenir of 6th International Symposium on Innovations in
Pharmaceutical Sciences and Technology, Ahmedabad 2010 entited “Recent update
on microparticulate drug delivery systems for potential drug and vaccines
carriers via peyer’s patch/G.I mucosal route”.
3
Personal details:
Date of birth :- 08/09/1987
Martial status :- unmarried
Gender :- male
Languages known :- English ,hindi, Marathi, gujarati.
Contact no :- 02602421684, +919016668433,+919687320336
Email id :- [email protected]
permanent address :- 27/598 new housing board
G.I.D.C , vapi, Dist – valsad
Gujarat, india
Declaration :-
I hereby declare that the above written particulars are true to the best of my knowledge and belief.
Date: Durgesh A Barhate
References:-
Dr. Neeta Shrivastva
Project director,
NIPER-Ahemdabad
Email:- [email protected]
Dr. Uttam Mandal Dr. Manju Misra
Assitant Professor Assistant Professor
NIPER, Ahmedabad NIPER, Ahmedabad
Contact No :– +91 7567738836 Contact No :- +91 9099069333
Email:- [email protected] Email :- [email protected]
BACK to Previous Page
CURRICULUM VITAE
SSaacchhiinn PPrraakkaasshh CChhaauuddhhaarrii MM..SS.. ((PPhhaarrmm)),, PPhhaarrmmaacceeuuttiiccss
Present Address: National Institute Of Pharmaceutical Education & Research c/o B.V Patel Perd Centre, SG Highway, Thaltej,Ahemdabad, Pin code -380054
Career Objective: To secure position in pharmaceutical R & D and contribute to organizations success EDUCATIONAL QUALIFICATIONS
Other Qualification:
• Successfully completed the distance learning course General Course on Intellectual Property from “World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland.”
Sr No
Year Course Institute/ University % Marks Class
1 2010-11 M.S. Pharm
(Pharmaceutics)
National Institute of Pharmaceutical Education
And Research(NIPER), Ahmedabad
Appearing -
2 2010-11
Industrial Program in
Pharma Regulatory
Affairs
Bioinformatics Institute of India(BII), Noida
Appearing -
3 2008-09 B.Pharm University of Pune 70.5 First Class
With Distinction
4 2005 HSC Jai- Hind Junior college,
Dhule (Maharashtra) 82.83
First Class With
Distinction
5 2003 SSC S.R.R.K. Vidyalay,
Holnanthe (Maharashtra) 78.93
First Class With
Distinction
Dissertation Topic: Design and Development of Gastro-Retentive Osmotic Pump of an Anti-hypertensive Drug. Summary
Atenolol is highly cardioselective β blocker and having sparingly solubility. Short retention time in stomach and no absorption from lower GI tract serves as the basis for low bio-availability of atenolol which rationalise gastro-retentive formulation. Atenolol has a t1/2 of 6 hrs hence necessitates controlled release formulation. Osmotic controlled release supersedes other controlled system by avoiding plasma drug fluctuations.
Hence current project undertaken involves combining advantages of two drug delivery systems ultimately leading to completion of objective of enhancement of bio-availability of atenolol. Achievement:
• Qualified GATE 2009 with 99.72 Percentile(AIR 65) • Qualified NIPER JEE 2009 (AIR 73)
Instrument Knowledge: Expertise in handling, analyzing and interpreting data from various instruments like
Brookfield Viscometer Dissolution Test Apparatus DSC FBD Franz Diffusion cell HPLC Tablet Coater Tablet punching machine UV Spectrophotometer Zeta-Sizer
Presentations and Publications:
• Published review in souvenir of 6th International Symposium on Innovations in Pharmaceutical Sciences and Technology, Ahmedabad 2010 entited “Oral osmotic drug delivery system: a potential NDDS option in twenty first century”
• Accepted poster for presentation in 62nd IPC 2010 Manipal, entitled “Formulation and Evaluation of Thermoreversible Mucoadhesive Microemulsion Based In-situ Gel (TMMIG) of an Anti-osteoporotic Agent”
• Acts as co-author in poster accepected in 62nd IPC 2010 Manipal, entitled “Section 3(d) of Indian patents act: a boon to India, preventing evergreening of patents”.
• Preparation of exhaustive summary report on “Self Emulsifying Drug Delivery System” at undergraduate level
Area of Interest:
Formulation Development Novel Drug Delivery System Regulatory affairs
Personal Details: Date of birth : 18th June, 1988 Marital status : Unmarried Gender : Male Languages known : English, Hindi, Marathi Contact no. : +91 9687320366 E-mail : [email protected] [email protected] Permanent address : Plot No. 51 Indrasing Bhausaheb Colony, A/P Holnanthe Tal- Shirpur Dist- Dhule (Maharashtra) Pin- 425448 I hereby declare that the above written particulars are true to the best of my knowledge and belief. Date: Sachin Prakash Chaudhari
References:
Dr. Uttam kumar Mandal Assistant Professor
NIPER, Ahmedabad Contact No - +91-7567738836 [email protected]
Mr. Vivek Ramkrushna Shitole Assistant Manager Drug Regulatory Affairs Medley Pharmaceuticals Ltd. Andhery (E) Mumbai 93 Contact No - +91- 9892201120 [email protected]
BACK to Previous Page
CURRICULUM VITAE
GGaajjeennddrraa SShhaarrmmaa MM..SS.. ((PPhhaarrmm)),, PPhhaarrmmaacceeuuttiiccss
Present Address: National Institute Of Pharmaceutical Education And Research (NIPER), Ahmedabad c/o – B.V.Patel PERD Centre, S.G.Highway, Thaltej, Ahmedabad, Gujrat Pin - 380054
Career Objective: To achieve a responsible and challenging position in your esteemed organization where I get opportunity to bring out to my best of creativity, talent and technical knowledge. To be a part of dynamic teamwork together towards growth of the organization. EDUCATIONAL QUALIFICATIONS
Other Qualification:
• Successfully completed the distance learning course General Course on Intellectual Property from “World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland.”
Dissertation Topic: Design and Development of Self Emulsifying Drug Delivery System of an anti HIV agent Aim: The objective of the project is to enhance the oral bioavailability and prefential lymphatic uptake of drug. It includes selection of oil/surfactant /cosurfactant and there ratio in formulation based on different parameters. The evaluation of the formulation for speed of emulsification, globule size, zeta potential & stability study. The formulation will be evaluated for enhancement of oral bioavailability and prefential lymphatic uptake in suitable animal(rat) model.
Sr No Year Course Institute/ University % Marks Class
1 2010-11 M.Pharm National Institute of
Pharmaceutical Education And Research(NIPER), Ahmedabad
Appearing -
2 2008-09 B.Pharm Shri G.S.I.T.S. Indore 66.84 First
3 2002 AISSCE JNVR PANNA MP (CBSE)
73.2 % First
4 2000 AISSE JNVR PANNA MP (CBSE)
74.6 % First
Achievement:
• NIPER JEE 2009 All India Rank 51 • Qualified GATE 2009 with 99.67 Percentile. • Qualified GATE 2008 with 94.36 Percentile.
Instrument Knowledge: Expertise in analyzing and interpreting data from various instruments like
HPLC Zeta sizer Dissolution Test Apparatus Brookefield viscometer Tablet punching machine Tablet coater Franz diffusion cell FBD DSC
Extra Curricular Activities:
• Poster accepted at 62th Indian pharmaceutical congress, 2010, Manipal on the topic "Overview: Drug Patent Linkages"
• Published review in souvenir of 6th International Symposium on Innovations in Pharmaceutical Sciences and Technology, Ahmedabad 2010 entited “Recent update on microparticulate drug delivery systems for potential drug and vaccines carriers via peyer’s patch/G.I mucosal route”. Area of Interest:
Formulation Development Novel Drug Delivery System Regulatory Affairs Intellectual property rights
Personal Details: Date of birth : 3rd June, 1984 Marital status : Unmarried Gender : Male Languages known : English, Hindi, Contact no. : +91 9687815225, +91 7878277975. E-mail : [email protected] [email protected] , Permanent address : V/P Patna kala Tahsil Gunaur, Dist –Panna, Madhya Pradesh Pin - 488050
I hereby declare that the above written particulars are true to the best of my knowledge and belief.
Date: Gajendra Sharma
Reference:
Dr Neeta Shrivastava Project Director NIPER- Ahmedabad Contact No: +91 9824250226 Email: [email protected]
Dr. Uttam mandal Dr. Manju Misra Assistant Professor Assistant Professor NIPER, Ahmedabad NIPER, Ahmedabad Contact No :– +91 7567738836 Contact No :- +91 9099069333
Email:- [email protected] Email :- [email protected]
BACK to Previous Page
I
CCUURRRRIICCUULLUUMM VVIITTAAEE
CAREER OBJECTIVE To perform the task assigned to me with the best of my ability and to work dedicatedly towards the success of the organization. EDUCATIONAL QUALIFICATIONS Sr. No. COURSE INSTITUTE/ UNIVERSITY YEAR %
MARKS CLASS
1 M.S.Pharma Pharmaceutics
National Institute of Pharmaceutical Education And
Research(NIPER), Ahmedabad
2009-11CGPA 8.00
(Up to 2nd Sem)
-
2 B. Pharma Gujarat University, Ahmedabad 2009 64.14% First
3 D.Pharma Saurashtra University, Rajkot 2005 54% Second
4 HSC GHSEB 2003 61% First
5 SSC GSEB 2001 88.71% Distinction
Other Qualification • Successfully completed the distance learning course General Course on Intellectual
Property from “World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland.”
AREA OF INTEREST
• Formulation and Development • Novel Drug Delivery System • Regulatory affairs • Intellectual property rights
HHaassmmuukkhh MM JJeeppaall MM..SS PPhhaarrmmaa ((pphhaarrmmaacceeuuttiiccss))
Present Address: National Institute Of Pharmaceutical Education And Research (NIPER), Ahmedabad c/o – B.V.Patel PERD Centre, S.G.Highway, Thaltej, Ahmedabad, Gujrat Pin - 380054
II
AWARDS / ACHIEVEMENTS
• Qualified NIPER JEE 2009 with all India Rank 221 • Qualified GATE 2009 with 98.45 percentile • Qualified GATE 2008 with 81.74 percentile • Qualified BET (B-Pharm Entrance Test) 2006
TECHNICAL SKILLS
• Expertise with the basics of various instruments those are required for formulation
development & evaluation like Tablet punching machine, Tablet coating machine, extruder, Dissolution Test Apparatus, DSC, HPLC, UV Spectrophotometer, pH meter, and Zeta sizer.
• Computer skills: I have good knowledge about MS office. • Study software: I can use DOE for statistics
DESSERTATION TOPIC
“Design and Development of controlled porosity osmotic pump for an antispastic agent” Available marketed Tizanidine HCl Tablet are conventional type and so they must be given three times a day due to short half-life of drug, this problem could be overcome by development of the system which can deliver drug for extended period of time. We can reduce the side effects by minimizing fluctuation in plasma drug concentration by adopting controlled release formulation, among other controlled release system osmotic drug delivery system (ODDS) is ideal for this purpose and it is most suitable to deliver drug in zero order. Drug release from these systems is independent of pH and other physiological parameters to a large extent and it is possible to modulate the release characteristics by optimizing the properties of drug and system.
PRESENTATION / PUBLICATION
• Paper accepted for poster presentation at 62nd Indian Pharmaceutical Congress 2010 will held in December, 2010 Manipal, on “Formulation Development and Statistical Optimization of Elementary Osmotic Pump of Tizanidine Hydrochloride”.
• Review Article published in 6th international symposium held in November, 2010 Ahmadabad, on “Oral osmotic drug delivery system: a potential NDDS option in twenty first century”.
• Paper accepted for poster presentation at 62nd Indian Pharmaceutical Congress 2010 will held in December, 2010 Manipal, on “Hatch Waxman Act (HWA) and its significant effect on Indian pharmaceutical industries”.
• Paper accepted for poster presentation at 62nd Indian Pharmaceutical Congress 2010 will hold in December, 2010 Manipal, on “Era of “Knowledge Transfer” Symbiotic Relationship between Industries and Academia”.
PERSONAL DETAILS Date of Birth : 19th July 1985 Marital status : Unmarried Gender : Male Languages known : English, Hindi, Gujarati
III
Contact No. : (M) 09725239595, (Home) +91-2737-223960 Email : [email protected] [email protected] Permanent address : Prakash Traders, Opp. Bus station, Tharad-385565, Dist: Banaskantha, Gujarat, India.
I hereby declare that the above written particulars are true to the best of my knowledge and belief.
REFERENCES
Date: Hasmukh Jepal
Dr. Uttam Mandal Assistant Professor NIPER, Ahmedabad Contact No :– +91 7567738836 Email ID:- [email protected]
Dr. Manju Misra Assistant Professor NIPER-Ahmedabad Mobile:- +91 9099069333 Email ID:- [email protected]
BACK to Previous Page
CURRICULUM VITAE
MMaannaallii MMaallaavviiyyaa Career Objective: To pursue a challenging career in a progressive organization and intend to build a growth oriented career in competitive corporate environment with full commitment & dedication.
Area of interest: • Formulation Development of Conventional as well as Novel Drug Delivery system • Preformulation studies • Regulatory Affairs
Educational Qualifications:
*cGPA: Cumulative Grade per Annum
M. S. Pharm. Dissertation: Design and development of extended release solid dispersion of Nisoldipine In my research work, I am developing solid dispersion of Nisoldipine with an aim to improve its bioavailability by enhancing its solubility using different solubilizers and further extending its release till 24 hr with the help of various release controlling polymers. I will be subjecting the Solid dispersion and their respective formulation to DSC, XRPD and Microscopic studies for its characterization. The optimized formulation will also be evaluated for the stability of amorphous form of drug in formulation along with other evaluation parameters.
Sr. No.
Course Board/ University Year cGPA*/
Percentage Class
1. M.S.Pharm NIPER, Ahmedabad Pursing
9.07/10 (Up to 2rd Sem) -
2. B.Pharm
Gujarat University (Ramanbhai Patel
College of Pharmacy (RPCP), Changa)
2009
67.5%
First Class
3. HSC GSHEB 2005
79.23%
Distinction
4. SSC GSEB 2003 87.43% Distinction
Correspondence Address: National Institute of Pharmaceutical Education & Research (NIPER), Ahmedabad C/o – B.V.Patel PERD Centre, S.G.Highway, Thaltej, Ahmedabad-380054 (Guj).
Scientific Expertise:
• Knowledge about formulation development of conventional & novel drug delivery systems
• Creative skills in the design of scientific experiments and interpretation of results • Awareness about the basics of various instruments which are required for development
& evaluation of formulation • Familiar with concepts related to Preformulation study • Knowledge about IPR
Achievements: • Secured All India Rank 54th in NIPER-JEE, 2009 • Qualified GATE 2009 conducted by IIT Roorkee with a score of 96.82 percentile • Successfully completed distance learning course on IPR by WIPO, 2009
Publications:
• Poster entitled “Issues and controversies in patenting Biotechnology based innovations” has been presented at the 61st Indian Pharmaceutical Congress at the the Nirma University of Science and Technology, Ahmedabad during 11th -13th December, 2009.
• Review article entitled as “Emerging era of polymer based Nanotechnology: Cancer Targeting” published in Sovenior of 6th International Symposium organized by & at B.V.Patel PERD Centre, Ahmedabad during 26th -28th November, 2010.
Seminar presented at NIPER Ahmedabad: • Functionlized Carbon Nanotube as emerging nanocarrier for delivery of Therapeutics • Role of reverse engineering in development of generics
Conference/workshop: • 3 day workshop on “IPR for Healthcare SMEs” organized by FICCI & foundation for
MSME clusters at Ahmedabad on 18th - 20th March, 2010. • Attended 6th International symposium on “Advancement In Pharmaceutical Sciences
And Technology” held at B.V. Patel PERD Centre, Ahmedabad on 26th – 28th Nov, 2010.
Professional Activities:
• 2 month summer training at Relish Pharmaceuticals, Rakanpur, Ahmedabad • 1 month summer training at Intas Pharmaceuticals, Matoda, Ahmedabad
Extracurricular Activities: • Winner in Volleyball match at college level, 2006 • Runner-up in Girls’ Cricket match at college level, 2006 • Active participation in various events at institute level
Personal Details:
Full Name : Malaviya Manali Manubhai Father’s Name : Manubhai B. Malaviya Date of Birth : 18th February, 1988 Gender : Female Marital Status : Single Languages known : English, Gujarati, Hindi Contact No. : +91-9558906753 Email-id : [email protected] Permanent Address : B/57, Nilkanth Society, Bh/ Bajrang Ashram,
N.H.No. 8, Thakkarbapanagar, Ahmedabad- 382350, Gujarat, India.
I, hereby, declare that the above written particulars are true to the best of my knowledge and belief.
Date: Manali M. Malaviya
References:
Dr. Manju Misra Assistant Professor, NIPER- Ahmedabad. [email protected]
Dr. Uttamkumar Mandal Assistant Professor, NIPER - Ahmedabad. [email protected]
BACK to Previous Page
CURRICULUM VITAE
Vishal T. Mogal M.S. (Pharm.) in Pharmaceutics Contact No: +91-9016838999 E-mail: [email protected]
Address for correspondence National Institute of Pharmaceutical Education & Research (NIPER)-Ahmedabad c/o B. V. Patel Pharmaceutical Education & Research Development (PERD) Centre, Sarkhej -Gandhinagar Highway, Thaltej, Ahmedabad-380054, Gujarat, India Phone: +91-79-27439375 Fax: +91-79-27450449 E-mail: [email protected] Web: www.niper-ahmedabad.in Career Objective Aim to work in Formulation Development sector of healthcare organization and intend to build a career in competitive corporate environment with full commitment and dedication to achieve a praiseworthy position in the area of pharmaceutical research. Academic Qualifications
Research experience Design and Development of Solid Lipid Nanoparticles for delivery of Carvedilol Carvedilol has limited aqueous solubility, which limits the active agent's absorption in the gastrointestinal (GI) tract of the patient. Prior attempts to improve the solubility of carvedilol include the use of a solubilizer with the active agent, or the formation of various carvedilol salt forms which have varying degrees of solubility when compared to carvedilol free base. Still, there remains a need in the art for carvedilol compositions having improved aqueous solubility. The oral bioavailability of carvedilol is only 25% as it undergo extensive first pass metabolism in liver.
Sr. No.
Course Year Of Passing
Institute/ University % Marks/
CGPA Class
1. M.S.(Pharm.) Pharmaceutics
May-2011
NIPER, Ahmedabad. Appearing -
2. B.Pharm. June-2009
NDMVPs College of Pharmacy, Nasik
University of Pune 65.41 First Class
3. H.S.C. Feb-2005
K.T.H.M College Dist: Nasik
76.83 Distinction
4. S.S.C. March-2003
Maratha highschool Dist : Nasik
74 First class
Publications/ Presentations
• Presented a poster entitled “Nanotechnology: Current Regulatory Perspectives”, at 61st Indian Pharmaceutical Congress, Dec. 2009 at Ahmedabad.
• Accepted a poster entitled “Section 3(d) of Indian patents act: a boon to India, preventing evergreening of patents” for 62nd Indian Pharmaceutical Congress, Dec. 2010 at Manipal.
Other qualification
• Successfully completed the distance learning course General Course on Intellectual Property from “World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland.”
• All India 19th rank at National level Pharmacy talent Search Examination (NTS), organized by Pharma Helpline Society.
Instrument Knowledge Expertise in analyzing and interpreting data from various instruments like
• Spectrofluorometer • Zetasizer • Tablet Punching Machine • Tablet Coating Machine • Fluidized Bed Dryer • Brookefield Viscometer • UV Spectrophotometer • HPLC • Differential Scanning Calorimetry
Achievements
• Qualified GATE 2009 with All India Rank 137 (99.44 percentile) • Qualified GATE 2008 with All India Rank 287 (98.93 percentile) • Qualified NIPER- JEE 2009 with All India Rank 70
Area of Interest
• Formulation & Development • Research & Development • Regulatory Affairs • IPR
Personal Information
References
Declaration
I hereby declare that all the information in this CV is true and complete to the best of my knowledge and belief. Place : Ahmedabad Yours Sincerely Date : Mogal Vishal Tukaram
Date of Birth : 7th March 1988 Father’s Name : Tukaram B. Mogal Nationality : Indian Gender : Male Languages Known : English, Hindi, Marathi, Sanskrit. Permanent Address : 2- M.J. Park, opp. Rathi amrai, Gangapur road,
Nashik. Maharashtra-422013.
Dr. Manju Misra Assistant Professor, NIPER Ahmedabad [email protected] Mobile No. 09099069333
Ms. Amita Joshi Guide, NIPER Ahmedabad [email protected] Mobile No. 09925152223
BACK to Previous Page
CCUURRRRIICCUULLUUMM VVIITTAAEE BBrriijjeesshhkkuummaarr BBaalluubbhhaaii PPaatteell MM..SS.. ((PPhhaarrmm)),, PPhhaarrmmaacceeuuttiiccss Permanent address At & Post: Kanjan Ranchhod, Vanjar falia Ta & Dist: Valsad Gujarat-396055 Contact no: +91 9979306123. E-mail: [email protected]
Career objective:
Seeking a challenging career with a progressive organization that will utilize my skills, abilities and education in product development.
Educational qualifications
Dissertation Topic:
Design and Development of swellable & floating gastroretentive dosage form weakly basic drug. Weakly basic drugs have better solubility at acidic pH, and tends to precipitate out at higher pH. The primary aim of the work was to develop a dosage form that get retains in the stomach for longer period of time. The dosage form releases the drug in the stomach and the released drug get absorbed from the upper part of small intestine.
Achievement:
• Qualified GATE 2009 with 99.67 Percentile, all India rank 77.
Instrument handled:
HPLC UV Spectrophotometer
Sr No Year Course Institute/ University % Marks Class
1 2010-11 M.Pharm National Institute of
Pharmaceutical Education And Research(NIPER), Ahmedabad
Appearing -
3 20-08 B.Pharm Gujarat University 58 Second class 4 20 D.Pharm Gujarat University 59 Second class
Dissolution test apparatus DSC 16 Station tablet compression machine Single station tablet compression machine
Computer proficiency
Microsoft Word, Microsoft Excel Information retrieval using internet
Area of interest:
Formulation Development Novel Drug Delivery System
Personal details:
Date of birth : 31st July, 1986 Marital status : Unmarried Gender : Male Languages known : Gujarati, Hindi, English I hereby solemnly, do affirm that the particulars furnished above are true to the best of my knowledge Date: Brijesh B. Patel Place: Ahmedabad
Reference: Dr. Manju Mishra Dr. Amita Joshi
Assistant Professor Research associate NIPER, Ahmedabad NIPER, Ahmedabad Contact No -9099069333 Contact No -09925152223 [email protected] [email protected]
BACK to Previous Page
Curriculum Vitae Khushbu Patel
Address : 100/1189, Laxmikrupa Flats, Parasnagar, Sola road, Ahmedabad-380063, Gujarat, India
Contact No. : (M) +91-9638038524 Career Objective: To apply my knowledge and skills in the R&D sector of progressive pharmaceutical industry so as to contribute to the global healthcare system; as well as to improve my abilities in various dimensions of pharmaceutical research.
Area of interest: • Preformulation and formulation study of Conventional and Novel Drug Delivery System • Regulatory Affairs
Educational Qualifications:
M. S. Pharm. Dissertation: “Melt Granulation as an approach for development of stable Rabeprazole sodium Formulation” In my research project, I am working on Rabeprazole Sodium which is highly sensitive to acid, oxidation and moisture because of its highest solubility & Log P among all PPIs (Benzimidazoles). My aim is to investigate the stabilizing effect of Melt granulation approach on the enteric formulation of Rabeprazole sodium. Assessment of formulation stability by use of analytical techniques like HPLC will help me in concluding my hypothesis.
Sr. No. Course Board/ University Year cGPA*/
Percentage Class
1. M.S.Pharm NIPER, Ahmedabad Pursing
8.63/10 (Up to 2rdsem) -
2. B.Pharm NIRMA 2009
8.63
Distinction
3. HSC GHSEB 2005
88.41%
Distinction
4. SSC GSEB 2003 88.43% Distinction
Academic Achievements/Awards: • Successfully completed the distance learning course General Course on Intellectual
Property from “World Intellectual Property Organization (WIPO) Worldwide Academy”, Geneva, Switzerland, 2009
• Secured All India Rank 37th in NIPER-JEE, 2009 • Qualified GATE 2009 conducted by IIT, Roorkee with a score of 99.96 percentile • Qualified GATE 2008 conducted by IISc, Bangalore with a score of 96.83 percentile
Industrial Training:
• 1 month training at Cadila Healthcare Pvt. Ltd., Changodar, Ahmedabad • 2 month training at Lincoln Pharmaceutical Pvt. Ltd., Khatraj Chokadi, Ahmedabad
Scientific Expertise:
• Well versed with equipments and processes related to formulation development of oral solid dosage forms as well as NDDS
• Use of various analytical instruments and techniques (DSC, PXRD, microscopic and spectroscopic instruments and HPLC)
• Understanding of the concepts related to polymorphs/amorphous systems, QbD and ICH Guidelines
• Knowledge related to the basic concepts of intellectual property rights and regulatory affairs
Presentation/Publication:
• Review article entitled as “Bottlenecks to Drug Discovery and Development” published in Souvenir of 6th International Symposium organized by & at B.V.Patel PERD Centre, Ahmedabad on 26th – 28th Nov. 2010
• Poster entitled as “Issues and controversies in patenting Biotechnology based innovations” has been presented as Co-author at the 61st Indian Pharmaceutical Congress at the the Nirma University of Science and Technology, Ahmedabad on 11th-13th Dec. 2009
Seminars delivered at NIPER, Ahmedabad: • Process Analytical Technology (PAT) in pharma industry • Complexation Hydrogel: Novel Approach for Oral Delivery Of Protein & Peptide
Conference/workshop attended:
• 6th International symposium on “Advancement in nanotechnology based innovations” held at B.V. Patel PERD Centre, Ahmedabad on November, 2010
• Workshop on “IPR for Healthcare SMEs” organized by FICCI & foundation for MSME clusters at Ahmedabad on February, 2010
Personal details:
Full Name : Patel Khushbu Dineshbhai Date of Birth : 21th January, 1988 Gender : Female Marital Status : Single Languages known : English, Hindi, Gujrati Contact no. : +91-9638038524 E-mail : [email protected]
I hereby declare that the above written particulars are true to the best of my knowledge and belief. Date: Khushbu D. Patel References:
Dr. Manju Misra Assistant Professor, NIPER Ahmedabad. [email protected]
Dr. Uttamkumar Mandal Assistant professor, NIPER Ahmedabad. [email protected]
BACK to Previous Page
CURRICULUM VITAE
PPaatteell DDiippaakkbbhhaaii MMaahheennddrraakkuummaarr MM..SS.. ((PPhhaarrmm)),, PPhhaarrmmaacceeuuttiiccss
Present Address:
National Institute Of Pharmaceutical Education
And Research (NIPER), Ahmedabad
c/o-B.V.patel PERD centre,
S.G.Highway, Thaltej, Ahmedabad, Gujarat
Permanent address:
53/A gayatri nagar society,
Near Adarsh Vidhyalaya,
Mehsana road,
Dist: Mehsana, Gujarat
Visnagar-384315
Career Objective:
To consistently learn & work in a challenging & competitive environment for the fulfillment of
organization’s objectives & prove myself as a key factor for the growth of the organization.
EDUCATIONAL QUALIFICATIONS
Dissertation Topic:
COMPARATIVE ANALYSIS OF REGULATORY STRUCTURE AND FRAMEWORK IN US,
EUROPE AND JAPAN
In my MS project I am compiling the differences and similarities in regulatory framework of few
developed nations like US, Europe and Japan. The areas on which I am specifically working
Sr No Year Course Institute/ University % Marks Class
1 2009-11 M.S.
(Pharm)
National Institute of
Pharmaceutical Education And
Research(NIPER), Ahemdabad
Appearing
8.35 CGPA
(up to II SEM.) -
2 2005-09 B.Pharm L.M.C.P /Gujarat university 66 First
3 2004-05 H.S.C Gujarat secondary and higher
secondary education board. 72.46 distinction
4 2002-03 S.S.C Gujarat secondary and higher
secondary education board. 80.43 distinction
upon are approval process related to medical devices, drugs including pediatric drugs and orphan
drugs. The idea behind selecting such project was to prepare a short hand guide which will
expedite the process of thoroughly knowing the regulatory approval process in these countries
and thus reduction in overall time required for approval of any product. Though ICH and GHTF
bodies are in existence to bring about harmonization in this area, still there is some dissimilarity
in the regulatory approval skeleton of all these countries. In my thesis I am trying to summarize
such differences or similarities in approval process of these nations to facilitate harmonization,
which is currently a vital necessity for Pharmaceutical Regulation
Achievements:
• NIPER JEE 2009 All India Rank 408 ( 3rd in PH category)
• Qualified GATE 2009 with 99.54 Percentile and All India Rank 108 ( 1st in PH category)
• Recipient of Dhirubhai Ambani under graduate scholarship on securing first rank
amongst handicapped candidates in Mehsana district of Gujarat state in March-2005.
Technical skills
• Well versed with requirements of Drug regulatory approval process.
• Well versed with requirements of regulatory approval process of medical devices.
• Fair idea about intellectual property rights
• Thorough understanding of all formulation development steps and procedures.
•
Extra Curricular Activities:
� Actively involved with all activities of DIA YPC (Drug Information Association’s Young
Professional Chapter) as a member
� Presented poster entitled “Comparative analysis of regulatory structural/approval
process for medical device in US and EUROPE” at 62nd
Indian pharmaceutical
congress held on 17 Dec to 19 Dec 2010 at Manipal University, on
� Review Published in souvenir of 6th
International Symposium on Innovations in
Pharmaceutical Sciences and Technology, Ahmedabad 2010 entited “Challenges In
Ophthalmic Drug Delivery: Current Scenario”.
� Attended CII-MSME work shop on “ Role of IPR to enhance business of SME” held
on 14-15 May 2010 in Ahmedabad
Area of Interest:
� Regulatory affairs
� IPR
� Documentation
Personal Details:
Date of birth :9th
June 1988
Marital status :Single
Gender :Male
Languages known :English, Hindi, Gujarati
Contact no. :+919824310798 , +918000235668
E-mail :[email protected]
Hobbies :Listening to Music, Reading
I hereby declare that the above written particulars are true to the best of my knowledge and
belief.
Date: 22/11/2010 Dipak M Patel
Reference:
Dr. Manju Misra Dr. Uttam Kumar Mandal
Assistant Professor Assistant Professor
NIPER, Ahmedabad NIPER, Ahmedabad
Contact No :- +91 9099069333 Contact No:+91 7567738836
Email :- [email protected] Email:- [email protected]
Back to Previous Page
CURRICULUM VITAE PPaatteell VViippuullkkuummaarr BBaabbuullaall MM..SS.. ((PPhhaarrmm)),, PPhhaarrmmaacceeuuttiiccss Correspondence Address: National Institute Of Pharmaceutical Education and Research (NIPER), Ahmedabad c/o – B.V.Patel PERD Centre, S.G.Highway, Thaltej, Ahmedabad, Gujrat PIN - 380054
Career Objective:
To work in an organization that provides me opportunity to sharpen my acquired skills and to contribute positively in the growth of organization.
EDUCATIONAL QUALIFICATIONS
Other Qualification:
Successfully completed the distance learning course General Course on Intellectual Property from “World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland.”
Achievement:
NIPER JEE 2009 All India Rank 25 Qualified GATE 2009 with 99.29 Percentile and Rank 165
Sr. No
Course Institute/ University Year Percentage
1 M.Pharm National Institute of
Pharmaceutical Education And Research(NIPER), Ahmedabad
2009-2011 Appearing
2 B.Pharm L.M.Collage of Pharmacy,
Gujarat University 2005-2009 66.14
3 12th G.S.H.S.E.B 2005 89.11
4 10th G.S.E.B 2003 87.11
Seminar: Application of the Melt granulation Technology In the stabilization of the Moisture
Sensitive drug Doping and analytical method development for the Prohibited substance
Extra curricular activities:
Attended conference on “IPR for Healthcare SMEs” organised by FICCI and Foundation for MSME clusters
Attended conference on “ Role of the IPR to enhance Business of SMEs” Organised by CII-MSME.
Dissertation Topic:
Design, development and evaluation of the controlled release formulation of the Rosuvastatin Calcium.
The target site for the action of Rosuvastatin Calcium is the Liver. The Aim of the Present Work target absorption of the drug to liver from the gut by the controlling the rate of the release. The rate of the release of the will be achieved by the means of the Matrix tablet. The various parameters for the matrix tablet will be optimized. The Stability study of the Final Optimized Formulation will be carried out.
Instrument Knowledge: Expertise in analyzing and interpreting data from various instruments like
HPLC UV Spectrophotometer Dissolution Test Apparatus DSC
Area of Interest:
Formulation Development Novel Drug Delivery System Regulatory affairs
Personal Details:
Date of birth : 3rd Aug, 1987 Marital status : Unmarried Gender : Male Languages known : English, Hindi, Gujarati Contact no. : +91 9727832882 E-mail : [email protected]
[email protected] Permanent address : Patelvas,
At-Digadi, Ta-Kadi, Dist-Mahesana PIN-382715
I hereby declare that the above written particulars are true to the best of my knowledge and belief.
Date: Vipul B. Patel Place: Ahmedabad
Reference:
Dr. Manju Misra, Ms. Swati Pund M. Pharm., PhD M. Pharm., PhD Assistant Professor
BACK to Previous Page
CURRICULUM VITAE
RRaajjaann SSwwaammii
MM..SS.. ((PPhhaarrmm)),, PPhhaarrmmaacceeuuttiiccss
Present Address: National Institute Of Pharmaceutical Education And Research (NIPER), Ahmedabad c/o – B.V.Patel PERD Centre, S.G.Highway, Thaltej, Ahmedabad, Gujrat Pin - 380054 Permanent Address House No. #1089 Sector 20 B, Chandigarh. Pin – 160020
Career Objective To work in a progressive and competitive environment wherein I can prove my knowledge, abilities and skills to their fullest and at the same time fulfill all responsibilities conferred to me by the organization EDUCATIONAL QUALIFICATIONS
Other Qualification • Successfully completed the distance learning course General Course on Intellectual
Property from “World Intellectual Property Organization (WIPO) Worldwide Academy, Geneva, Switzerland.”
Sr No Year Course Institute/ University % Marks Class
1 2009-10 M.Pharm National Institute of
Pharmaceutical Education And Research(NIPER), Ahmedabad
Appearing -
2 2010-11 P.G.
Diploma In Patents Law
National Academy of Legal Studies And Research
(NALSAR), Hyderabad Appearing -
3 2007-08 B.Pharm Swami Devi Dyal Institute of
Pharmacy, Kurukshetra University
70.89 % First
Dissertation Topic Design and Development of Novel Particle for DNA Delivery Aim: To treat genetic diseases, delivering DNA having proper genetic sequence is a novel task but due to negative charge and large size of DNA, It is very difficult to encapsulate it in negatively charged PLGA, which give it stability towards enzymatic action and help in its sustained release. So the objective behind the work is to enhance encapsulation efficiency of DNA by conjugating it with some cationic polymer like Polyethylenimine(PEI) to decrease the size, stabilize the DNA and giving it positive charge. So that complex can be easily encapsulated inside the PLGA particles. So the primary work is to optimize the proper PEI-DNA particle on the bases of size and then optimizing the formulation parameter require to encapsulate this complex in PLGA, like Conc. of Polymer, Conc. of Stabilizer/Emulsifier, Encapsulation Efficiency, Uptake Efficiency, Expression Level.
Achievement • NIPER JEE 2008 All India Rank 62 • Qualified GATE 2009 • Topped in college in B.Pharmacy • Student representative and cultural secretary in NIPER-A.
Instrument Knowledge
Expertise in analyzing and interpreting data from various instruments like UV Spectrophotometer Dissolution Test Apparatus Zeta Sizer DSC Single Station compression machine
Presentations / Publications
• Paper accepted for poster presentation at 62nd Indian Pharmaceutical Congress 2010, will be held in December, 2010, Manipal, on “Hatch Waxman Act (HWA) and its significant effect on Indian pharmaceutical industries”.
• Review Article published in 6th International Symposium held in November, 2010 Ahmadabad, on “Break in Break Out: Superseding the Barriers In Non Viral Gene Delivery”.
• Paper accepted for poster presentation at 62nd Indian Pharmaceutical Congress 2010, will be held in December, 2010, Manipal, on “Era of “Knowledge Transfer” Symbiotic Relationship between Industries and Academia”.
• Paper accepted for poster presentation at 62nd Indian Pharmaceutical Congress 2010, will be held in December, 2010, Manipal, on “Formulation Development and Statistical Optimization of Elementary Osmotic Pump of Tizanidine Hydrochloride”.
• Presented a poster at 61st Indian Pharmaceutical Congress 2009 held in December, 2009 Ahmedabad, on “Nanotechnology: Current Regulatory Perspective”.
Extra Curricular Activities • Got first prize for presenting a poster at Pharmacy week intercollege poster presentation in
B.Pharmacy on “Alzhiemer’s Disease: Its Pathogenicity and Current pipeline drugs”. • Participated in many declamation contests and won prizes. Area of Interest
Formulation Development Novel Drug Delivery System Intellectual Property Rights Regulatory affairs
Personal Details Date of birth : 15th SEP 1987 Marital status : Unmarried Gender : Male Languages known : English, Hindi, Punjabi Contact no. : +91 9537820345. E-mail : [email protected],
[email protected] Permanent address : House No. 1089, Sector 20-B, Chandigarh Pin-160020 I hereby declare that the above written particulars are true to the best of my knowledge and belief.
Date: Rajan Swami
Reference Dr. Manju Misra Guide & Asst. Profassor NIPER-Ahmedabad Pin Code-380054 Mobile: 09099069333 Email ID: [email protected]
Prof. Harish Padh Guide & Vice Chancellor Sardar Patel University, Vallabh Vidyanagar, Gujarat Mobile No:09924452200 Email ID: [email protected]
BACK to Previous Page
CURRICULUM VITAE
Shah Neha S.
Career Objective: To apply my knowledge and skill in the area of formulation and development of conventional as well as novel drug delivery system. To further improve my capabilities in various dimensions of Pharmaceutical Research.
Area of interest: Formulation and Development of Conventional as well as Novel Drug Delivery System Regulatory Affairs
Educational Qualifications:
*cGPA: Cumulative Grade per Annum
Seminars presented at NIPER Ahmedabad: • Intranasal delivery of liposomes to brain. • Biosimilars: Hope or hype.
Sr. No.
Course Board/ University Year cGPA*/
Percentage Class
1. M.S.(Pharm) NIPER, Ahmedabad Pursuing
8.97*/10 (Up to 2nd Sem) -
2. B.Pharm Gujarat University (Shree Swaminarayan Sanskar
Pharmacy College) 2009
71.42%
Distinction
3. HSC GSHSEB 2005
79.33%
Distinction
4. SSC GSEB 2003 88.43% Distinction
Permanent Address: C/1, New Girdhar Park Soc., Opp., C.N.Vidhyalaya, Ambavadi, Ellisbridge, Ahmedabad- 380006 Contact No. : +91-9537160390
M. S. (Pharm) Dissertation: “Development and evaluation of pulsatile delivery of Valsartan” The aim of my work is to develop an oral formulation that releases valsartan after a certain lag time i.e. in case of hypertensive patients, in early morning hours, to prevent rise in BP seen during this period which is the major cause of various cardiovascular events. Such a lag time will be achieved by coating the core tablet using various polymers. My work includes optimization of the core tablet formula, use of various coating techniques (like pan and compression coating) and polymers to achieve burst release after required lag time and comparison amongst these methods. I will also subject my final formulation for stability studies as recommended. Professional Capabilities:
• Knowledge about formulation development of conventional & novel drug delivery systems.
• Creative skills in the design of scientific experiments and interpretation of results. • Well acquainted with different instruments used in formulation development and
its evaluation. • Knowledge about IPR.
Academic Achievements: • Successfully completed distance learning course on IPR by WIPO, 2009 • Secured All India Rank 68th in NIPER-JEE, 2009 • Qualified GATE 2009 conducted by IIT Roorkee with a score of 98.8 percentile • B.Pharm : 1st Year- University 2nd rank
2nd Year- University 9th rank 3rd Year- University 5th rank
Conference/Workshop: • Attended 6th International symposium on “Advancement In Pharmaceutical
Sciences And Technology” held at B.V. Patel PERD Centre, Ahmedabad in November-2010
• Workshop on “IPR for Healthcare SMEs” organized by FICCI & foundation for MSME clusters at Ahmedabad in February, 2010
Industrial Training:
• 3 months training at Texas Laboratories, Mehsana, Gujarat
Extracurricular Activities:
• Runner-up in Badminton (Singles) at 1st State Level Inter Pharmacy College Sports Competition, organised by Shri Sarvajanik Pharmacy College, Mehsana, 2008.
• Winner in Badminton (Doubles) held at the college level, 2009 • Active participation in various events organised at the institute level
Personal Details:
Full Name : Shah Neha Surendra Date of Birth : 5th May, 1988 Gender : Female Marital Status : Single Languages known : English, Gujarati, Hindi, Marathi Contact No. : +91-9537160390 Email-id : [email protected]
I, hereby, declare that the details written above are authentic to the best of my knowledge and belief. Date: Shah Neha Surendra References:
Dr. Manju Misra Assistant Professor, NIPER- Ahmedabad. [email protected]
Dr. Uttamkumar Mandal Assistant Professor, NIPER - Ahmedabad. [email protected]
BACK to Previous Page
RM P
NR
P E
Career
Tgrsk
Area of
• F• R
Educat
*cGPA: Academ
• S• S• Q
2
Sr. No.
C
1. M.SPhar
2. B
3.
4.
Ravi S.M.S. (Pharm
Permanen113/B NemiNear, VadigRanip, AhmGujarat, IndPhone No. :
: Email ID: r
ObjectiveTo apply myrowth of Orkills can be b
f Interest: ormulation &
Regulatory af
tional Qua
Cumulative
mic Achievuccessfully ecured all In
Qualified GA008 conduct
Course
S. (Pharm.) rmaceutics
B.Pharm
HSC
SSC
. Sutham.), Pharma
t Address inath Society
gam Society,medabad – 38dia
(M) +91-96(R) +79 -27avi5pharmac
e: y knowledgrganization; best utilized
& Developmffairs
alifications
e Grade per
vements: completed d
ndia rank 67ATE 2009 cted by IIS- B
N
Gujarat UPharmac
Adalaj
ar aceutics
y, Shak Marke
82 480
624913292 7522698 cist@gmail.
e and skillsas well astowards ach
ment of Nove
s:
r Annum
distance learnth in NIPER-
conducted byBangalore wi
Board/ Uni
NIPER- Ahm
University (Acy & Bio- Raj, Gandhinag
GSHE
GSEB
et,
com
s in Formulseeking ch
hieving Orga
el and conve
ning course -JEE, 2009.y IIT-Roorkith a score o
iversity
medabad
Arihant Schoesearch Cengar, Gujarat
EB
B
ll C
lation & Deallenging enanizational g
entional Drug
on IPR by W
kee with 99f 96.97 perc
Ju
(E
ool of ntre, .)
Jun
Ma
Ma
Curriculu
evelopment,nvironment goals.
g delivery Sy
WIPO, 2009.
.03 percenticentile.
Year
une, 2011
Expected)
ne, 2009
arch, 2005
arch, 2003
um Vitae
for superiowhere in m
ystems,
.
ile & GATE
cGPA*Percenta
7.6/10(Up to 2Semeste
64.64%
67.55%
78.14%
ll
or my
E-
*/ age 0 2nd
er)
%
%
%
Professional Expertise: • Knowledge about formulation development of conventional & Novel drug delivery
systems. • Creative skills in the design of scientific experiments and interpretation of results. • Awareness about the basics of various instruments such as UV spectrophotometer,
HPLC, Dissolution Tester, Tablet punching machines (Single punch, Rotary Tablet punching machine, Bilayer Rotary tablet machine) which are required for development & evaluation of formulation.
• Computer proficiency in using MS office, Statistical packages like Sigma-stat, GraphPad Prism.
• Scientific Information retrieval using search engines such as Pubmed, Science direct, etc. and patent databases search.
M. S. Pharm. Dissertation: “Development and Evaluation of Extended Release, Non-Infringing Formulation of Alfuzosin hydrochloride” In my research work, I am developing Non-Infringing ER formulation of Alfuzosin HCl with an aim to increase patient convenience, decreasing side effects and which can be used as Para-IV candidate. For this work two approaches have been selected, floating Matrix bilayer tablet and floating osmotic bilayer tablet. Similarity factor will be calculated of optimised formulation with Innovators’ formulation of Alfuzosin HCl (UROXATRAL-ER). Stability study will be done on Optimised formulation. The developed technology can then be handed over to industry for commercialization. Industrial Training:
• 3 months training at Shantam Pharmaceuticals Pvt. Ltd., Rakanpur, Kalol, Gandhinagar-382 721, Gujarat, India.
Publications:
• Presented Nano-Technology Based Model entitled as “Nanobubble: An emerging transfection vector for lung diseases” in Myriad-The clusters of events held at Gujarat Forensic Science University on 29th November 2010, Gandhinagar, Gujarat.
• Review article entitled as “Challenges in ophthalmic drug delivery: Current scenario” published in Souvenir of 6th International Symposium organized by B.V. Patel PERD Centre, Ahmedabad during 26th -28th Nov, 2010.
Conference/Workshop attended: • 6th International symposium on “Advancement in Pharmaceutical Sciences and
Technology” held at B.V. Patel PERD Centre, Ahmedabad on 26th – 28th Nov, 2010. • 3 day workshop on “IPR for Healthcare SMEs” organized by FICCI & foundation
for MSME clusters at Ahmedabad on 18th - 20th March, 2010. • One day Conference on “Future of Pharmacist in India and Abroad” organized
by Arihant school of Pharmacy & Bio Research Institute -Adalaj, in Association with IPA, Gujarat Branch held on 23rd February,2009.
Seminar presented: • Positron Emission Tomography-An Imaging Technique, March 2010. • Pulsatile drug delivery system, Aug 2009.
Extracurricular Activities: • Winner in Volleyball Tournament- 2006 held at college level, 2006. • Active participation in various events organized at the institute level.
Personal Information: Full Name : Ravi Suresh Suthar Date of Birth : 5th April, 1988 Marital status : Single Gender : Male Languages known : English, Hindi, Gujarati Hobbies : Cricket
I hereby declare that the above written particulars are true to the best of my knowledge and belief.
Date: Place:Ahmedabad Ravi S. Suthar
1) Dr. Manju Misra 2) Dr. Uttamkumar Mandal Assistant professor, Assistant Professor,
NIPER - Ahmedabad. NIPER - Ahmedabad. Email : [email protected] Email : [email protected]
BACK to Previous Page